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1. ABSTRACT 
 
 
Compared to other expression platforms, plants present several advantages for the expression of 
recombinant molecules represented by the ability to assemble complex multimeric proteins such as 
antibodies, the possibility to achieve post-translational modifications similar to those found in 
mammalian cells, low management costs and ease of scalability. Despite these evident advantages, 
some drawbacks need to be addressed.  
One of the factors limiting plant expression systems is the downstream purification in which many 
elements could influence the effectiveness of the purification, such as low antibody concentration, 
extraction methodologies and purification strategy. Another important issue is represented by the 
plant typical glycosylation patterns. In fact, a major drawback in the application of plant-derived 
immunoglobulins for human therapy is indeed represented by differences between sugar moieties 
harbored by proteins expressed in plants and mammals. The presence of typical plant sugars has 
been demonstrated capable of inducing immunogenic responses in humans, leading also to a 
remarkable reduction of pharmacokinetic properties and biological activity of plant derived 
proteins. An additional drawback of recombinant antibodies obtained from plants is represented by 
the final yield that can be, in some cases, reduced by unintended proteolytic processees taking place 
in the plant cell. Particularly, in the case of antibody overexpression degradation may account for 
up to ninety percent reduction of the final purified product. 
In this work, we describe the expression of the human recombinant tumour targeting mAb H10 in 
Nicotiana benthamiana using a transient expression system based on vacuum agroinfiltration, 
focusing our research efforts on optimizing expression and purification strategies, glycosylation 
profile and in planta proteolysis follow-up. The optimization of the extraction/purification steps 
was carried out evaluating different strategies in terms of antibody yield, degradation and level of 
contaminants in the final purified product. We optimized a pilot-scale purification method, using a 
two-step purification protocol starting from 250 g of fresh agroinfiltrated leaves, achieving an 
average yield of 40 mg per Kg fresh weight of intact IgG at a purity of > 99.4%, with endotoxin 
levels < 1 EU/ml, clearly free of any phenolic, alkaloid compounds. In addition, the glycosylation 
pattern of the plant produced mAb H10 was modulated evaluating the effects of the different glycan 
moyeties on antibody quality and final yield. Results suggest that, among all factors contributing to 
protein stability, glycosylation might play an important role. Finally, we characterised the 
degradation profile of the tumour targeting H10 antibody, identifying specific proteolytic cleavage 
sites of the plant produced immunoglobulin localized in the three inter-domain regions of the H10 
heavy chain. Moreover, based on a bioinformatics analysis, three proteolytic enzymes were 
identified, as belonging to the cystein proteases family. Overall data indicate that possible ‘fragile’ 
sites in the H10 antibody reside in the hinge region, particularly prone to cleavage by the plant 
protease machinery. The identification of these cleavage sequences is a first step towards the 
development of new strategies to reduce antibody degradation in plants and to increase the yield of 
intact IgG molecules.  
 
2. INTRODUCTION 
 
 
- 2 - 
 
 
 
 
 
 
 
 
 
2. INTRODUCTION 
2. INTRODUCTION 
 
 
- 3 - 
2.1 Heterologous expression systems for the production of 
biopharmaceuticals 
 
During the past decade the need for high quantities of correctly folded, pure and biologically active 
proteins for both applied biological research and medicine has increased constantly. 
Biopharmaceuticals based on recombinant proteins (antibodies, vaccines, antigens, hormones) are 
used in research diagnostic and in current medicines and have reached about 10 % of the 
pharmaceutical market value in 2007 (Lowe and Jones, 2007). With fast-growing demand of 
recombinant biopharmaceuticals, the capacity of the current production systems (yeast, microbes, 
animals cells and transgenic animals) is often not sufficient to respond to the market requirements 
(Obembe et al., 2011). Therefore, it is crucial to increase the manufacturing capacity of 
heterologous proteins to satisfy the existing request.  
There are several examples of molecules expressed using different hosts, these include monoclonal 
antibodies as anti-tumour agents, enzymes or hormones for replacement therapies, cytokines and 
growth factors for in vivo or in vitro systems, antigens for anticancer treatments, and vaccines 
against infectious diseases. The main heterologous expression systems used to produce recombinant 
proteins are based on bacteria, yeast, insect and mammalian cells (Demain et al., 2009). Not all 
systems are able to yield a final product with the required characteristics in terms of biological 
functionality. In fact, biochemical modifications occurring in the cell (formation of disulfide bonds, 
glycosylation, proteolytic cleavage, phosphorylation, acetylation, myristylation), generically 
referred to as post-translational modifications, are essential for the synthesis of correctly folded and 
bioactive proteins (Pogue et al., 2011). The most used organisms for heterologous protein 
production are bacteria such as Escherichia coli and the gram-positive Bacilli strains. These 
recombinant protein expression systems are widely used in laboratory practices because of their 
high growth rate on inexpensive substrates (Saida, 2007). Moreover, these organisms present a well 
characterized genome, easy to manipulate with a large number of cloning vectors and mutant strains 
available. However, bacterial systems have also several drawbacks. Prokaryotic cells are not able to 
perform most post-translational modifications necessary for the correct assembly and functionality 
of many complex mammalian proteins (Terpe, 2006). In particular, the production of proteins with 
disulfide bonds is difficult to achieve since bacteria lack most of the enzymatic machinery for this 
post-translational modification, often leading to the formation of inclusion bodies. Besides, bacterial 
systems produce proteins lacking glycosylation, which is often required for biological activity of 
some classes of molecules (Li, 2011).  
2. INTRODUCTION 
 
 
- 4 - 
For this reason, yeasts are often used to express heterologous proteins that require glycosylation or 
disulfide bond formation for their correct folding and function (De Pourcq et al., 2010). Yeast 
combines the advantages of bacterial systems, such as rapid growth, scalability, reduced media cost 
and relative ease of genetic manipulation, with its capacity to perform typical eucaryotic post-
translational modifications (Gasser et al., 2006). Saccharomyces cerevisiae is the most important 
host used for the expression of recombinant proteins (Sleep et al., 1991), but it is gradually replaced 
by methylotrophic yeasts, in particular Pichia pastoris, for their capacity to grow in high cell 
density fermentations, without the risk of accumulation of toxic levels of ethanol (Jeong et al., 
2011). However, also yeast has several disadvantages primarily due to undesirable post-
translational modifications which are different from those performed by mammalian cells. One of 
the  post-translational modification which could affect the quality of protein products produced in 
these microorganisms, is represented by glycosylation. In fact, it has been shown that yeasts, in 
many cases, could produce an over-glycosylation of N-linked sugar chains, leading sometimes to 
the production of recombinant proteins with impaired biological activity. Besides, the presence of 
these sugars may cause also immunogenicity problems if the protein is used for human therapy 
(Demain et al., 2009). Another efficient strategy for the expression of recombinant proteins is 
represented by insect cells. The most important expression system is based on baculovirus 
expression vectors. Baculoviruses are a rod-shaped double strand DNA viruses able to infect insect 
cells. These viruses are able to direct the production of proteins at high levels in insect cells and this 
natural ability has been exploited to create recombinant expression vectors. The most commonly 
used vectors are derived from the nuclear polyhedrosis virus Autographa californica that naturally 
contains a circular double-stranded DNA. This virus is a common pathogen of lepidopterans, and 
can infect and replicate in cell suspensions of the fall armyworm Spodoptera frugiperda (Hitchman 
et al., 2009). The baculovirus expression system is capable of post-translational modifications 
similar to those occurring in mammalian cells, including phosphorylation, N- and O-glycosylation, 
correct cleavage of the signal peptide, acylation, myristoylation, carboxymethylation (Luckow and 
Summers, 1988). The possibility to clone the gene of interest under the control of the strong viral 
polyhedrin promoter, can produce high levels of recombinant proteins with reported yields of up to 
30 % of total soluble proteins (TSP) (Morrow, 2007). However, also insect cell systems show some 
limitations such as the need to verify case by case the specific patterns of post-translational 
processing, the improper folding of some recombinant proteins and some differences in the N-
linked glycosylation patterns compared to their mammalian counterpart.  
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Production of proteins requiring specific mammalian post-translational modifications is usually 
performed in mammalian expression systems that ensure correct glycosylation, folding, fatty acid 
chain addition and phosphorylation (Griffin et al., 2007). The first biopharmaceuticals produced in 
mammalian cell cultures have been the tissue plasminogen activator (tPA) and erythropoietin (EPO) 
in the 1980s (Swartz, 1996). Among the cell types commonly used for protein expression, such as 
NS0 murine myeloma cells (Andersen and Krummen, 2002), baby hamster kidney cells (BHK), 
green monkey kidney cells (Wrotnowski, 1998) and human hembryonic kidney cells (HEK), the 
most employed are the chinese camster ovary cells (CHO). The expression yield of recombinant 
proteins in mammalian cells has dramatically increased in the last decades principally due to 
improvements in the in vitro cultural conditions (Aldridge, 2006). There are several examples of 
high yield production of recombinant proteins using this cell system and at industrial scale protein 
titers have even reached levels of 10 g/L (Ryll, 2008). A new expression platform is represented by 
the human cell line PER.C6 that was reported to produce up to 26 g/L of a monoclonal antibody 
(Jarvis, 2008). Despite high yields obtained in mammalian cells, this expression system requires 
high culture costs and time-consuming maintenance, with the need of complex processing 
techniques coupled by a high risk of contamination by human pathogens (Pogue et al., 2002).  
An alternative production system for the expression of recombinant proteins, is based on the use of 
transgenic animals. Initially designed with the aim of improving the characteristics of the breed, 
genetically modified (GM) animals have proved suitable for large-scale production of recombinant 
proteins in milk, blood and eggs (Houdebine et al., 2009). The main disadvantage of this strategy is 
linked to high costs and time consuming procedure to obtain transgenic animals as well as the risks 
associated to contamination of the final product with human pathogens (Sands et al., 2003). A 
summary of the features of the previously described expression systems is reported in Table 1. 
 
Table 1: Comparison between heterologous protein expression systems. The table reports the main features of each 
expression systems in terms of growth, costs, expression levels and post translational modifications (adapted from Yin 
et al., 2007).  
 
Host system  Cell 
growth  
Cost of 
medium  
Expres-
sion 
levels 
Post-translational modifications 
Protein 
folding 
N-linked 
glycosyla-
tion 
O-linked 
glycosyla-
tion 
Phospho-
rylation 
Acetyla-
tion 
Acylatio
n 
E. coli  Rapid 
30min 
Low High Refolding 
usually 
required 
None No No No No 
Yeast Rapid 
90min 
Low Low-
High 
Refolding 
may be 
required 
High 
mannose 
(mostly) 
Yes Yes Yes Yes 
Insect     
Cells 
Slow 
18–24h 
High Low-
High  
Proper folding Simple, no 
sialic acid 
Yes Yes Yes Yes 
Mammalian  
Cells 
Slow 
24 h 
High Moderate Proper folding Yes Yes Yes Yes Yes 
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2.2 Production of biopharmaceutical proteins in plants 
 
Genetic modification of plants has been extensively used in the last 30 years for the expression of 
heterologous proteins, transforming plants into “biofactories” of biopharmaceutical products. The 
first examples of expression of therapeutic proteins in plants were the Human Serum Albumin 
(HAS) produced in tobacco and potato (Sijmons et al., 1990) and a monoclonal antibody expressed 
in tobacco leaves (Hiatt et al., 1989). These pioneering studies were the premises to the 
development of a new biotech area known as “molecular farming”. This term generally  refers to 
the production of valuable recombinant proteins in plants (Schillberg et al., 2003). The capacity of 
plant cells to synthesize, process and target large complex mammalian proteins in a similar manner 
to their natural hosts makes them an attractive alternative system for the expression of heterologous 
proteins. Moreover, plants offer the possibility to produce proteins at lower costs compared to 
mammalian cell based bioreactor systems and their well established technologies for processing and 
harvesting favor the production scale-up of heterologous proteins in many crops (Mett et al., 2008). 
Different plant species have been used for the production of biopharmaceutical proteins in leaves 
and fruits (such as tobacco, tomato, alfalfa and lettuce) (Twyman et al., 2003), tubers (potato) or in 
seeds, including cereals (rice, wheat and maize) and legumes (pea and soybean) (Table 2) (Stoeger 
et al., 2000). Several crucial factors need to be considered when choosing a production crop 
including biomass yield per hectare, yield of recombinant protein per unit of biomass, ease of 
transformation, and scalability. An alternative expression platform to the use of transgenic plants is 
represented by plant cell suspensions. Plant cell cultures are commonly used for the production of 
small molecule drugs, but they are proving also advantageous in ‘molecular farming’ for the high-
level of containment and the possibility of producing proteins under current good manufacturing 
practice (cGMP) conditions. Interesting examples are represented by the BY-2 tobacco cells, carrot 
cell cultures and the moss Physcomitrella patens. The latter perfectly suits the requirements for the 
production of complex biopharmaceuticals. In fact, this eukaryotic system offers an outstanding 
genetic accessibility and proteins can be produced safely in scalable photobioreactors without the 
need animal-derived medium compounds (Büttner-Mainik et al., 2011).  
Biosafety issues and public acceptance are essential concerns for the successful use of plants to 
produce biopharmaceuticals. During the last years, it has become clear that transgenic food and feed 
plants producing biopharmaceuticals present a certain risk of spreading transgenes to wild type 
edible species increasing the possibility to contaminate food chain with unwanted heterologous 
products. Therefore, in the last years much effort has been focused on the use of non-food plants in 
molecular farming. Among the species used for heterologous protein expression, Nicotiana tabacum 
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is certainly the most used and best characterized (Ma et al., 1995). There are several advantages in 
the use of tobacco such as genetic manipulation, prolific seed production, high biomass yield and 
the existence of a well estabilished large-scale processing infrastructure (Ma et al., 2003). 
 
Table 2: Some of the plant expression hosts used for biopharmaceutical production (adapted from Fisher et al., 2004). 
Species Advantages Disadvantages 
Model plants 
Arabidopsis thaliana  
 
 
Range of available mutants, 
accessible genetics, ease of 
transformation 
 
Not useful for commercial 
production (low biomass) 
Simple plants 
Physcomitrella patens, 
Chlamydomonas reinhardtii, 
Lemna minor 
 
Containment, clonal propagation, 
secretion into medium, regulatory 
compliance, homologous 
recombination in Physcomitrella 
 
Scalability 
Leafy crops 
Tobacco  
 
High yield, established 
transformation and expression 
technology, rapid scale-up, non-
food/feed 
 
Low protein stability in harvested 
material, presence of alkaloids 
Alfalfa, clover  High yield, useful for animal 
vaccines, clonal propagation, 
homogenous N-glycans (alfalfa) 
Low protein stability in harvested 
material, presence of oxalic acid 
Lettuce Edible, useful for human vaccines Low protein stability in harvested 
material 
Cereals  
Maize, rice  
 
Protein stability during storage, 
high yield, easy to transform and 
manipulate 
 
Wheat, barley  Protein stability during storage Low yields, difficult to transform 
and manipulate 
Legumes 
Soybean  
 
Economical, high biomass, 
expression in seed coat 
 
Low expression levels, difficult to 
transform and manipulate 
Pea, pigeon pea  High protein content Low expression levels 
Fruits and vegetables 
Potato, carrot  
 
Edible, proteins stable in storage 
tissues 
 
Potato needs to be cooked 
Tomato  Edible, containment in 
greenhouses 
More expensive to grow, must be 
chilled after harvest 
 
Another successful non-food plant used for the expression of high levels of recombinant proteins is 
represented by Nicotiana benthamiana especially used in transient expression systems. Despite its 
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reduced biomass, this plant is very suitable for large scale heterologous protein production due to its 
rapid growth and ease of manipulation (Marillonnet et al., 2005) (Figure 1). 
 
  
 
Figure 1: Nicotiana tabacum left picture; Nicotiana benthamiana right picture 
 
An important advantage in the expression of proteins in plant is represented by the possibility to 
direct the molecules to a specific tissue or cell compartment using tissue specific promoters and 
signal peptides respectively. This allows the identification of optimal expression strategies in order 
to ensure high stability, high yields, and ease of purification. 
For a certain class of proteins the Endoplasmic Reticulum (ER) represents the ideal cell 
compartment. The low concentration of proteases, the presence of numerous chaperones and the 
oxidizing environment for protein folding and disulfide bond formation, ensures a correct protein 
conformation (Petruccelli et al., 2006). ER retention, obtained by the addition of a signal peptide to 
the recombinant protein has been shown to increase the accumulation levels of many recombinant 
molecules (Pogue et al., 2010). In addition, retention in this cell compartment avoids the addition to 
the recombinant protein of typical plant sugars, favoring the formation of a “human like” 
glycosylation profile. In fact, it has been demonstrated that the presence of typical plant sugars 
attached the recombinant protein could induce, in some cases, adverse effects in human 
administration, reducing the therapeutic value of the final product (Gomord et al., 2010).  
A further advantage of plant expression is related to the safety of the final product. In fact, while the 
use of mammalian cell cultures involves the risk of contamination by pathogens harmful to human 
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health, plant expression systems minimize the presence of human pathogens and guarantee high 
safety in their use (Pogue et al., 2010). 
Two main strategies are used to express proteins in plants based either on stable genetic 
transformation or on transient expression technologies. 
 
2.3 Stable transformation 
 
Stable genetic transformation of plants allows to insert a gene, coding for a protein of interest, in the 
nuclear or chloroplast genome. The heterologous gene, inserted in the genome of the plant becomes 
an hereditary character. The stable transformation has been achieved using two main strategies 
represented by the Agrobacterium tumefaciens-mediated transformation and the “gene gun” 
technology (Pogue et al., 2002). 
Attenuated and engineered A. tumefaciens is the most generally used organism to transform a 
variety of dicots and some monocots (Lessard et al., 2002). This soil borne bacterium has the 
natural capability to integrate a fragment of DNA (T-DNA contained in the Ti plasmid) in the 
genome of host cells (Escobar and Dandekar, 2003). Exploiting this innate capacity of the 
bacterium, it is possible to replace the DNA sequence between the left and right border of the T-
DNA segment with sequences of interest, without affecting its transformation ability (Lorence and 
Verpoorte, 2004) (Figure 2). In this way the gene coding for a protein of interest can be inserted in 
the nuclear genome leading to the expression of the protein of interest.  
 
 
 
Figure 2: Agrobacterium tumefaciens infection mechanism. A tumefaciens transfers a copy of T-DNA to the plant 
nucleus making possible the expression of the protein of interest. (From http://www.plantsci.cam.ac.uk) 
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This method has excellent advantages such as ease of manipulation, high efficiency of insertion and 
possibility to transfer long DNA sequences (Krishnamohan et al., 2001). The extensive use of 
procedures for the Agrobacterium-mediated transformation of tobacco leaf disks have made the 
regeneration of transgenic tobacco lines a routine laboratory procedure (Horsch et al., 1986). 
The main limitation of the stable transformation mediated by A. tumefaciens is the narrow host 
spectrum of this plant pathogen that does not include plants of commercial interest such as cereals. 
For these plants, the transformation of the nuclear genome can be obtained using the “gene gun” 
technology which involves the bombardment of the tissue to be transformed with microparticles of 
inert metal (gold or tungsten) to which the DNA sequence of interest is adsorbed. Once in the plant 
cell, DNA is released from the surface of the microparticles and occasionally transferred and 
integrated into the genome (Predajňa et al., 2010).  
One of the main problems associated with the stable transformation mediated by A. tumefaciens or 
gene gun is related to the randomness with which the transgene integrates into the host genome. In 
fact, integration could take place in non transcriptional regions of the genome, leading to low 
expression levels of the heterologous protein.  
An alternative method for stable transformation of plants is based on 
the integration of the exogenous gene in the chloroplast genome 
(Cardi et al., 2010). The transformation of this organelle can be 
achieved delivering the heterologous DNA by the use of the gene gun 
technology. After the integration in the chloroplast genome, due to 
the polyploid nature of plastids, the primary regenerants are usually 
in a heteroplasmic state containing a mixed population of wild-type 
and transformed plastids. The homoplasmic state (in which every 
chloroplast carries the transgene), with a homogeneous population of 
transformed plastids, is achieved after a sufficient number of cell 
divisions under high selective pressure (Scotti et al., 2011). This 
organelle is particularly attractive for the expression of recombinant proteins, not only because of 
its ease of manipulation, but also because of the high transcriptional capability due to the large 
number of copies present in each cell (each plant cell contains from 50 to 100 chloroplasts). In fact, 
it has been shown that chloroplast transformation allows expression levels of up to 46 % of the total 
soluble proteins (TSP) in the case of the insecticidal protein Cry B, leading to the folding of 
cuboidal protein crystals in the chloroplast lumen (De Cosa et al., 2001; Petersen and Bock, 2011) 
(Figure 3).  
 
Figure 3: Electron micrograph 
showing the presence of the 
insecticidal protein Cry2Aa2 form 
Bacillus thuringiensis (Bt) Cry 
folded into cuboidal crystals in 
the chloroplast lumen (De Cosa et 
al., 2001). 
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Table 3: Overview of the immunotherapeutic molecules and enzymes recently produced in plant chloroplasts (From 
Scotti et al., 2011). 
Protein  Source of transgene Plant species Protein level References 
p24-Nef HIV-1 Tobacco 40 % TSP Zhou et al., 2008 
Pr55 gag  HIV-1 Tobacco 7–8 % TSP Scotti et al., 2009 
p24 
 
HIV-1 Tobacco (Maryland 
Mammoth) 
4.5 % TSP McCabe et al., 2008 
L1-2xCysM 
(Mutated L1) 
 
HPV-16 Tobacco 1.5 % TSP Waheed et al., 2011 
E7-CP   HPV-16 Tobacco 0.5 % TSP Morgenfeld, 2009 
F1-V  Yersinia pestis Tobacco 14.8 % TSP Arlen et al., 2008 
VP-βGUS  Footh-and-mouth 
disease virus 
Tobacco 51 % TSP Lentz et al., 2010 
CTB-AMA1  Vibrio cholerae-
Plasmodium 
falciparum 
 
Tobacco 
Lettuce  
13.2 % TSP 
7.3 % TSP 
Davoodi-Semiromi 
et al., 2010 
CTB-MSP1   Vibrio cholerae- 
Plasmodium. 
falciparum 
Tobacco 
Lettuce  
10.1 % TSP 
6.1 % TSP 
Davoodi-Semiromi 
et al., 2010 
LTB-STa  Escherichia coli Tobacco 2.3 % TSP Rosales-Mendoza et 
al., 2009 
 
    
CTB-proinsulin  Human Tobacco 47 % TSP Boyhan and Daniell, 
2010 
Insulin like growth 
factor-1 
Human Tobacco 32.7 % TSP Daniell et al., 2009a 
Cardiotrophin-1   Human Tobacco 4.8 % TSP Farran et al., 2008 
t1:9 Aprotinine Bovine Tobacco 0.5 % TSP Tissot et al., 2008 
 
t1:10 Alpha1-
antitrypsine 
Human Tobacco 2 % TSP Nadai et al., 2009 
 
t1:11 CTB-F.IX 
(Coagulation factor IX) 
Human Tobacco 3.8 % TSP Verma et al., 2010 
t1:12 Thioredoxin 1 Human Lettuce 1 % TSP Lim et al., 2011 
 
    
Endo-β-1,4-glucanase 
E1 catalytic domain  
Acidothermus 
celluloyticus 
Tobacco 12 % TSP Ziegelhoffer et al., 
2009 
Endoglucanase Cel6A Thermobifida fusca  
 
Tobacco 10.7 % TSP Gray et al., 2009 
1-Deoxy-D-xylulose 
reductoisomerase 
 
Synechosystis sp. Strain 
PCC6803 
Tobacco 7.4 % total stroma 
protein 
 
Hasunuma et al., 
2008 
 
∆9 desaturase  
 
Solanum commersonii 
and Anacystis 
nidulans 
 
Tobacco NR Craig et al., 2008 
 
L-aspartate-α-
decarboxylase  
 
 
Escherichia coli Tobacco NR Fouad and Altpeter, 
2009 
 
Chitinase BjCHl1  
 
Brassica juncea Tobacco NR Guan et al., 2008 
β-glucosidase BglC  Termobifida  fusca Tobacco 12 % TSP Gray et al., 2011 
NR: Non Reported, TSP: Total Soluble Proteins 
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Despite the advantages in terms of expression levels, the chloroplast lacks enzymes responsible of 
the post-translational modifications which are necessary for the expression of active mammalian 
proteins. Furthermore, another drawback of this strategy is represented by the time-consuming 
processes needed to achieve the plant homoplastomic chloroplast transformation. A summary of 
immunotherapeutic molecules and enzymes recently produced in plant chloroplasts is reported in 
Table 3. 
Another interesting methodology for the expression of recombinant proteins is based on genetic 
engineering of plant cell suspension cultures to be used in bioreactor based systems. The advantages 
of this system are both the possibility to guarantee the expression of proteins in sterile conditions 
coupled with a high-level of containment and the cost-effective downstream processing and 
purification given by the absence of many plant cell structural elements (Franconi et al., 2010). In 
addition, this technology is quite fast since stable cell lines can be generated in two-three months 
(Shaaltiel et al., 2007; Aviezer et al., 2009 ). Plant as N. tabacum, N. benthamiana, carrot, rice cell 
cultures, the aquatic plant Lemna minor (duckweed) and the moss Physcomitrella patens, have been 
considered for the expression of several biopharmaceuticals that need contained growth conditions.  
Examples of the production of recombinant proteins in bioreactors include the use of tobacco cell 
cultures to produce the veterinary Newcastle virus vaccine (Miller et al., 2009) and the carrot cells 
for the expression of the high-value therapeutic protein glucocerebrosidase (Aviezer et al., 2009) 
which is in fast track for U.S. FDA approval (Xu et al., 2011). Nevertheless, the production of 
heterologous proteins using this system presents several disadvantages such as difficulties in protein 
recovery and purification, low accumulation levels (10–250 mg/L) of secreted products, plant 
typical glycosylation profile of produced molecules, degradation phenomena of proteins secreted in 
the media (Hellwig et al., 2004) and higher costs in comparison to open-field and green house 
management. Some examples of proteins expressed in plant cell suspension cultures are reported in 
Table 4. 
An alternative to the use of plant cell suspensions is represented by the natural rhizosecretion 
mechanism of the plant, characterized by the release of proteins from roots (Drake et al., 2009). 
Plants rhizosecrete several molecules involved in many plant physiological mechanisms such as 
nodulation, mycorrhizal colonization, growth inhibition of neighbouring plants, acquisition of 
nutrients from soil and in defense against toxic metals (Gleba et al., 1999).  
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Table 4: Example of recombinant proteins expressed in seeds, leaves or suspension cultures (Adapted from Wilken et 
al., 2011). 
FW, Fresh Weight; DW, Dry Weight; NR, not reported; TSP, total soluble protein. 
 
 
Platform  Recombinant protein Application  Product 
concentration 
Reference 
Corn seed  Aprotinin Protease inhibitor 0.7 µg/mL TSP Azzoni et al., 
2002 
Corn seed (defatted germ) Collagen  120 mg/kg DW  Zhang et al., 
2009 
Corn seed  IgG (2 G12) Anti-HIV 75 mg/kg DW  Ramessar et al., 
2008 
Rapeseed  Chymosin  Industrial / food 
enzyme 
4.2 % TSP (47 
mg/kg FW)  
Van Rooijen et 
al., 2008 
Rice seed  Human lysozyme  Gastrointestinal 
infections, formula 
and cell culture 
4.4 mg/g FW (3.3 
mg/g FW for 
selected extraction 
conditions) 
Wilken and 
Nikolov, 2006 
Rice seed  Human lactoferrin Gastrointestinal 
infections, formula 
and cell culture 
6 mg/g FW (4.2 
mg/g FW for 
selected extraction 
conditions) 
Nandi et al., 
2005 
Tobacco leaves  Aprotinin Protease inhibitor ~750 mg/kg FW 
(greenhouse), 
~300 mg/kg FW 
(open field) 
Pogue et al., 
2010 
Tobacco leaves  β-Glucuronidase Model protein 1.4 mg/mL TSP  Holler and 
Zhang, 2008 
Tobacco leaves Influenza virus like 
particles (H5-VLP) 
 
Avian influenza 
vaccine (A/H5N1) 
NR  D'Aoust et al., 
2010 
Tobacco leaves IgG (patient 69) Idiotype vaccines 
for non-Hodgkin's 
lymphoma 
1.5 g/kg FW  Bendandi et al., 
2010 
Tobacco leaves  IgG  Anti WNV 0.8 g/kg FW  Lai et al., 2010 
Tobacco leaves  IgG (H10) anti tenascin C 600 mg/kg FW Lombardi et al., 
2010 
Carrot suspension 
cell culture 
Glucocerebrosidase 
(intracellular) 
Gaucher's disease NR  Shaaltiel et al., 
2007 
Lemna fronds  IgG1 (anti-CD 30) Non-Hodgkin's 
lymphoma and 
anaplastic large-cell 
2 % of TSP  Cox et al., 2006, 
Nikolov et al., 
2009 
Lemna fronds IgG1 (CNTD) NA 50 % of TSP at pH 
4.5; 
10 % TSP at pH 
7.5 
Woodard et al., 
2009 
Tobacco 
suspension 
cell culture 
Anti-rabies mAb 
(intracellular) 
 
Human anti-rabies 
virus mAb for 
treatment 
3–10 mg/Kg leaf 
FW  
Girard et al., 
2006 
Tobacco 
suspension 
cell culture 
Anti-rabies mAb 
(intracellular) 
 
Human anti-rabies 
virus mAb for 
treatment 
250 mg/Kg FW Girard et al., 
2006 
Tobacco 
suspension 
cell culture 
GFP-fusion protein 
(intracellular) 
 
Reporter tag 10.7 mg TSP  Peckham et al., 
2006 
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Many studies have been carried out showing the high capability of transgenic N. tabacum plants to 
rhyzosecrete different recombinant proteins such as green fluorescent protein (GFP), bacterial 
xylanase, human placental alkaline phosphatase (SEAP), monoclonal murine IgG1 antibody Guy’s 
13 and the cyanobacteria anti HIV-1 Microcystin protein (Drake et al., 2003, Drake et al., 2009).  
All the secreted proteins showed conserved biological functionality and accumulated in higher 
amounts in the medium than in the root tissue. One of the advantages offered by this strategy is 
represented by the possibility to produce the protein of interest in a controlled environment with 
low levels of plant contaminants and a low concentration of proteases.  
The reduced concentration of plant contaminants (e.g. poliphenols, alkaloids) in the culture medium 
reduces the difficulty of the downstream purification processes, favoring the purification of a high 
quality final product. Although rhizosecretion remains a promising platform for the expression of 
recombinant proteins, the main disadvantage of this technology is represented by the relatively low 
yields of recombinant proteins. Various strategies have been used to increase the production yield, 
the most successful is represented by the exposure of roots to plant growth regulators which 
increases  secretion of the recombinant product (Drake et al., 2009). 
Among other strategies used to increase the production yield in transgenic plants, the targeting and 
accumulation of heterologous proteins in seeds demonstrated to be a valid approach. There are 
several examples of molecules successfully produced in plant seeds which include cytokines (Zhu 
et al., 1994), therapeutic monoclonal antibodies (Petruccelli et al., 2006), industrial enzymes (Hood 
et al., 2007) and antigens (Streatfield and Howard, 2003; Wu et al., 2007). In 2008 the United States 
Department of Agriculture (USDA) approved a field release of transgenic seeds expressing human 
lysozyme, lactoferrin, and serumalbumin in rice, apolipoprotein in safflower, and hepatitis B 
surface antigen and brazzein in corn (Wilken et al., 2011). This expression system results to be a 
very useful platform since recombinant proteins can accumulate in a naturally desiccant storage 
compartment with reduced levels of proteolytic enzymes, ensuring protein stability for long periods 
of time (Table 4) (Fischer et al., 2009; Stoger et al., 2005). Many plant-derived proteins obtained 
with some of the previously described strategies have been included in clinical trials. A summary of 
these molecules is reported in Table 5. 
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Table 5: Proteins expressed in different plant systems included in clinical trial or on market (adapted from Obembe et 
al., 2010). 
 
Product  Disease  Plant  Clinical 
trial status  
Company  Source: URL/academic 
Gastric lipase, 
Merispase®  
Cystic fibrosis Maize On market Therapeutics France 
Meristem 
http://www.meristem-therapeutics. 
com 
 
α-Galactosidase  
 
Fabry disease Tobacco Phase I Planet Biotechnology, 
USA 
http://www.planetbiotechnology.com/ 
Lactoferon™ 
(α-interferon) 
 
Hepatitis B and 
C 
Duckweed  
 
Phase II Biolex, USA http://www.biolex.com/ 
Fibrinolytic drug 
(thrombolytic drug) 
 
Blood clot Duckweed  
 
Phase I Biolex, USA http://www.biolex.com/ 
Human 
glucocerebrosidase 
(prGCD) 
Gaucher ‘s 
disease  
Carrot 
suspension 
cells 
 
Awaiting 
USDA's 
approval 
 
Protalix 
Biotherapeutics, 
Israel 
 
http://www.protalix.com/ 
glucocerebrosidase.html 
 
Insulin  Diabetes Safflower  
 
Phase III SemBioSys, Canada http://www.sembiosys.com/ 
Apolipoprotein  
 
Cardiovascular Safflower Phase I SemBioSys, Canada http://www.sembiosys.com/ 
Nutraceuticals 
ISOkine™ 
DERMOkine™ 
Human growth 
factor 
Barley On market ORF Genetics http://www.orfgenetics.com 
 
Human intrinsic 
factor 
 
 
Vitamin B12 
deficiency 
 
Arabidopsis 
 
On market 
 
Cobento Biotech AS 
 
http://www.cobento.dk 
 
Human lactoferrin  
 
 
 
Anti-infection, 
anti-
inflammatory 
 
Rice Advanced, 
on market 
as fine 
chemical 
Ventria, USA http://www.ventriabio.com/ 
 
Human lysozyme Anti-infection, 
anti-
inflammatory 
 
Rice Advanced, 
on market 
as fine 
chemical 
Ventria, USA http://www.ventria.com/ 
 
Immunosphere™  
 
Food additive 
for shrimps 
 
Safflower Marketing 
expectedfor 
2010 
SemBioSys, Canada http://www.sembiosys.com/ 
 
2.3.2 Transient transformation systems for the high yield accumulation of 
heterologous proteins in plants  
 
Protein production using transient expression systems is a strategy that involves the use of 
pathogenic agents (bacteria, viruses) to deliver DNA sequences coding for a protein of interest in 
the genome of plant cells. The gene of interest is not transferred to the offspring of the plant, but the 
expression is limited to a particular stage of the plant life cycle and confined only in the infected 
tissues (Fischer et al., 1999). Protein production obtained with transient expression systems is 
perhaps the most suitable technology for plant molecular farming (Rybicki, 2010). These systems 
which have been  normally used in molecular biology for quick validation of expression constructs 
are now being used routinely for the production of considerable amounts of proteins within a few 
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weeks (Villani et al., 2009, Lombardi et al., 2010). The use of transient expression strategies 
presents many advantages in comparison to stable genetic transformation. In fact, this technology 
ensures the expression of high levels of heterologous protein in a short time-period, usually within 
one or two weeks. Moreover, the system offers the possibility to scale up the protein production 
extending this technology to different plant species. This strategy does not imply vertical or 
horizontal gene transfer and allows to operate in a contained environment (Santi et al., 2009). 
Transient expression systems are mainly based on the use of A. tumefaciens T-DNA-based 
expression cassettes or viral vectors. T-DNA expression cassettes vectors are based on DNA 
modules in which the gene of interest is controlled by strong promoters (e.g. 35S Tobacco mosaic 
virus (TMV) promoter or beta-phaseolin promoter) and other transcriptional enhancer components 
(transcriptional enhancer or strong transcription terminators ) (Gleba et al., 2007). On the other 
hand, viral vectors can be classified, based on their construction, in first and second generation 
vectors. In the case of first generation vectors, constructs consist essentially in whole functional 
viruses carrying in their genome the gene of interest as an additional ORF (“full virus” strategy) 
(Pogue et al., 2010). Vectors belonging to the second generation, rather than using complete viral 
genomes, are based on the construction of an integrated system in which only the viral elements 
(strong promoters, terminators, enhancers, silencing suppressor genes) required for efficient 
expression of the sequence of interest are maintained in the expression vector (“deconstructed 
virus” strategy) (Gleba et al., 2007; Sainsbury et al., 2009). 
 
2.3.2.1 Protein expression using T-DNA vectors delivered by A. tumefaciens 
 
These vectors comprise a basic structure composed of two parts: a 
T-DNA containing multiple cloning sites, a selectable marker 
gene for transformed plant cells, a gene of interest and a vector 
backbone carrying plasmid replication components for E. coli and 
A. tumefaciens, selectable marker genes for bacteria and 
optionally genes encoding plasmid mobilization functions (Lee et 
al., 2008). These vectors are delivered to the plant cells through 
the use of a delivery system (Agroinfiltration) exploiting the 
infective Agrobacterium tumefaciens. Agroinfiltration consists 
in the use of Agrobacterium to mediate the transfer of the gene 
of interest carried in T-DNA vectors to the genome of all plant 
Figure 4: Small scale representation 
of agroinfiltration performed by 
syringe. The Agrobacterium medium 
is forced to enter the mesophyl 
through the inferior leaf page after the 
execution of a little wound. 
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cells. In this methodology, Agrobacterium solution is forced to enter the leaf mesophyl either 
applying the solution with a needless syringe through the inferior page of the leaf (mechanical 
injection) (Figure 4 and Figure 5 B) or through the so called vacuum agroinfiltration process in 
which whole plants are submerged in the Agrobacterium solution where vacuum is applied and then 
suddenly released (Figure 5 panel A). This causes the entrance of the solution in the apoplastic 
space of the leaves. Depending on the vector used, the host organism and the Agrobacterium strain, 
the expression of the recombinant protein requires from 4 to 10 days and, based on the heterologous 
gene, it is possible to obtain several grams of recombinant protein per kg of fresh leaf biomass or 
over 50 % of total soluble protein. In addition, since the vector is composed only by few 
components it can contain long DNA sequences (up to 2.3 kb inserts or up to 80 kDa proteins) 
(Desai et al., 2010).  
This Agroinfiltration system has been employed to accumulate high levels of several recombinant 
proteins such as reporter genes (e.g. green fluorescent protein and β-glucuronidase) (Simmons and 
VanderGheynst, 2007), antigenic proteins (Lombardi et al., 2009) and complex multimeric 
molecules such as immunoglobulins (Villani et al., 2009, Kathuria et al., 2008). A major drawback 
of this strategy is represented by post-transcriptional gene silencing (PTGS) response that may take 
place in the infiltrated plant tissue, in the presence of an high number of transcripts coming from the 
heterologous gene expression (Johansen et al., 2001). To overcome this limitation and enhance 
transient expression levels, the protein of interest has been co-agroinfiltrated with a second 
Agrobacterium harbouring a gene coding for a viral protein suppressor of gene silencing. An 
example is represented by the use of the P19 gene silencing suppressor protein from Artichoke 
mottled crinckle virus and Tobacco bushy stunt virus able to block the silencing mechanism and 
enhance expression yields of a range of proteins (Voinnet et al., 2003; Lombardi et al., 2009; 
Circelli et al., 2010; Sainsbury et al., 2010). 
 
2.3.2.2 Protein expression using viral vectors 
 
Viral vectors based on the use of the whole viral genome (first generation vectors), or deconstructed 
genome elements able to enhance the transcription and translation mechanisms (second generation 
vectors), are widely used to obtain high levels of recombinant proteins in plants. In the case of the 
first generation vectors, in order to obtain high expression levels, the heterologous gene is put under 
the control of a sub-genomic promoter, in place of the gene coding for the coat protein or as a 
fusion with the coat protein itself (e.g. for the expression of small protein fragments such as 
immunogenic epitopes). Among the viral genomes, RNA viruses are generally preferred for their 
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higher plasticity and stability. Recombinant expression vectors containing complete viral genomes 
allowed the transcription and translation of heterologous genes with high effectiveness (Awram et 
al., 2002; Gleba et al., 2008; Lico et al., 2008). These viral vectors are inoculated as virus particles 
or viral RNA and utilize the natural ability of cell-to-cell and systemic movement of the original 
virus to spread within the whole plant. Several plant viruses have been used to achieve this strategy 
among which Potato Virus X (PVX), Tobacco mosaic virus (TMV), Cauliflower mosaic virus 
(CaMV), Cowpea mosaic virus (CPMV) (Pogue et al., 2002; Lico et al., 2008). The first protein 
that has been expressed by transient expression using plant viruses is the enzyme dihydrofolate 
reductase (DHFR). In this case, the DHFR gene was inserted in the CaMV DNA genome as 
additional ORF under the control of a sub-genomic promoter (Brisson et al., 1984). These systems 
offer rapid and efficient expression characteristics, new genes can be tested for expression and test 
quantities of the recombinant protein can be obtained in as little as 4–8 weeks (Pogue et al., 2002).  
One of the drawbacks of this approach is the impossibility to insert long DNA sequences (larger 
than 1 kb), which may cause problems of virus assembly and systemic movement. Moreover, many 
vectors cannot infect all harvestable parts of the plant and the spread of the virus is asynchronous in 
different leaves. In addition, in some cases the vector is usually unstable, thus not all infected 
tissues express the protein of interest (Lico et al., 2008). Besides, the use of whole infective virus 
particles includes also several bio-safety problems. In fact, the direct use of whole transgenic 
viruses presents the risks of their spreading in the environment with dramatic consequences in terms 
of transgene vertical transfer, recombinant protein accumulation in the ecosystem and 
contamination of food and feed chains. Therefore, the employ of this system requires an appropriate 
green-house containment level leading to the increase of the management costs (Pogue et al., 2002).  
In the last decade, in order to solve the problems related to the limitations offered by first generation 
vectors, a second generation of viral vector was introduced. In this case, the expression vector 
consists in an integrated system of viral components able to ensure high expression of the protein of 
interest without the formation of infective virus particles. These vectors are unable to perform plant 
cell-to-cell or systemic movement in plant and require a system that ensures their delivery in all 
plant tissues and this is generally obtained using the Agroinfiltration process. The most known 
second generation viral vector-based transient expression system is the MagnICON® technology. 
This technology is based on the use of a TMV vector obtained with the “deconstructed virus 
technology”. This strategy is based on the efficient assembly of DNA modules (pro-vectors) 
obtained by recombination in plant cells (Komarova et al., 2010). Moreover, this system offers 
enhanced versatility and efficiency due to the possibility to vary the gene combinations, the 
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targeting signals and tags that can be tested without engineering each individual construct (Engler et 
al., 2009). This pro-viral expression platform proved to be very efficient for high-yield production 
of different proteins (> 10 % TSP) and is widely used in many laboratories.  
A significant aspect of this technology is the possibility to express complex multimeric proteins by 
simultaneous infection of the same tissues with several strains of A. tumefaciens, each harbouring a 
different cassette with genes coding for the single monomers. An example of complex protein 
assembly is represented by monoclonal antibodies (Ma et al., 2005) as the full size A5 mAb (Giritch 
et al., 2006) and the Yersinia pestis antigens fusion protein F1–V (Rosales-Mendoza et al., 2010). 
Another interesting strategy used for the expression of multiple polypeptides is represented by the 
CPMV-HT system in which the expression cassettes coding for different monomers and the 
sequence encoding P19 gene silencing suppressor protein have been incorporated into a single T-
DNA, allowing the high-level expression obtained through agroinfiltration of a single construct. 
The high production speed offered by this system makes CPMV-based expression vector an 
attractive alternative for biopharmaceutical development and production (Sainsbuty et al., 2010). 
Some examples of immunotherapeutic proteins expressed through the transient expression system 
based on viral vectors are reported in Table 6. 
Table 6: Yield of recombinant molecules of immunological interest obtained by plant virus-mediated transient expression 
systems.  
 
 
Virus vector  Type of inoculation  Pharmaceutical 
protein  
VLP  Highest yield  
TMV  TMV-30B-based 
vector-directed 
RNA transcript 
inoculation of 
spinach leaves 
HIV-1 Tat protein 
(86 aa)  
No  0.3–0.5 mg/g FW  
TMV  TMV-30B-based 
vector-directed 
RNA transcript 
inoculation of N. 
benthamiana leaves 
HPV-16 L1 protein 
(531 aa)  
Yes  ~0.03 x 10-3 mg/g 
FW  
TMV  ToMV-TocJ-based 
vector directed RNA 
transcript 
inoculation of N. 
benthamiana leaves 
The dengue virus 
envelope protein 
(102 aa fragment)  
No  ~0.1 mg/g FW  
TMV  N. benthamiana leaf 
agroinfiltration 
Mycobacterium 
tuberculosis Ag85B 
and ESAT6 proteins 
(342 aa)  
No  0.8–1.0 mg/g FW  
TMV  TMV TTO1A 
vector-directed 
RNA transcript 
inoculation of N. 
benthamiana leaves 
Human scFv 
proteins (~30 kDa) 
derived from human 
tumor 
immunoglobulin 
No  100–800 µg/ml of 
leaf interstitial fluid  
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genes of non-
Hodgkin’s 
lymphoma patients  
TMV  TMV launch vector 
pBID4 
agroinfiltration of N. 
benthamiana leaves 
hGH (~30 kDa)  No  0.7 mg/g FW  
TMV and PVX  N. benthamiana leaf 
agroinfiltration with 
two populations of 
recombinant 
Agrobacterium 
encoding the mAb 
light and heavy 
chains 
Anticancer full-size 
mAb (~160 kDa)  
No  100–300 µg/g FW, 
affinity purified  
TMV and PVX  MagnICON: N. 
benthamiana leaf 
agroinfiltration with 
two populations of 
recombinant 
Agrobacterium 
encoding the mAb 
light and heavy 
chains 
Anticancer full-size 
mAb (~160 kDa)  
No  0.3–0.5 mg/g FW, 
affinity purified  
TMV and PVX  MagnICON: N. 
benthamiana leaf 
agroinfiltration with 
two populations of 
recombinant 
Agrobacterium 
encoding the mAb 
light and heavy 
chains 
Anti-West Nile 
virus mAb (~160 
kDa)  
No  0.8 mg/g FW 
affinity purified  
TMV  MagnICON: N. 
benthamiana leaf 
agroinfiltration 
Yersinia pestis F1 
(362 aa) and V (150 
aa) antigens  
No  0.3–0.5 mg/g FW; 
1.2 mg/g FW 
(purified product)  
TMV  MagnICON: N. 
benthamiana leaf 
agroinfiltration 
VV B5 (275 aa) 
antigenic domain  
No  0.1 mg/g FW  
TMV  MagnICON: N. 
benthamiana leaf 
agroinjection 
Plasmodium antigen 
PyMSP4/5 (33 kDa)  
No  1–2 mg/g FW  
PVX  Inoculation of N. 
benthamiana leaves 
with pPVX201 
vector-based cDNA 
construct 
HBV nucleocapsid 
protein (21 kDa)  
Yes  0.005–0.01 mg/g 
FW  
PVX  Agroinfiltration of 
N. benthamiana 
leaves with 
pPVX201-based 
vector cDNA 
construct 
M. tuberculosis 
ESAT6 antigen 
fusion with PVX CP 
(31 kDa)  
No  0.5–1 % of the TSP  
PVX and  
TMV  
N. benthamiana leaf 
agroinfiltration 
GFP fused with 
CAV VP1, VP2 and 
VP3 (40–51 kDa)  
No  1.2–5.4 % of the 
TSP  
BeYDV  N. benthamiana leaf 
agroinfiltration 
HBc (21 kDa) and 
NV CP (58 kDa)  
Yes  HBc: 0.80 mg/g 
FW; NV CP: 0.34 
mg/g FW  
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Figure 5: Schematic representation of plant Agro-infiltration system used for recombinant antibody transient 
expression. Agrobacterium tumefaciens strain transformed with the T-DNA binary vector bearing the gene of interest 
(GOI) is used to infiltrate plant leaf tissue Agrobacteria are forced in the intercellular space of plant tissue. Leaves of 
greenhouse-grown plants may be infiltrated either by a needleless syringe (a) or by vacuum infiltration (b). Antibody 
expression can be directed in different sub-cellular compartment. LB: T-DNA left border; RB: T-DNA right border. 
 
All the expression systems described before rely on the use of the plant agroinfilitration process. 
This technique, as previously introduced, can be performed both on small scale (Figure 4, Figure 5 
B) or at large scale by vacuum agroinfiltration (Figure 5 A). In the last years the efforts of several 
companies operating in molecular farming allowed to scale up the vacuum agroinfiltration strategy 
in order to perform the infiltration of kilograms of plants per hour and lead to the accumulation of 
25–75 g of antibody per greenhouse batch using the MagnICON vectors (Figure 6, Pogue et al., 
2010). The facility was calculated to be able to process up to 750 kg of plant biomass in an 8 hours 
production cycle, depending to the plant growth conditions rendering plant transient expression 
very competitive to traditional bio-fermentor based systems. An alternative to the agroinfiltration 
method has been recently presented by Azhakanandam et al., (2007). This system provides an 
optional Agrobacterium delivery in plants of N. benthamiana, via ‘agrospray’ method. This strategy 
is obtained spraying an Agrobacterium solution containing surfactants agents directly on the plant 
leaf surface, in order to enhance the entrance of the bacterium through the abrasions caused by 
surfactants. The use of this methodology should reduce the agroinfiltration costs ensuring 
comparable expression levels of the recombinant protein. 
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Figure 6: Representation of the “at scale” agroinfiltration system set up by KBP company. (a) Trays used for the 
seeding designed with special lids that favorite the growth providing a barrier for soil and root components. After 
growing, plant trays are loaded on conveyors in order to enter the vacuum chamber (b). After a rotation of 180°, 
conveyors enter the chamber (c) and plants are submerged in Agrobacterium-containing solution. At this stage vacuum 
is applied and suddenly released. After vacuum agroinfiltration plants are transferred in a green house in order to favor 
the expression of the recombinant protein accumulation (d) (from Pogue et al., 2010). 
 
2.4 Expression of Antibodies in Plants 
 
2.4.1 Advantages and drawbacks of plant expression systems for antibody 
production 
 
Monoclonal antibodies (mAbs) are useful tools in medicine, biology and biochemistry because of 
their binding specificity and stability both in vivo and in vitro. Antibodies generated by hybridoma 
technology are widely used in medical research and disease diagnosis. Mammalian cell cultures are 
still the favored systems for the production of commercial mAbs, even if the increasing demand and 
the high costs are encouraging the development of alternative expression platforms. In fact, the 
facilities required for large scale production using mammalian cells necessitate long time to be set 
and their building and maintenance costs are extremely high, while validation under Good 
Manufacturing Practice (GMP) still requires an average of 3 years following construction (Vézina 
et al., 2009). Among alternative expression systems, plants represent ideal bioreactors for the large 
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scale over-expression of antibodies. In fact, plants offer a cost effective expression platform, (plant-
derived immunoglobulins estimated cost are 0.1–1 % of the production cost in mammalian cell 
culture and 2–10 % in bacteria systems (Chen et al., 2005), that can assemble such complex 
multimeric molecules with high quality (Conrad and Fiedler, 1994). Many antibody formats have 
been successfully produced in plants so far such as Fab fragments, scFvs, bispecific Fvs, diabodies, 
minibodies, single variable domains, antibody fusion proteins, large single-chain antibodies and 
camelid heavy-chain antibodies (Figure 7). These recombinant antibodies have been expressed in 
plants for different purposes such as modulators of plant cell processes (Owen et al., 1992), to 
confer virus resistance (Villani et al., 2005), for phytoremediation (Longstaff et. al, 1998; Drake et 
al., 2002) and for the production of valuable immunotherapeutic agents (Ma et al., 2003; Hull et al., 
2005; Ko and Koprowski, 2005; Ramessar et al., 2008; Villani et al., 2009). 
Another advantage of the production of antibodies in plants is represented by the possibility to 
direct the protein expression in specific cell compartments. Most antibodies have been directed to 
the ER which is their natural cell compartment due to the low concentration of proteases, the 
presence of numerous chaperones and the oxidizing environment (Petruccelli et al., 2006). In fact, 
these molecules find in the plant cell an oxidant environment that ensures a correct assembly of 
individual chains and the formation of inter and intra-chain disulfide bonds (Ma et al., 2003). 
Furthermore, ER retention increases expression levels and prevents the transfer of proteins through 
the Golgi, where the addition of typical plant sugar residues occurs (α 1,6-fucose and sialic acid 
instead of β 1,2 xylose and α 1,3-fucose).  
Antibody expression has been directed also to specific cell storage compartments such as seeds. 
Seed-specific production of recombinant proteins is an appealing alternative strategy for the 
production of complex molecules in transgenic plants (Boothe et al., 2010). Seeds proved to be 
versatile targets for recombinant protein or peptides accumulation, including short and long 
polypeptides as well as complex proteins like antibodies. Several interesting properties of seeds can 
be exploited in numerous molecular farming applications, mainly when it is desirable to accumulate 
in a naturally designed protein storage compartment high amounts of a recombinant molecule. 
Many factors could be controlled to ensure high accumulation levels of heterologous proteins in 
seed, such as, promoters and enhancers, which regulate transcript abundance (Wilken et al., 2011).  
In a recent study, the potential of A. thaliana seeds to produce mAbs was explored together with the 
determination of their intracellular trafficking and deposition (Loos et al., 2011). To this aim, two 
model antiviral mAbs, 2G12 (anti-HIV) (Trkola et al., 1996) and HA78 (anti-Hepatitis A Virus) 
(Cao et al., 2004) were expressed in Arabidopsis seeds in order to determine expression levels and 
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the subcellular localization. Depending on the mAb and the plant line, maximal expression levels of 
2–10 µg/mg dry seeds were observed, corresponding to 0.2 %–1 % of dry seed material. 
Using the same expression system in A. thaliana seeds, even higher expression levels have been 
achieved: 74 µg/mg seeds (De Jaeger et al., 2002) and 26 µg/mg seeds (Van Droogenbroeck et al., 
2007) for different formats of single-chain antibody fragments. An important result has been 
recently obtained with the HIV-specific monoclonal 2G12 antibody produced in maize seeds, 
expressed at levels of 75 µg/g dry weight and the purified product resulted fully functional as its 
CHO derived counterpart (Ramessar et al., 2008). Nevertheless, expression of antibodies in plants 
still presents several drawbacks related to the extraction procedures, purification steps, quality of 
the final product and regulatory issues. 
Extraction procedures represent an important step, since these can influence the quality of the final 
product even after purification. In fact, recombinant protein extraction is often conducted in the 
presence of unwanted plant proteins and compounds such as proteolytic enzymes, pigments, 
alkaloids, phenolics, polysaccharides and DNA that can reduce the efficiency of protein extraction 
and the final quality. Another limitation is represented by the high costs relative to the purification 
process based on protein A affinity chromatography. This purification methodology represents the 
most selective strategy to achieve high efficiency recovery of antibody in a single step (Hober et al., 
2007). However, susceptibility of protein A column to chemical and biological degradation caused 
by the aggressive characteristics of plant extracts, decreases column life with higher costs on large 
scale application (Platis et al., 2008). In addition, the possible leaching of protein A during the 
purification process could contaminate the eluted purified antibody causing immunogenic responses 
after its administration in humans (Terman et al., 1985). 
Another important concern to be addressed in the expression of immunoglobulins in plants is 
related to the intrinsic stability of immunoglobulins in the plant cell environment and their 
susceptibility to degradation (Gomord et al., 2005). In fact, unintended proteolytic mechanisms 
triggered by different plant cell processes can involve the degradation of plant derived antibodies 
causing a dramatic reduction of intact IgG recovery.  
Another important issue is represented by the strict parameters imposed by regulatory bodies that 
control the introduction of plant derived immunoglobulins in the market. Requirements for 
downstream processing techniques that meet the terms of the GMP involve extensive quality 
controls and assurance programs, including, in the case of transgenic plants, the establishment of 
master plant banking procedures (Schillberg et al., 2005).   
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2.4.2 Transgenic plants versus transient expression systems 
 
The production of antibodies in plants has been achieved using different expression strategies, 
including stable transformation of the nuclear genome and transient expression systems using viral 
or Agrobacterium T-DNA based expression vectors (Vaquero et al., 1999; Kathuria et al., 2002; 
Rodríguez et al., 2005; Sainsbury et al., 2008; Lombardi et al., 2010).  
In the case of stable genetic transformation the expression of complete IgG was traditionally 
obtained transforming plants separately with the genes coding for heavy or light chain (HC, LC); 
plants were then cross-pollinated in order to select, in the next generations, transgenic plants co-
expressing both chains. This approach allowed the production of correctly assembled IgG 
molecules with expression yields ranging from 0.1 to 5 % of total soluble protein (Hiatt et al., 1989; 
Ma et al., 1995). The first example of complex secretory antibodies expressed in tobacco plants, 
Figure 7: Several immunoglobulin types have been expressed successfully in plants, including several classes of IgG , 
IgA and a chimeric IgA/G. A variation on the classical IgG tetrameric structure is the camelid heavy-chain antibody, 
which lacks a light-chain component and can be expressed as a single transgene. Another example of antibody format is 
represented by secretory IgA composed by dimers of the typical IgG including two extra components: the secretory 
component and the joining chain. Other forms are represented by smaller engineered antibody derivatives as minibodies, 
diabodies, large single chains, single-chain Fv fragments (scFvs) and single variable regions, which have both the heavy  
and light chain variable regions on the same polypeptide chain. More specialized derivatives include bispecific 
scFvs,which contain the variable regions from two parent immunoglobulins and recognize two unrelated antigens, and 
scFv fusion proteins in which the scFv is genetically fused to a toxin, cytokine or enzyme (from Capodicasa et al., 2011). 
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achieved by sequential crossing of four lines carrying individual components, is represented by the 
CaroRx SIgA/G that specifically binds Streptococcus mutans adhesion molecules. This 
immunoglobulin was efficiently expressed in N. tabacum reaching levels of up to 5 % to 8 % of 
total soluble leaf protein (Ma et al., 1995). However, this strategy has been recently replaced by the 
use of binary vectors bearing both heavy and light chain coding sequences in the same T-DNA 
which allows to obtain transgenic plants expressing full IgGs in a single transformation event (van 
Engelen et al., 1994). In some cases this strategy revealed to be more efficient both in terms of 
rapidity and production yield. For example, the anti-cutinase antibody 21C5 produced in transgenic 
tobacco plants using a traditional cross-pollination approach showed significantly lower levels 
compared to tobacco plants obtained using T-DNA bearing both genes arranged in a divergent 
orientation on the same expression cassette (De Muynck et al., 2010). 
Several species have been used for stable transformation among which Nicotiana tabacum, 
Nicotiana benthamiana, Zea mays, Arabidopsis thaliana, Lactuca sativa, Medicago sativa, Solanum 
tuberosum. The best results in terms of production yield have been recently obtained by expressing 
the neutralizing anti-HIV-1 2G12 antibody in seeds of transgenic Z. mays plants. In this case, the 
extractable yield of 2G12 was 75 mg/Kg of dry seed weight, 75 % of which could be recovered 
(Ramasser et al., 2008). Most antibodies reported in literature have been expressed at good levels in 
N. tabacum leaves as the monoclonal mouse IgG1 MGR48 expressed at levels of 30-60 mg/Kg 
under strictly controlled growth conditions (Stevens et al., 2000) and the mouse IgG2 BR-55-2 (31 
mg/Kg FW ) (Brodzik et al., 2006). A summary of the most representative antibodies expressed in 
transgenic plants is listed in Table 7. There are many successful examples of antibody expression in 
plants using transient expression systems. Agroinfiltration was used for the production of mAb 
2G12 cloned in a T-DNA expression cassette harboring HC and LC in tandem obtaining a final 
yield of 110 mg/Kg FW (Schähs et al., 2007). A recent study demonstrated that the combined effect 
of a strong viral promoter (alfalfa plastocyanin promoter), together with the enhancing activity of 
the HcPro silencing suppressor in the same vector, could lead to high yield production in 
agroinfiltrated N. benthamiana plants of  both the secreted form of the anti-human globulin (AHG) 
C5-1 antibody (558 mg/kg FW) and of the ER-retained variant (757 mg/kg FW ). 
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Table 7: Antibodies expressed in transgenic plants (adapted from De Muynck et al., 2010). 
Antibody Isotype Promoter H Promoter L Host 
species  
Organ Expression 
Level 
Reference 
21C5κ  
Anti-cutinase 
mIgG1κ CaMV 35S mas1’2 N. 
tabacum 
Roots 0.6 % TSP van Engelen 
et al., 1994 
CaroRx 
Streptococcus 
mutans-
specific 
SIgA/G CaMV 35S CaMV 35S N. 
tabacum 
Leaves 5-8 % TSP Ma et al., 
1995 
mAb24  
TMV-specific 
mIgG2bκ CaMV 35S Single 
Native 
none N. 
tabacum 
Leaves F0: 
0.04–0.16 
% 
TSP; F1: 
0.07–0.3 % 
TSP 
 
Suspension 
Cells 15–16 
µg⁄g wet 
cell weight 
or 0.3 
%TSP 
 
Voss et al., 
1995 
 
 
 
 
 
Fischer et al., 
1999 
C5-1 
anti-human 
globulin 
mIgGκ CaMV 35S  
 
 
 
Native  none Medicago 
sativa 
Leaves  
0.13–1.0 % 
TSP 
Khoudi et al., 
1999 
 
rAb29  
TMV-specific 
mIgG1κ CaMV 35S None none N. 
tabacum 
Leaves 
8.5 µg⁄g 
FW, 0.14 
% TSP 
Schillberg et 
al., 1999 
MGR48    
anti- 
Globodera 
rostochiensis 
mIgG1κ CaMV 35S mas1’2’ none N. 
tabacum 
Leaves 
30–60 µg ⁄g 
FW (top 
leaves) 5–
15 µg ⁄g 
FW 
(bottom 
leaves) 
 
Stevens et 
al., 2000 
 
CB-Hep.1  
anti-HBsAg 
mIgG2bκ CaMV 35S Sweet potato 
sporamin 
KDEL 
none N. 
tabacum 
Leaves 
60 µg⁄g FW 
or 0.5 % 
TSP 
Seedlings 
17 µg/g 
DW 
Ramirez et 
al., 2003 
Triguero et 
al., 2005) 
SO57  
rabies virus 
  
  
 
hIgG1κ CaMV 35S Native ⁄ 
KDEL 
Native 
⁄ none 
N. tabacum 
Leaves  
Suspension 
cells 
10–30 µg ⁄ 
g DW 
3 µg ⁄g FW 
or 0.07 % 
TSP 
 
Ko et al., 
2003  
Girard et al., 
2006 
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14D9  
hydrolysis of 
enol ethers 
mIgG1 CaMV 35S Murine ⁄ 
none 
none N. tabacum 
Leaves 
2.9 % TSP Petruccelli et 
al., 2006 
BR55-2  
anti- LeY 
Cancer Cells 
mIgG2κ CaMV 35S Native ⁄ 
KDEL  
Native 
⁄ none 
Single 
N. tabacum 
Leaves 
31 µg⁄g FW Brodzik et 
al., 2006 
A5  
tumor specific 
hIgG1λ CaMV 35S Native ⁄ none none N. 
benthamian
a Leaves 
10–15 µg⁄g 
FW 
 
Giritch et al., 
2006 
2G12  
anti-HIV-1 
hIgG1  gt-1 Native ⁄ none  Zea mays 
Seeds 
75 µg⁄g 
DW 
Ramessar et 
al., 2008 
  CaMV 35S   A. thaliana 
Leaves 
0.2 % TSP Schahs et al., 
2007 
  gt-1  Native ⁄ 
SEKDEL 
 Zea mays 
Seeds 
F1: max 30 
µg⁄g DW; 
F3: 40–60 
µg⁄g DW 
Rademacher 
et al., 2008 
2F5  
anti-HIV-1 
hIgG1 CaMV 35S Native ⁄ 
SEKDEL 
 N. tabacum 
Suspension 
cells 
 
6.4 µg⁄g 
FW 
 
Sack et al., 
2007 
  CaMV 35S  
 
Native ⁄ c-
myc, KDEL 
Native⁄ 
c-myc, 
KDEL 
 
cross-
pollination 
Leaves 
0.1 % TSP 
0.3 % TSP 
Floss et al., 
2008 
FW, Fresh Weight; DW, Dry Weight; TSP, total soluble protein. hIgG: human IgG; mIgG: mouse IgG; κ: kappa light 
chain; λ: lambda light chain 
 
Viral vectors have been used for the production of the CCR5 mAb, specific for the ligand-binding 
region of the human chemokine receptor and HIV-1 co-receptor CCR5. The production of this 
humanized mAb was performed using the previously described MagnICON expression system. In 
this methodology, anti-CCR5 mAb HC and LC encoding genes were cloned into two different non-
competing viral vectors obtained from Turnip vein-clearing virus (TVCV) and PVX. Expression 
was performed in N. benthamiana plants processing batches of 40-60 Kg of plant material. The 
combination of these two non-competing viral vectors led to a final yield of 250 mg⁄kg of fully 
assembled IgG showing a high  purity (Pogue et al., 2010). Another efficient viral-derived 
expression system is based on the Cowpea mosaic virus (CPMV). This virus has a bipartite RNA 
which has been used to develop two types of deconstructed expression vectors able to ensure the 
production of complex multimeric proteins in plants such as antibodies (Sainsbury et al., 2007). 
Vectors were obtained engineering the viral RNA-2, using either the full-length RNA-2 or a deleted 
version (delRNA-2). Replication of the modified RNA-2 in plant cells is achieved by co-
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agroinfiltation with RNA-1. An application of this system was described for the production of the 
blood group-typing antibody C5-1 in which HC and LC coding genes were inserted into two 
separate RNA-2 and then agroinfiltrated in the presence of RNA-1. The results showed the 
accumulation of  high antibody levels using both full-length and deleted RNA-2 vectors, even if the 
latter gave the best results in terms of antibody yield. This work represents the first example in 
which a bipartite virus has been used as platform for high production level of immunoglobulins that 
does not rely on full virus replication (Sainsbury et al., 2008). A development of this vector is 
represented by the “hyper-translatable” Cowpea mosaic virus based protein expression system 
(‘CPMV-HT’). This vector system, differently from the previously described expression vectors, 
does not require co-agroinfiltration with RNA-1 for its replication. Furthermore, the sequences of 
interest and the gene encoding the P19 gene silencing suppressor protein have been incorporated 
into the same T-DNA, allowing the expression of complex multimeric proteins through 
agroinfiltration of a single construct. An example of application of this system is the expression of 
the 2G12 antibody in N. benthamiana plants leading to extremely high accumulation levels. The 
plant derived 2G12 produced with this system, resulted fully functional and equivalent to its 
mammalian counterpart.  
Both transgenic plants and transient expression system are valuable platforms for the production of 
biopharmaceuticals. However, recent results obtained using the MagnICON and the “hyper-
translatable” technologies showed that viral based expression systems have high potential in terms 
of yield, rapidity and possibility of contained GMP production. Even if the first antibody in Europe 
entering clinical trials is represented by the 2G12 mAb produced in stable transgenic tobacco plants, 
in the near future, viral based expression systems will be the preferential platform for the expression 
of biopharmaceuticals production in plants.  
 
2.4.3 Plant-made antibodies and immunotherapy of infectious diseases  
 
Anti-infective antibodies have the capacity to target viral, bacterial and fungal infections and are a 
valid alternative to traditional antibodies to combat infectious diseases, especially in cases of multi-
drug resistance pathogens. In the last years, there have been several examples of plant derived 
antibodies exhibiting a high neutralizing potential against several infectious pathogens. 
One of the first examples of a plant derived antibody developed for the treatment of infectious 
diseases is the secretory antibody directed against an exposed antigen of Streptococcus mutans, 
found to be as effective as the original mouse derived IgG (Guy’s 13) in protecting against S. 
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mutans colonization on teeth (Ma et al., 1994). The immunoglobulin has been further transformed 
by a biotech company (Planet Biotechnology) into a biopharmaceutical product to be used for 
clinical purposes with the name of CaroRX™, which has recently gained EU approval to be 
employed as medical device to prevent oral bacterial infection that causes dental caries (Kaiser, 
2008). Moreover, promising results have been described about the over expression of anti-HIV 
neutralizing antibodies. For example, two mAbs, the monoclonal antibody 2G12 previously 
described, specific for the glycans exposed on the HIV-1 envelope protein gp120 (Trkola et al., 
1996) and the 2F5 anti-gp41 (Conley et al., 1994), showing a strong HIV neutralizing activity, have 
been widely characterized for plant expression. In particular, an important result has been recently 
obtained with the monoclonal 2G12 antibody, produced in maize seeds. This plant produced 
antibody was found to be functional in terms of antigen-binding activity as its CHO derived 
counterpart (Ramessar et al., 2008). The same antibody derived from stable tobacco plants, 
produced by the ‘Pharmaplanta’ Consortium, a program aiming to develop a production pipeline for 
pharmaceutical proteins made in plants, has obtained the permission to enter into a human clinical 
trial phase, the first under the new cGMP guidelines (Scotti et al., 2010). 
In the case of the 2F5 monoclonal antibody produced in transgenic tobacco plants, it has been 
described that the addition of an elastin-like peptide (ELP) repeat to the heavy and light chain of the 
immunoglobulin increased the production yield by improving protein stability. Besides, this 
strategy resulted also useful to simplify the recovery and purification of the protein product (Floss 
et al., 2008). Another example of therapeutic antibody described by Zeitlin et al., (1998) is the anti-
herpes humanized mAb produced at high levels in soybean. The biological activity of this antibody 
resulted perfectly comparable to the same molecule produced using mammalian cell culture. In fact, 
this antibody was able to protect mice against herpes simplex virus-2 with high efficiency (Horn et 
al., 2004). Plant transient expression systems were successfully used for the production of a 
neutralizing humanized mAb against the West Nile virus to be used in post-exposure prophylaxis 
(Hu-E16). This antibody was expressed using the MagnICON system and led to an accumulation of 
8.1 g⁄Kg FW with a yield of purified antibody of 0,8 g/Kg. Furthermore, the antibody showed a 
strong neutralizing activity and an effective pre- and post-exposure protection in mice, similarly to 
what observed using the mammalian cell derived antibody (Lai et al., 2010). A recent example of 
wide-spectrum antifungal immunotherapeutic molecules are the chimeric mAb 2G8 and its 
recombinant scFv-Fc derivative produced in N. benthamiana plants by agroinfiltration (Capodicasa 
et al., 2010). These plant derived antibodies showed the capability to confer significant protection 
against different opportunistic pathogens such as Candida albicans, Aspergillus fumigatus and 
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Cryptococcus neoformans in animal models (Torosantucci et al., 2009). A successful example of 
protective plant-derived antibody is the production of the glycosylated and non-glycosylated 
versions of an antibody directed against protective antigen (PA) of Bacillus anthracis using 
agroinfiltration in N. benthamiana plants. It has been shown that these antibodies were able to 
neutralize anthrax lethal toxin activity in vitro and protected mice against an intraperitoneal 
challenge with spores of B. anthracis Sterne strain. A single 180 µg intraperitoneal dose of 
glycosylated mAb or non glycosylated mAb provided 90 % and 100 % survival, respectively. A 
summary of the anti infectious Abs transiently expressed in plants and their relative yield is 
presented in Table 9. 
 
Table 9: Summary of the anti infectious Abs transiently expressed in plants (Adapted from Capodicasa et al., 2011). 
 
2.4.4 Anti-cancer immunotherapeutic antibodies 
 
In the last decades, several monoclonal antibodies targeting different types of cancer have been 
efficiently expressed in plant systems. One of the first examples of plant production of a 
recombinant anti-cancer antibody is represented by the carcinoembryonic antigen-specific diabody 
produced in tobacco (Vaquero et al., 2002). Another example is represented by the TheraCIM 
recombinant humanized antibody targeting the Epidermal Growth Factor receptor (EGF-R), 
produced in tobacco leaves. The antibody gene constructs were transiently-expressed in an 
aglycosylated format by vacuum agroinfiltration resulting as active as the cognate mammalian 
product (Rodriguez et al., 2005). Recently, another humanized monoclonal antibody, which 
recognizes HER2/neu on the surface of a human mammary gland adenocarcinoma cell line SK-BR-
Target/mAb name Host plant Expression method Yields Antibody format 
HIV 
(2G12) 
N. benthamiana Agroinfiltration 50 mg/Kg Human IgG1 
HIV 
(2G12) 
N. benthamiana Cowpea mosaic virus 
 
100 mg/Kg Human IgG1 
HIV 
(4E10) 
N. benthamiana Agroinfiltration Not reported Human IgG1 
West Nile Virus 
(Hu-E16) 
N. benthamiana MagnICON system 30 mg/kg Human IgG1 
B. anthracis PA (pp-
mAbPA, pp-
mAbPANG) 
N. benthamiana Agroinfiltration 
 
(TMV)-based vectors + 
Agroinfiltration 
250 mg/Kg 
 
120 mg/kg 
Human IgG 
Candida albicans 
(Hu2G8) 
N. benthamiana Agroinfiltration 50 mg/Kg Humanized murine 
IgG1; scFv-Fc 
Ebola Virus GP1 
(6D8) 
N. benthamiana BeYDV-derived DNA replicon Not reported Humanized murine 
IgG1 
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3, has been produced at high levels in N. benthamiana leaves using the MagnICON viral-based 
transient expression system. It has been demonstrated that this immunoglobulin is able to 
specifically bind the Her2/neu oncoprotein exposed by adenocarcinoma cells (SK-BR-3) showing a 
high capability to inhibit cell proliferation in vitro. Furthermore, intraperitoneal administration of 
the antibody in mice, showed to efficiently retard the growth of xenografted Her2+ human ovarian 
tumors (Komarova et al., 2011). A particular application of plant-produced antibodies was 
developed for the treatment of non-Hodgkin’s lymphoma by individualized idiotype vaccines 
created from patient's own cancer cells (Bendandi et al., 2011). In this cancer, several clonal 
immunoglobulin idiotypes are displayed on the surface of most malignant B cells, and these can be 
exploited for therapeutic vaccination. Thanks to the rapid and high level expression offered by 
plants, it was possible to proceed from biopsy to vaccine in less than 12 weeks. Several antibodies 
directed against different types of cancer have been expressed in plants and some examples of 
plant-derived anti-cancer immunoglobulins are reported in Table 8.  
 
 Table 8: Examples of plant derived anti-cancer immunoglobulins (Adapted from Capodicasa et al., 2011). 
 
Transient expression systems have proved their potential in producing large quantities of 
recombinant antibodies in plants. Therefore antibodies will be among the first clinical grade 
biopharmaceuticals for human treatment to be produced in plants. Currently, five different plant-
produced monoclonal antibodies have been included in clinical trials confirming this trend (Table 
10) (Obembe et al., 2010). 
 
Target Host plant Expression 
method 
Yields Antibody format 
HER2/neu  
(Trastuzumab) 
N. benthamiana TMV and PVX 
vectors 
200/300 mg/Kg Humanized murine 
IgG1 
HER2/neu 
(Trastuzumab) 
N. benthamiana MagniICON viral-
based 
45 mg/Kg Humanized murine 
IgG1 
Human tumor 
specific mAbA5 
N. benthamiana TMV and PVX 
vectors 
500 mg/Kg Human IgG1 
EGF-R 
(TheraCIM) 
Tobacco Vacuum 
agroinfiltration 
Not reported Humanized 
antibody 
Tenascin-C 
(H10) 
N. benthamiana Vacuum 
agroinfiltration 
50-100 mg/Kg Human IgG1 
CEA 
(T84.66/GS8) 
Tobacco Agroinfiltration 1-5 mg/Kg Diabody 
Individualized 
idiotype vaccines 
for non-Hodgkin’s 
lymphoma 
Tobacco 
 
 
N. benthamiana 
TMV vector 
 
 
Magninfection 
5-800 µg/ml 
 
0.5-4.8 g/Kg 
scFv 
 
 
IgG 
2. INTRODUCTION 
 
 
- 33 - 
Table 10 Examples of antibodies included in clinical trials. 
Product  Disease Plant  Clinical trial 
status  
Company URL/academic 
CaroRX  Dental caries  Tobacco EU approved 
as medical 
advice 
Planet 
Biotechnology, 
USA 
http://www.planetbiotechnology.com/ 
DoxoRX  Side-effects of 
cancer therapy 
 
Tobacco Phase I 
completed 
Planet 
Biotechnology, 
USA 
http://www.planetbiotechnology.com/ 
RhinoRX  Common cold Tobacco Phase I 
completed 
Planet 
Biotechnology, 
USA 
http://www.planetbiotechnology.com 
Fv antibodies  Non-Hodgkin's 
lymphoma 
 
Tobacco Phase I Large Scale 
Biology, USA 
http://www.lsbc.coma 
IgG (ICAM1)  Common cold Tobacco Phase I Planet 
Biotechnology, 
USA 
http://www.planetbiotechnology.com/ 
 
2.4.5 The tumour-targeting anti tenascin-C mAb H10 
 
In this work we describe the expression and characterization of the human recombinant mAb H10 
antibody specific for the large isoform of tenascin-C (TNC-C). TNC is a glycoprotein of the 
extracellular matrix that comprises several alternatively spliced domains (domains A1, A2, A3, A4, 
B, C, D). It is over-expressed in adult tissues undergoing remodelling and neoplasia (Borsi et al., 
1992), but remains undetectable in healthy adult tissues. The C domain of TNC exhibits a restricted 
pattern of expression (Carnemolla et al., 1999), and therefore represents a preferential tumor-
associated antigen target for both therapy and diagnosis. Tumor targeting by anti-tenascin 
antibodies has been already achieved, but most antibodies are either of murine origin or human–
mouse chimeras, and may therefore be unsuitable for repeated administration and for the generation 
of therapeutic derivatives (Rizzieri et al., 2004). We previously described the expression of the 
human tumor targeting monoclonal antibody H10 both by vacuum co-agroinfiltration of N. 
benthamiana plants with a T-DNA 35S based Agrobacterium expression vector and by stable 
transformation of N. tabacum plants (Villani et al., 2009). mAb H10 was obtained fusing the 
variable regions of an anti-TNC scFv(H10) selected from a human phage display library against the 
C domain of TNC, to the constant regions of the human γ chain subgroup III and human λ chain 
subgroup IV domains. Both genes coding HC and LC were then cloned into the plant binary vector 
(pBI-Ω) (Marusic et al., 2007) under the control of the Cauliflower mosaic virus (CaMV) 35S 
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promoter and the omega (Ω) translational enhancer sequence from Tobacco mosaic virus (TMV) 
(Figure 8). 
 
 
 
Figure 8: Schematic representation of the constructs used for plant expression. Both heavy (HC) and light (LC) chain 
and p19 gene silencing suppressor coding sequences were put under the control of the CaMV 35S promoter (35S) and 
Ω translational enhancer sequence of the TMV.  
 
Over 100 transgenic T0 plants were screened by both PCR and quantitative enzyme-linked 
immunosorbent assay (ELISA) for the expression of individual chains, and the lines with the 
highest expression levels were selected and cross-pollinated. After the germination of T1 seeds on 
appropriate selection medium, the plants were screened for antibody expression by ELISA. Tobacco 
lines showing the highest expression levels are reported in figure (Figure 9). 
 
 
 
Figure 9: Functional ELISA for monoclonal antibody (mAb) H10 expressed in 9 transgenic N. tabacum lines. Plant 
extracts were normalized for total soluble protein (TSP) content and were assayed at different dilutions for their binding 
to mouse tenascin-C. Dilutions are reported from the undiluted to the 1:20. As positive control (+), 100ng of purified 
mAb H10 were used, negative control (-) was obtained using a WT plant (from Villani et al., 2009).  
 
Transgenic lines exhibiting the highest expression levels of mAb H10 evidenced a final antibody 
yield comprised in a range of  0.6–1.1 mg/kg FW.  
In the case of the transient expression strategy, a vacuum-agroinfiltration system was used for the 
antibody production. Furthermore, in order to enhance the yield of recombinant product in the co-
agroinfiltration method, the gene silencing suppressor protein p19 from Artichoke mottled crinckle 
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virus (AMCV) has been used (Lombardi et al., 2009). This strategy led to an increase of at least 10-
fold of mAb H10 expression levels in comparison to the expression in absence of the p19 protein.  
 
 
 
Figure 30: Typical sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of eluted 
fractions (1–9) obtained after Protein A affinity chromatography. Lane 1, 1 µg of a reference human IgG; lanes 2 and 3, 
1 µg of two different batches of purified H10; lane 4, 1 µg of a reference human IgG; lanes 5 and 6, 2 µg of two 
different batches of purified H10; M, molecular mass marker (from Villani et al., 2009). 
 
Purification of the antibody was performed using a Protein A column, and the average yield 
obtained after purification was typically 50–100 mg/kg FW. A typical SDS-PAGE analysis of the 
eluted fractions after affinity chromatography is shown in Figure 10. These expression results are 
comparable to those obtained using virus-based systems for either the production of the blood 
group-typing IgG C5-1 (75 mg/kg fresh plant tissue) (Sainsbury et al., 2008) or the human tumor-
specific mAb A5 (500 mg/kg fresh plant tissue) (Giritch et al., 2006). The functionality of the 
antibody purified from agroinfiltrated leaves was assessed by surface plasmon resonance, and the 
dissociation constant calculated for mouse TNC was 14 nM. The purified antibody also retained full 
biological activity, as demonstrated by immunohistochemical analysis, which showed specific 
accumulation of H10 around tumour blood vessels. 
 
2.4.6 Optimization of the purification of antibodies in plants 
 
Many efforts have been made in the last years to increase the expression levels of heterologous 
proteins in plants by developing novel efficient expression systems. Promising results have been 
obtained from the use of production systems based on viral vectors, and in many cases recombinant 
protein yield is not a limitation any more. Therefore, the interest is gradually shifting from 
optimization of expression systems to the improvement of the extraction/purification strategies 
(Gottschalk, 2008). Based on the product and its application, downstream processing can represent 
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a significant percentage of the total managing costs for product manufacturing. For this reason, the 
development of efficient and selective extraction and purification processes, able to ensure high 
recovery and final product quality, is a crucial point to be addressed (Basaran and Rodriguez-
Cerezo, 2008). The efficiency of downstream steps is influenced by the recombinant protein 
concentration, the plant extracts composition and the purification method used. Moreover, 
recombinant protein extraction is often conducted in the presence of unwanted plant proteins and 
compounds such as DNA, pigments, alkaloids, phenolics, polysaccharides, and proteases that could 
interact with the recombinant protein affecting final quality and yield or limiting the efficiency of 
chromatographic steps. For this reason, extraction needs to be optimized evaluating different 
parameters such as tissue homogenization, buffer composition, and subcellular protein localization 
(Hassan et al., 2008; Woodard et al., 2009; Zhang et al., 2005, 2010). The control of these 
conditions can improve the purification processes by reducing the impact of contamination of plant 
compounds on the final recovery steps. 
A detailed study has focused on the initial extraction steps from plant leaves, evidencing that 
optimal procedures are mainly influenced by the antibody expression strategy (secretory, ER 
retained or membrane bound) (Hassan et al., 2008). In this study, three different transgenic plant 
lines were analyzed in order to set up the parameters to improve extraction procedures of a 
monoclonal antibody addressed to different cell compartments (apoplastic space, plasma membrane 
or ER). Seven methodologies for physical extraction were evaluated for each transgenic line. It has 
been shown that the optimal extraction strategy depends on the recombinant protein localization 
within the cell and, in some cases, the addition of a detergent in the extraction buffer may improve 
the yield. It has also been shown that recovery of secretory antibodies from leaf disks of transgenic 
tobacco plants can be improved using mild extraction techniques (passive elution and freeze-thaw) 
reducing plant contaminant levels in the extract. In fact, contaminants as polyphenols and alkaloids 
(especially in the case of tobacco) represent a major issue in downstream purification processes. 
Homogenization of the plant material is the common methodology used for plant protein extraction 
and is usually followed by clarification using centrifugation and/or microfiltration. An example of 
this methodology is represented by large-scale purification (50–200 kg of leaves) of the anti-HBsAg 
antibody from a partially clarified transgenic tobacco leaves extract using protein A affinity 
chromatography. This purification strategy showed high efficiency in terms of elution capacity, 
antigen purity, purification cycles and ligand leakage, but plant pigments and phenols were still 
present in the elution fractions (Valde´s et al., 2003). Recent strategies were focused on the removal 
of polyphenols/alkaloids content before the protein A affinity chromatography step for both safety 
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and economical reasons. In fact, plant contaminants may have a negative impact on protein A resin 
reducing column performances. An example of purification strategy aiming to reduce plant 
contaminants was efficiently used for the purification on lab scale (5 g of leaf tissue) of the anti-
HIV monoclonal antibody 2G12 (mAb 2G12) and 4E10 (mAb 4E10) from unclarified transgenic 
tobacco crude extract. In this study, antibodies were purified by the use of an aqueous two-phase 
partitioning system followed by cation-exchange chromatography and immobilized metal affinity 
chromatography. This strategy revealed an high antibody recovery with over 96 % purity grade and 
absence of polyphenol and alkaloid contaminants (Platis et al., 2008; Platis and Labrou, 2009). A 
similar study was carried out by Lee and Forciniti (2010) that evaluated the use of the aqueous two-
phase partitioning as a single recovery and purification strategy of an aglycosylated IgG expressed 
in corn seeds. They controlled pH and ionic strength in order to partially purify the antibody in a 
process composed of three steps, with the aim to deliver the antibody in a clarified solution. The 
first two steps were based on the delivery of the antibody in the aqueous salt bottom phase keeping 
plant impurities in the top (PEG) phase. These two-extraction stages resulted in a poor mAb 
purification of 1.3- and 1.4-fold, respectively. The third step consisted in the accumulation of the 
antibody at the two-phase interface resulting in a purification of 10-fold. At the end, the three-stage 
processes led the accumulation of a 72 % pure mAb with 49 % of final yield. Clearly, additional 
adsorption steps, most likely affinity chromatography, would be needed to purify the antibody for 
biopharmaceutical applications. In a recent study, using a similar approach a 94 % removal of 
tobacco proteins from the acidic recombinant protein β-glucuronidase extracts was reported (Ross 
and Zhang, 2010). Another example of IgG purification from tobacco extracts is represented by the 
anti-WNV monoclonal antibody Hu-E16 (Lai et al., 2010). Leaf extracts after clarification were 
first treated with 25 % ammonium sulfate to remove impurities and then concentrated by 
precipitation with 50 % ammonium sulfate. After solubilization, pellet enriched with Hu-E16 IgG 
was processed by protein A affinity chromatography followed by a weak anion-exchange column. 
This methodology was applied at 5 kg of plant leaves and IgG purity was > 95 % with 49 % yield, 
in spite of the three column steps. 
An interesting purification strategy has been used in the case of the 2F5 monoclonal antibody 
produced in transgenic tobacco plants, in which an elastin-like peptide (ELP) repeat was fused to 
the heavy and light chain C-terminus. ELP consists in a protein tag obtained repeating the 
pentapeptide VPGVG. This peptide can undergo a reversible phase transition from water-soluble 
forms into aggregates after a temperature transition. Therefore, after protein extraction from plant 
leaves expressing the 2F5-ELP antibody, a temperature increase (up to 40°C) was operated in order 
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to induce the precipitation of antibody aggregates. Although the final recovery of 2F5-ELP antibody 
was quite low, the system offered a valuable strategy to improve a rapid and cost-effective 
purification process (Floss et al., 2008). 
 
2.4.7 Modulation of IgG glycosylation in plants 
 
Post-translational modifications occurring in antibodies have been extensively studied and it has 
been demonstrated that glycosylation is crucial for many fundamental biological processes, 
including antibody dependent cellular cytotoxicity (ADCC), complement activation and Fcγ 
receptor binding ability (Gomord et al., 2005). These modifications are often essential for the 
stability and biological activity of a protein especially in the case of antibodies (Gomord et al., 
2010). In fact, it has been evaluated that in these molecules, different glycosylation patterns could 
affect protein half-life in blood and, in some cases, the capability to interact with the components 
responsible of the stimulation of the immune system (Jefferis, 2005). In eukaryotes, 
oligosaccharides are added on specific sequences of secreted proteins before entry into the ER in a 
process called N-glycosylation. An example of plant N-glycosylation is shown in Figure 11. 
Figure 11: Reference pathway for protein N-glycosylation in plants. Assembly of the lipid-linked oligosaccharide 
precursor begins on the cytoplasmic side of the endoplasmic reticulum (ER) membrane. The resulting Man5GlcNAc2-
PP-Dol then flips into the ER lumen, where four further Man residues and three glucose residues are added to produce 
the complete Glc3Man9GlcNAc2-PP-Dol.  
After transfer of the oligosaccharide precursor from the lipid carrier onto the nascent protein by the action of the 
multisubunit oligosaccharyltransferase complex, the newly formed N-glycoprotein enters the calnexin-calreticulin 
(CNX–CRT) cycle. The alternate action of glucosidase II and UDP-glucose:glycoprotein glucosyltransferase drives 
the glycoprotein through this cycle until it is correctly folded and exported from the ER to the GA (From Gomord et 
al., 2010). 
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The addition of the N-glycan chain contributes to the folding process of the protein and the 
following sugar modifications occurring in the ER have a signaling function in the protein-folding 
quality-control mechanism. Biosynthesis of N-glycans can be divided into two steps which occur 
sequentially in the ER and downstream in the Golgi. In the ER, glycosylation between mammals 
and plants is highly similar showing minimal differences in N-glycans found on mature 
glycoproteins (Gomord et al., 2010). The major differences are found in the Golgi apparatus were 
plant specific complex-type glycans are specifically added by the enzymes β 1,2-xylosyltransferase 
and α 1,3-fucosyltransferase instead absent in mammalian cells (Lerouge et al., 1998) (Figure 11). 
Furthermore, plant glycoproteins differ from their mammalian counterpart for the lack of β 1,4-
galactose, sialic acid complex-type glycans, core α 1, 6-fucose and the homologous of the 
mammalian N-acetylglucosaminyltransferases involved in further branching of the bi-antennary N-
glycans (Figure 12). 
 
 
 
Figure 12: N-glycans of human native antibodies (a) and recombinant antibodies produced in hamster CHO cells (b), 
murine cells (SP2 ⁄ 0 or NSO cell lines) (c), or tobacco plants (c) (Adapted from Gomord et al., 2010) 
 
Among differences, the lack of core α 1,6-fucose in plant produced IgGs is an advantage since it has 
been demonstrated that the elimination of these sugar moieties on the Fc portion of 
immunoglobulins drastically increases antibody-dependent cellular cytotoxicity (ADCC) (Shields et 
al., 2002). On the contrary, plant typical oligo-mannosidic IgG glycosylation profiles could induce 
the rapid clearance of the IgG from the blood stream exhibiting lower complement-dependent 
cytotoxicity (CDC) generated by binding to the antibody Fcγ (Raju, 2008; Jefferis, 2009). The main 
limitation of plant expression of recombinant protein, is represented by the presence of the typical 
plant sugars β 1,2-xylose and α 1,3-fucose, normally absent in mammalian proteins. As described in 
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literature, proteins harbouring these plant sugars could induce adverse side effects when used in 
human therapy. In fact, the immunogenicity of these N -glycan epitopes is well documented and 
their role in allergy has not yet been clarified (van Ree et al., 2000; Bardor et al., 2003; Gomord et 
al., 2005; Altmann, 2007). Based on this concern, new strategies have been adopted to engineer 
antibody glycosylation profiles in order to reduce problems related to the presence of typical plant 
sugars. Modulation of the N-glycosylation profile of plant produced antibodies, is largely described 
in literature and known as “glycoengineering”. Several strategies have been exploited until now to 
modulate the glycan structure such as retention of immunoglobulins in the endoplasmic reticulum 
(ER) using C-terminal KDEL tags (Floss et al., 2008; Kajiura et al., 2009; Sainsbury et al., 2010; 
Loos et al., 2011) production of aglycosylated antibodies through mutation of the HC specific N-
glycosylation site (Rodriguez et al., 2005; Nuttal et al., 2005) co-expression of antibodies with 
mammalian glyco-enzymes (Vézina et al., 2009) and expression of antibodies in plants in which 
genes coding for glycotransferase are inactivated or silenced by expression of siRNA (Strasser et 
al., 2008; Schahs et al., 2007; Gomord et al., 2010). Specific alterations of Fc glycosylation can 
improve antibody biological activity as recently shown by Forthal et al., (2010). Such alterations 
may result in better immunotherapeutic reagents in the case of antiviral activity, because complex 
glycan structures influence the binding to Fcγ receptors. In this study, five different glycoforms of 
the mAb 2G12 in wild-type and glycoengineered plants and CHO cells were produced. As a 
consequence, two 2G12 glycoforms produced in glycoengineered plants lacking β 1,2-xylose and α 
1,3-fucose and harbouring a uniform human-like glycosylation profile, exhibited considerably 
improved binding to FcγRIIIa in comparison to the 2G12 expressed in CHO cells or wild-type 
plants (Forthal et al., 2010). This work demonstrates that plant-produced antibodies may be 
endowed with improved biological functions compared to their mammalian derivatives (bio-
betters). The expression of antibodies harbouring the KDEL signal peptide at their C-terminus 
generally leads to accumulation of mAbs with high mannose-type N-glycans lacking β 1,2-xylose 
and α 1,3-fucose residues (Petruccelli et al., 2006; Floss et al., 2009; Sainsbury et al., 2010; Loos et 
al., 2011). However, in some cases, ER retention in plant cells seems not to be complete since 
KDEL tagged antibodies with a percentage of complex type plant typical sugars in the glycan chain 
have been documented. This event could be likely ascribed to a partial escape from the ER retrieval 
system during intracellular trafficking or to a partial proteolytic cleavage of the KDEL tag (Tekoah 
et al., 2004; Triguero et al., 2005; Floss et al., 2008; Kajiura et al., 2009). 
In order to avoid the potential immunogenicity deriving from the presence of typical plant sugars, 
aglycosylated mAbs have also been produced in plants. These immunoglobulins without N-linked 
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glycans are correctly assembled showing an antigen-binding capability comparable to their 
mammalian counterpart (Nuttal et al., 2005). Nevertheless, aglycosylated antibodies have some 
disadvantages such as shorter half-life in vivo (Saint-Jore-Dupas et al., 2007) or impaired binding 
to Fc receptors. Moreover, recent studies demonstrated that aglycosylated IgGs opportunely 
engineered are still able to interact with FcγRs both in vitro and in vivo, demonstrating that Fc 
glycosylation is not necessarily required for the activation of immune cells by IgGs (Jung et al., 
2010). 
Gene knock-out or silencing represents another alternative strategy used to decrease or eliminate the 
activity of plant-specific glycoltransferases. Plants in which the glycotransferases responsible for 
the addition of β 1,2-xylose or α 1,3-fucose have been down-regulated allowing the synthesis of 
proteins devoid of plant-specific glycoepitopes harbouring a “human-like” sugar profile. The N-
glycan composition was modulated using RNA interfering (RNAi) constructs to obtain a targeted 
down regulation of the expression of endogenous FucT and XylT genes in both A. thaliana and N. 
benthamiana. The absence of β 1,2-xylose and α1,3-fucose in the final purified antibodies was 
confirmed by Mass Spectrometry analysis (MS) and immunoblotting, demonstrating the possibility 
to use these engineered plants as an efficient expression platform for the production of human 
mAbs without detectable plant-specific N-glycan residues (Schahs et al., 2007; Strasser et al., 2008; 
Loos et al., 2011).  
Another glyco-engineering strategy was based on the co-expression of specific human 
glycosyltransferases in wild type N. benthamiana plants, in order to generate recombinant 
antibodies with β 1,4-galactose or sialic acid residues (Vézina et al., 2009; Strasser et al., 2009; 
Fujiyama et al., 2007). A very significant result in the production of a “human like” glycosylation 
pattern was obtained by Castilho et al., (2010). They demonstrated  the possibility to incorporate the 
entire biosynthetic pathway for protein sialylation in a plant host naturally lacking sialylated glyco-
conjugates, for the expression of mAb 2G12. This result was accomplished expressing, by 
agroinfiltration, the six enzymes responsible of the complete mammalian syalylation pathway, for 
the biosynthesis, activation, transport, and transfer of Neu5Ac to terminal galactose in N. 
benthamiana plants. The co-expression of these glycoenzymes with the HC and LC of the 2G12 
monoclonal antibody, resulted in quantitative sialylation of the Fc domain with the lack of plant-
specific N-glycan residues. This strategy showed the possibility to obtain immunoglobulins 
harbouring a N-glycosylation pattern similar to that obtained in mammalian cells, representing a 
model system for the manipulation of complex plant metabolic pathways. 
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2.4.8 Antibody proteolysis in plants 
 
A major issue for the production of recombinant proteins in plants is represented by degradation 
phenomena taking place in the cell or during downstream processes. In fact, unintended proteolysis 
processes could cause a dramatic reduction of the final yield of intact heterologous proteins. 
Moreover, quality and yield of the recombinant protein is significantly influenced by the relative 
intrinsic stability of polypeptide chains expressed in a heterologous cell environment (Faye et al., 
2005). Within cells, several proteolytic processes, crucial to guarantee fundamental metabolic 
functions, but in some cases these processes could represent a drawback for the production of 
biologically active recombinant products (Goulet et al., 2008). Proteases contribute to the regulation 
of several metabolic pathways by directing the activation of proteins involved in essential 
regulatory processes, by eliminating misfolded or mistranslated proteins and by recycling essential 
amino acids from short-lived proteins (van der Hoorn, 2008). Hundreds of genes encoding enzymes 
involved in proteolytic pathways have been identified in plants (Rawlings et al., 2008); for instance, 
about 800 genes have been discovered in Arabidopsis thaliana directly or indirectly involved in the 
hydrolysis of peptide bonds (Smalle and Vierstra, 2004). Moreover, the presence of proteases is 
very abundant in some subcellular compartments such as the vacuole and tonoplast or in the 
apoplast, the final destination of antibodies targeted to the secretory pathway (De Wilde et al., 1998; 
van der Hoorn, 2008). According to this data, it is important to consider that the plant cell 
environment presents a complex net of proteolytic processes and a multitude of possible proteases 
could heavily affect accumulation of the recombinant product (Beers et al., 2004).  
In the case of antibodies, unintended proteolysis driven by this complex proteolytic machinery 
could dramatically affect the final yield of intact IgG and in some cases could lead to an almost 
complete degradation (more than 90 %) of the final product (Villani et al., 2009). Many studies of 
antibodies expressed in plant leaves reported strong antibody degradation phenomena visible in 
SDS-PAGE analysis for the presence of additional smaller gel fragments between 20 and 150 kDa 
under non-reducing conditions (de Neve et al., 1993; Ma et al., 1994; Stevens et al., 2000; Sharp 
and Doran, 2001; Villani et al., 2009). Proteases may reduce the integrity of heterologous proteins 
in different manners, both in planta during protein synthesis and intracellular trafficking (Villani et 
al., 2009) and ex planta during the extraction procedure and subsequent purification phases (Sharp 
and Doran, 2000; Rivard et al., 2006). In fact, antibody fragments in plants have been interpreted as 
results of three phenomena: i) antibody assembly intermediates; ii) extracellular peptidase activity 
after secretion; iii) activity of peptidases released during sample homogenization (Sharp and Doran, 
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2001) (Table 11). As shown by a pioneering study, MAK33 antibody presented a stronger 
degradation when produced in N. tabacum than in A. thaliana confirming the hypothesis that 
proteolysis could be also a species-dependent event (De Neve et al., 1993). Besides, it is possible 
that degradation fragments resulting from a first “opening cleavage” might be further processed into 
smaller fragments by plant proteases (De Muynck et al., 2010). In addition, it is important to point 
out that the detection of IgGs by Western blotting analysis may not help to identify all generated 
degradation fragments, since antibodies used for detection, could bind proteolytic fragments with 
different affinity. Consequently, it is possible that degradation is largely underestimated in some 
cases (De Muynck et al., 2010). Recent studies have been focused on the identification of the 
degradation fragments obtained from in planta proteolysis. These fragments were analyzed by 
either MS (Ramessar et al., 2008; Villani et al., 2009) or N-terminal sequencing with Edman 
degradation (De Muynck et al., 2009) in order to localize the cleavage sites in the antibody 
aminoacid sequence. In the case of mass analysis, two major degradation products derived from an 
hypothetical cleavage occurring close to the hinge region of the H10 antibody were identified 
(Villani et al., 2009). Instead the study performed by De Muynck et al., (2009) thorough Edman 
Degradation led to the identification of the N-terminal sequence of a HC degradation product of the 
chimeric rat/human Lo-BM2 antibody localized in the hinge region. Data presented in these studies 
has been obtained expressing different antibody sequences in different host species, using different 
production systems and extraction procedures, therefore, the possibility to find a common 
degradation mechanism for all these antibodies is very difficult. 
Different strategies have been used to overcome unintended in planta proteolysis, some are based 
on the subcellular localization of the protein in specific tissues or cellular organelles. Antibody 
delivery in cellular compartments exhibiting low levels of total proteolytic activity could reduce the 
unintended antibody proteolysis, increasing the accumulation of the final product (Vitale and 
Pedrazzini, 2005; Stoeger et al., 2005). An example is represented by the production of a scFv 
antibody expressed in the ER of potato tubers cells. In this case, the antibody remained detectable 
and functional even after 1.5 years of tuber storage at 4 °C (Artsaenko et al., 1998). It has been 
proposed that ER retained antibodies, due to their protracted interactions with ER resident 
chaperones, can increase their folding efficiency, ensuring higher protection from plant proteolytic 
degradation and increasing accumulation levels (Ko et al., 2005; Petruccelli et al., 2006). However, 
a recent study performed by Loos and colleagues demonstrated that the secretory form anti-HIV-1 
2G12 antibody produced in N. tabacum seeds, accumulated at higher levels than the ER retained 
antibody (Loos et al., 2011).  
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Table 11: Putative degradation products noted on SDS-PAGE of plant-produced antibodies (es), size estimation from 
authors’ SDS-PAGE; (p), purified antibody (Adapted from De Muynck et al., 2010). 
Antibody Host species Organ ⁄ ER 
retention 
signal (X) 
Additional bands 
under non-reducing 
conditions 
Additional bands 
under reducing 
conditions 
 
References 
MAK33  
 
N. 
tabacum 
 
Callus  
 
35 kDa 
40 kDa 
44 kDa 
65 kDa  
88 kDa  
110 kDa (es) 
126 kDa (es) 
139 kDa (es) 
144 kDa (es)  
No 
 
De Neve et al., 
1993 
 
 A. thaliana 
 
Callus 35 kDa (es)  
88 kDa (es) 
126 kDa (es) 
139 kDa (es) 
144 kDa (es) 
45 kDa (es) 
 
 
 A. thaliana  Leaves 2 bands > 110 kDa (p) Not mentioned De Wilde et al., 
1996 
 Solanum 
tuberosum 
 
Tubers (X) Not mentioned 28 kDa (p) 
34 kDa 
De Wilde et al., 
2002 
Guy’s 13  
 
N. tabacum  Leaves 
 
40 kDa (es)  
72 kDa (es) 
116 kDa (es) 
44 kDa (es) 
40 kDa 
 
Ma et al., 1994 
 
  Hairy root 
cultures 
40 kDa (es) 
(biomass) 
50 kDa (es) (biomass) 
60 kDa (es) (biomass)  
90 kDa (es) (biomass) 
115 kDa (es) (biomass) 
140 kDa (es) (biomass) 
40 kDa (es) 
(biomass) 
 
 
Wongsamuth and 
Doran, 1997 
 
  Hairy root 
cultures 
40 kDa (es) (biomass) 
45 kDa (es) (biomass) 
50 kDa (biomass and 
medium) 
90 kDa (biomass 
and medium) 
120 kDa (biomass 
and medium)  
140 kDa (biomass and 
medium) 
40 kDa Sharp and Doran, 
1999 
  Suspension 
Cells 
135 kDa (es) (biomass)  
120 kDa (es) (biomass) 
80 kDa (biomass and 
medium) 
50 kDa (biomass 
and medium) 
Not mentioned  
  Roots 
(rhizosecretion) 
20 kDa  
60 kDa  
110 kDa  
125 kDa 
140 kDa 
Not mentioned  
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Similarly, the SEKDEL-tagged version of 2G12, expressed in maize seeds, accumulated to a lower 
amount compared to its secretory counterpart, showing an higher degradation (Rademacher et al., 
2008; Ramessar et al., 2008). These results indicate that ER retention of antibodies is not always an 
effective strategy to increase the accumulation levels of intact immunoglobulins in plants. 
Another interesting strategy to minimize in planta hydrolysis of recombinant proteins is to use 
plants expressing specific protease inhibitors. An example of this application has been described by 
Rivard et al., (2006). In this study, transgenic lines of potato expressing tomato cathepsin D 
inhibitor, active against trypsin and chymotrypsin, were obtained by A. tumefaciens mediated 
nuclear transformation. Protein extracts obtained from leaf exhibited decreased levels of Cathepsin 
D protease activity in vitro against ribulose 1,5-bisphosphate, even if a decreased proteolytic 
activity in vivo was not verified on recombinant proteins.  
Production of protease knock down organisms proved to be a successful strategy in bacteria and 
yeasts, but its application to complex multicellular organisms such as higher plants is very difficult 
since transgenic plants lacking specific proteases would not be viable (Schaller, 2004). For this 
reason, transient co-expression of recombinant proteins with protease inhibitors was recently 
described (Rivard et al., 2006). A study presenting a similar approach was reported by 
Komarnytsky et al., (2006). In this work, transient co-expression of a Bowman-Birk serine protease 
inhibitor, together with different mAbs in N. tabacum decreased breakdown of immunoglobulins 
favoring a sensible increase of the final IgG yield. 
C5-1 N. 
benthamiana 
 
Leaves (X) 35 kDa 
50 kDa 
60 kDa 
75 kDa 
95 kDa 
130 kDa 
Not mentioned Sainsbury et al., 
2008 
MGR48  N. tabacum Leaves 44 kDa (p) 
65 kDa (p) 
125 kDa (p) 
160 kDa (p) 
Not mentioned Stevens et al., 2000 
SO57 (X)   N. tabacum Leaves Not mentioned 22 kDa (es) Ko et al., 2003 
  Suspension 
cells (X) 
Not mentioned 60 kDa 
(biomass) 
75 kDa 
(biomass) 
Girard et al., 2006 
CL4  
 
 
N. tabacum Suspension 
Cells 
Not mentioned 33 kDa (p) (es)  
37 kDa (p) (es) 
39 kDa (p) (es) 
41 kDa (p) (es) 
Yano et al., 2004 
2G12  Zea mays Seeds Not mentioned  40 kDa (p) Ramessar et al., 
2008 
 A. thaliana Leaves Not mentioned 30 kDa (es) 
40 kDa (es) 
Schahs et al., 2007 
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In a recent study, genomic data for Arabidopsis, rice and some Nicotiana species were assessed in 
order to evaluate the presence of different proteases in the cell secretory pathway. The analysis of 
plant protease families present in N. benthamiana was performed using the MEROPS database 
(http://merops.sanger.ac.uk), a catalogue that contains the classification and nomenclature of 
peptidases, including their inhibitors and substrates. From this study the relative distribution of 
secreted protease-encoding genes among protease families in Arabidopsis, rice and Nicotiana 
species were recorded. In addition, an in vitro protease assay was carried out to confirm the 
presence and activity of N. benthamiana proteases predicted from the MEROPS analysis. Current 
genomic data suggested the presence of several protease families in N. benthamiana apoplast, 
including asparagine proteases, cysteine proteases and serine proteases. Subsequently, the inhibitors 
of the protease classes found (asparagines, serine and cystein proteases) both by the in silico and in 
vitro analysis were tested by transient expression in N. benthamiana, in order to verify the efficacy 
of protease inhibitors in stabilizing proteins targeted to the apoplast. As first result, transient 
expression and secretion of a tomato cathepsin D inhibitor (cystein proteases inhibitor) increased of 
45 % the total amount of the leaf apoplast protein favouring the accumulation of a murine 
diagnostic antibody C5-1, co-secreted in the apoplast. The same effect of stabilization on the same 
antibody was observed when this immunoglobulin was co-expressed in presence of a SlCYS9 
(Cysteine protease inhibitor) (Goulet et al., 2011). These preliminary data show that the use of 
proteases inhibitors could increase the in situ protection of recombinant proteins along the plant cell 
secretory pathway. 
At the moment, no general conclusions about proteases involved in the specific degradation of plant 
derived antibodies can be made. For this reason, an effective strategy to better investigate the 
mechanisms of plant proteolysis, aiming to increase the yield of intact plant derived recombinant 
proteins, should be focused on the analysis of several factors such as plant species and relative 
typical protease families, expression system used for the immunoglobulin production, and 
susceptibility of the specific antibody sequence to the proteolytic attack. 
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2.5 Thesis Scope of investigation 
 
This PhD work intends to give a contribution to knowledge in the field of plant-made 
biopharmaceuticals by providing new data on the transient over-expression of a tumour targeting 
antibody (mAb H10) with a particular focus on the optimization of plant extraction procedures, 
optimization of glycosylation profile and characterization of plant proteolysis. In this work a 
transient expression system based on vacuum-agroinfiltation of N. benthamiana plants, using the 
viral gene silencing suppressor protein P19 from Artichocke mottled crinckle virus (AMCV, 
Lombardi et al., 2009) allowed high protein expression yields, demonstrating to be a rapid and cost-
effective strategy for the production of the fully human anti-tenascin-C mAb H10 (Villani et al., 
2009). The aim of this PhD thesis was to optimize antibody extraction/purification methodologies, 
modulate the glycosylation profile and characterize in planta proteolysis.  
The optimization of the extraction/purification steps was carried out evaluating different strategies 
in terms of antibody yield, degradation and level of contaminants in the final purified product. In 
addition, the glycosylation pattern of the plant produced mAb H10 was modulated evaluating the 
effects of the different glycan moyeties on antibody quality and final yield. Results also suggest 
that, among all factors contributing to protein stability, glycosylation might play an important role. 
Finally, we characterised the degradation profile of the tumour targeting H10 antibody in the 
attempt to identify specific proteolytic cleavage sites of the plant produced immunoglobulin. 
Overall data indicate that possible ‘fragile’ sites in the H10 antibody reside in the hinge region, that 
is particularly prone to cleavage by the plant protease machinery. The identification of these 
cleavage sequences is a first step towards the development of new strategies to reduce antibody 
degradation in plants and increase the yield of intact IgG molecules.  
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3.1 Bacterial Strains 
 
Escherichia coli XL1-Blue: supE44 hsdR17 recA1 endA1 gyrA46 thi relA1 lac -. 
Agrobacterium tumefaciens LBA 440 (Ach5 pTiAch5) Sm/Sp(R) 
 
3.2 Plant Material 
 
Seedling and germination of N. benthamiana plants used for transient expression and N. tabacum 
used for protoplast recovery were performed under artificial illumination (16 hour light /dark cycle) 
at a constant temperature of 26 °C. After 2 weeks from seedling, plants were transferred in single 
pots and grown under the same conditions.  
 
3.3 Vectors 
 
pGEM-Nos. Cloning vector derived from the pGEM ®-4Z (Promega). The pGEM-4Z (Figure M1) 
contains a polylinker riarranged from pUC18 plasmid, in the region of Lac-Z gene coding for the α 
peptide of β-galactosidase, required for the α-complementation assay. Polymarese promoters SP6 
and T7, are localized respectively upstream and downstream of the multiple cloning site; the gene 
used for the antibiotic resistence is the β-lactamase that confers resistance to ampicillin. The 
pGEM-Nos was obtained by cloning the terminator sequence (253 bp) gene of the enzyme nopaline 
synthase (NOS) derived from Agrobacterium tumefaciens. 
 
 
Figure M1: Vector pGEM-4Z. SacI-EcoRI restriction sites used to insert the terminator sequence of nopaline synthase 
gene (Nos) are highlighted in yellow. 
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pBIΩ. Binary vector derived from plasmid pBI121. The pBI121 contains an expression cassette (T-
DNA) harbouring the GusA gene controlled by the strong constitutive promoter of the Cauliflower 
Mosaic Virus CaMV-35S, between the "right" and the "left" border, the gene coding for the GusA 
gene, the nptII gene encoding neomycin phosphotransferase, which confers resistance to 
kanamycin, and the NOS terminator sequence of nopaline synthase gene. The pBIΩ was obtained 
by cloning the nucleotide sequence of “Ω translational enhancer" (Gallie et al., 1992) derived from 
the Tobacco mosaic virus TMV downstream the 35S-CaMV promoter, in the XbaI-BamHI sites, 
and replacing the pgip2 with the GusA gene in the BamHI-SACI site (Figure M2). 
 
 
 
FiguraM2. Schematic representation of the pBIΩ. Expression cassette. In yellow are reported the XbaI-BamHI site 
used for the insertion of the Ω translational enhancer and the Bam HI-SacI site used to replace the pgip2 with the GusA 
gene. 
 
3.4 Manipulation of Escherichia coli and Agrobacterium tumefaciens 
 
3.4.1 Preparation of elettrocompetent Escherichia coli XL-1 Blue 
 
Two millilitres of Luria Bertani (LB) medium (10 g/l bacto-tryptone; 5 g/l yeast extract; 10 g/l 
sodium chloride) was inoculated with 10 µl of XL-1 Blue (in 50 mM CaCl2; 20 % (v/v) glycerol), 
and incubated overnight at 37 °C shaking at 250 rpm. One millilitre of this culture was then used to 
inoculate 100 ml of LB sterilised in a 1l conical flask. The cells were incubated at 37 °C shaking at 
250 rpm until the culture had reached an O.D.600 of 0.6. The culture was then cooled on ice for 30 
minutes, and transferred into two sterile 50 ml Falcon tubes. Cells were harvested by centrifugation 
at 3000 × g (Beckman centrifuge, Avanti JA-25) at 4 °C for 10 minutes. Centrifugation was 
repeated 3 times. The supernatant coming from the last centrifugation was discarded, and the pellets 
resuspended in 25 ml cold water each, by swirling. The resuspended cells were kept on ice for 30 
minutes and centrifuged again as previously described. The supernatant was discarded, and the 
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pellet was gently resuspended in 3 ml cold 10 % (v/v) glycerol. Finally, a further 3 ml cold 10 % 
(v/v) glycerol was added and, after mixing, cells were transferred to pre-cooled 1.5 ml eppendorfs 
in 50 µl aliquots. These aliquots were frozen immediately in liquid nitrogen, and stored at −80 °C. 
 
3.4.2 Preparation of electro-competent Agrobacterium tumefaciens LBA 4404 
 
Several colonies from a stock agar plate were transferred to 100 ml LB media supplemented with 50 
mg/ml rifampicin in a large conical flask. The culture was incubated at 28 °C shaking at 250 rpm 
overnight. Fifty millilitres of the overnight culture was used to inoculate a similar, 500 ml culture 
which was allowed to grow under the same conditions until O.D.600 of 0,6. The resulting culture 
incubated on ice for 20 minutes before centrifugation at 4,000 g for 15 minutes at 4 °C (Beckman 
centrifuge, Avanti JA-25). This step was repeated 4 times. The supernatant coming from the last 
centrifugation was discarded and the pellet resuspended in 25 ml ice-cold ddH2O. After the sixth 
centrifugation, the cell pellet was resuspended in 5 ml sterile ice-cold 10 % glycerol and combined 
into two 50 ml centrifuge tubes. Following a final centrifugation at 3,000 g for 10 minutes at 4 °C, 
the cell pellets were resuspended in 1 ml ice-cold 10 % glycerol and divided into pre-cooled 
Eppendorf tubes in 50 µl aliquots. Cells were either used immediately or flash-frozen in liquid 
nitrogen before storage at -80 °C for up to 1 year. 
 
3.4.3 Transformation of electro-competent Agrobacterium tumefaciens LBA 4404 
and Escherichia coli XL-1 Blue 
 
Fifty nanograms DNA in 1 µl ddH2O was mixed with 50 µl electro-competent cells in a 1.5 ml 
eppendorf tube and immediately transferred to a pre-cooled electroporation cuvette (Biorad). The 
mixture was subjected to a 2,5 kV discharge with a capacitance of 25 mF and a resistance of 200 Ω 
(Biorad Gene Pulser). The newly-transformed cells were mixed with 1 ml LB broth and incubated 
horizontally at 28 °C in the case of LBA 4404 and 37 °C for XL1-Blue, shaking at 250 rpm for 1 
hour. Cells were harvested by centrifugation at 3000 rpm (bench microfuge) for 2 minutes, 800 µl 
supernatant was removed, and the pellet was resuspended in the remaining broth and plated on LB-
agar plates (LB, 2 % (w/v) bacto agar) containing the appropriate selective antibiotics. Plates were 
incubated inverted overnight at the specific temperature 
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3.5 Nucleic acid techniques 
 
3.5.1 Preparation of plasmid DNA from Escherichia coli XL-1 Blue 
 
Mini-preparation of plasmid DNA was performed using the QIAprep Spin Plasmid Kit. An 
overnight culture of the plasmid-containing E. coli was prepared by inoculating 3 ml LB, containing 
the appropriate selective antibiotic, with the colony of interest and incubating at 37 °C with 250 rpm 
shaking. The following day, 1.5 ml of this culture was transferred to a 1.5 ml eppendorf and cells 
were harvested by centrifugation at 13000 rpm (bench microfuge) for 1 minute. The supernatant 
was discarded, and the resulting cell pellet was used according to the manufacturer's protocol. The 
DNA was recovered in 50 µl of ddH2O, and either used immediately or stored at −20 °C. 
 
3.5.2 Restriction digestion of DNA 
 
Restriction endonucleases were used to digest DNA constructs in order to prepare them for ligation. 
Typically, 1-2 µg DNA was incubated with the appropriate NEB (New England Biolabs) buffer to a 
final concentration of 1 X in the presence of 1 µl enzyme (5-10 U/µl) in a total volume of 20 µl at 
37 °C for 1-2 hour. The resulting DNA fragments were analysed by agarose gel electrophoresis. 
When more than one enzyme was used on the same DNA, and these enzymes did not have 
compatible buffers, the cut DNA was isolated and purified between each digestion. When plasmid 
DNA was cut in preparation for the ligation of an insert, it was dephosphorylated by incubation 
with 1 µl (20 U/µl) Antarctic Phosphatase (AP, NEB) for 1 hour at 37 °C, before being isolated and 
purified. 
 
3.5.3 Agarose DNA gel electrophoresis  
 
Agarose gels were prepared with 1-2 % (w/v) agarose dissolved in 1 X TAE buffer (2 M Tris-
Acetate, 0.05M EDTA, pH 8.3) containing 0.05 % (w/v) ethidium bromide, to stain the DNA. DNA 
samples were mixed with 5X DNA sample buffer (40 % (w/v) sucrose; 0.25 % (w/v) bromophenol 
blue, 10 % glycerol) to a final concentration of 1 X buffer, and the mixture loaded into the wells. 
DNA was subjected to electrophoresis at 80 V. The DNA was visualized by placing the gels on a 
short wave ultra-violet transilluminator. 
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3.5.4 Isolation and purification of DNA from agarose gels 
 
DNA digests were carried out and run on agarose gels. Fragments were excised from the gel under 
short wave ultra-violet illumination, keeping exposure time to a minimum, using clean scalpel 
blades and transferred to eppendorf tubes. DNA was then either stored in the gel fragment at −20 
°C, or purified immediately, according to the manufacturer's protocol, using the QIAprep Gel 
Extraction Kits. DNA was typically recovered in 30 µl ddH2O, and either used immediately or 
stored at −20 °C. 
 
3.5.5 Ligation of DNA fragments 
 
DNA ligations were performed using T4 DNA ligase, either blunt-ended or following restriction 
endonuclease digestion and subsequent generation of cohesive DNA ends. DNA fragments, 
typically in a 5:1 molar ratio of insert to vector, were mixed with 2 µl of 5 X T4 DNA ligase buffer 
(250 mM Tris-HCl, pH 7.6; 50 mM MgCl2; 5 mM ATP; 5m M DTT; 25 % (w/v) polyethylene-
glycol 8000) and 1 µl T4 DNA ligase (1 U/µl), and made up to a total volume of 10 µl with ddH2O. 
The mixture was normally incubated for 1.5 hours at 37 °C. Typically, 5 µl of the ligation reaction 
was used to transform competent E. coli cells. 
 
3.5.6 DNA mutagenesis 
 
Point mutations performed to obtain H10 Mut, H10 CH1-VH, H10 CH1-CH2, H10 VH-CH1-CH2 
were generated using Pfu DNA polymerase from the QuikChange™ Site-Directed Mutagenesis Kit 
(Stratagene). Mutagenic primers were designed to contain the desired mutation and anneal to the 
same sequence on opposite strands of the plasmid. The primers were built in order to have a 
minimum G/C content of 40 %, a melting temperature (Tm) ~10 °C above the extension 
temperature of 68 °C, and with standard purity. 30 ng of dsDNA template was mixed with 125 ng 
of each oligonucleotide primer, 1 µl of 10 mM dNTP mix (2.5 mM of each NTP), and 5 µl of 10X 
reaction buffer, in a total reaction volume brought to 50 µl with ddH20. 1 µl Pfu DNA polymerase 
(2.5 U/µl) was added, mixed, and the reaction subjected PCR (polymerase chain reaction) according 
to the manufacturer's protocol. Once at 37 °C, 1 µl Dpn1 (10 U/µl) restriction enzyme (10 U/µl) was 
added, and the reaction mixed and incubated for 1 hour at 37 °C to digest the parental, non-mutated 
DNA. 5 µl of the DNA left after this digestion, containing the nicked, mutated vector, was then 
used to transform competent cells. 
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3.5.7 Gene construction 
 
All constructs encoding sequences were cloned into the pBI-Ω plant expression vector (Marusic et 
al., 2007) under the control of the constitutive CaMV 35S promoter and the nopaline synthase 
(NOS) terminator sequence. To enhance translational efficiency, the Tobacco mosaic virus (TMV) 
5' leader sequence Ω (Gallie and Kado, 1989) was fused in frame with the protein sequences.  
The H10 antibody was obtained starting from the anti-TNC scFv(H10) selected from the human 
ETH-2 phage display library (Viti et al., 2000) against hC-TNC, as described in Villani et al., 
(2009). Sequences encoding VH and VL, derived from human germ-line segments DP47 H and 
DPL16 L, were amplified from the pDNEK scFv(H10) plasmid using the following primers: SP-
VH1for (5′-
TCTTCCTCCTGTCAGGAGCTGCAGGTGGTACCTCGGAGGTGCAGCTGGTGGAGTCTGG- 
3′), VH-CH1rev (5′-CCTTGGTCGACGCTCTCGACACGGTGACCAGGGTTCC- 3′) and SP-
VL1for (5′-GTCAGGAGCTGCAGGTGGTACCTCGTCTGAGCTGACTCAGGACCCTGC- 3′), 
VL-CL rev (5′-GCAGCCTTGGGCTGGCCTAGGACGGTCAGCTTGGTCC- 3′), respectively. 
The signal sequence of an embryonic mouse IgG HC gene was subsequently added at 5′ of both VH 
and VL sequences, amplifying with the forward primer SP2. For the generation of (H10) heavy 
chain and (H10) light chain constructs, the amplified VH and VL segments were fused to the heavy 
γ1 and light λ constant regions of a human IgG1 (provided as cDNA by Philogen S.p.A., 
Monteriggioni, Italy) by SOE-PCR (Ho et al., 1989). Briefly, a set of primers was used to generate 
two DNA fragments having overlapping ends using PCR with Pfu polymerase (Stratagene, La Jolla, 
CA, USA). PCR-generated DNA fragments were first purified from agarose gel and then used in a 
subsequent overlap extension reaction to obtain the resulting fusion products. The IgGγ1 constant 
region was amplified using the primers VH-CH1for (5′- 
CACCGTGTCGAGAGCGTCGACCAAGGGCCCATCGG- 3′) and CH3rev (5′- 
TCTTACCCGGGTCATTATTTACCCGGAGACAGGGAGAGGC- 3′), and the λ constant region 
was amplified using the primers VL-CLfor (5′- 
CCGTCCTAGGCCAGCCCAAGGCTGCCCCCTCG-3′) and CLrev (5′- 
CATTATGAACATTCTGTAGGGGCCACTGTCTTC-3′).  
The H10-Mut was obtained mutating the Asn 297 to Ala by using the QuikChange™ Site-Directed 
Mutagenesis Kit (Stratagene, USA). An oligonucleotide containing the site-specific mutation was 
used for the mutagenesis reaction following the manufacturer indications. H10-SEKDEL was 
constructed fusing the DNA sequence coding for the SEKDEL to the 3’-end of both HC and LC 
chain antibody coding genes. Fusion was conducted using specific primers (LCSEKDEL: 5’ 
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TTGAGCTCTCATTACAGCTCATCCTTCTCTGATGAACATTCTGTAGGGGCCACTGTC 3’; 
HCSEKDEL: 5’ 
TTGAGCTCTCATTACAGCTCATCCTTCTCTGATTTACCCGGAGACAGGGAGAGGCTCTT
C 3’) through an overlap extension PCR. For transient expression in N. benthamiana plants all 
constructs were cloned into the binary vector pBI-Ω, confirmed by DNA sequencing and introduced 
into Agrobacterium tumefaciens strain LBA4404 by electroporation. The mAb H10 forms obtained 
with the agroinfiltration of this vector are indicated in Table M1: 
 
Table M1: Description of all the H10 constructs used for transient expression in N. benthamiana plants of different H10 
formats. An indication of the property of every antibody format is enlisted. 
 
For transient expression in tobacco protoplasts, 35S expression cassettes of all constructs were 
cloned in a pGEM-nos plasmid vector. The H10 forms obtained with this vector are enlisted in 
Table M2: 
 
Table M2: Description of all the H10 constructs used for transient expression in tobacco protoplasts of different H10 
formats. An indication of the property of every antibody format is indicated. 
 
 
H10 FORM COSTRUCTS CO-EXPRESSED ANTIBODY PROPERTY 
H10 p35:HC, p35:LC, p35:P19 Secretory form 
H10 SEKDEL p35:HC-SEKDEL, p35:LC-SEKDEL, p35:P19 ER retained form 
H10 Mut p35:HC-Mut, p35:LC, p35:P19 Aglycosylated form 
H10VH-CH1 p35:HCVH-CH1, p35:LC, p35:p19 Mutated in the VH-CH1 region 
H10CH1-CH2 p35:HCCH1-CH2, p35:LC, p35:p19 Mutated in the “hinge region” 
H10VH-CH1-CH2 p35:HCVH-CH1-CH2, p35:LC, p35:p19 Mutated in both VH-CH1 and 
“hinge region” 
H10XylT/FucT p35:HC, p35:LC (expressed in  XylT/FucT 
RNAi-silenced N. benthamiana plants) 
Antibody harbouring a “human 
like” glycosylation profile 
H10 FORM COSTRUCTS EXPRESSEDIN 
PROTOPLASTS 
ANTIBODY PROPERTY 
H10 pGem:HC, pGem:LC Secretory form 
H10 SEKDEL pGem:HC-SEKDEL, pGem LC-SEKDEL ER retained form 
H10 Mut pGem:HC-Mut, pGem:LC Aglycosylated form 
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3.6 Manipulation of N. benthamiana and N. tabacum plants 
 
3.6.1 Agroinfiltration of Nicotiana benthamiana leaf cells by needleless syringe 
 
Five millilitres overnight cultures of A. tumefaciens transformed with the different constructs (p35: 
HC, p35:LC, p35:p19) were grown separately to O.D.600 of 0.4–1.5 at 28 °C shaking at 250 rpm. 
The culture was centrifuged at 5000 g in a Eppendorf 5810R centrifuge for 5 minutes. The pellet 
was resuspended in a volume of infiltration medium (10 mM MES, 10 mM MgCl2, pH 5.5) to reach 
a final O.D.600 of 0.5-0.6 for each Agrobacterium. The cells were pressure injected into the lower 
epidermis of the leaf through an 1 ml disposable syringe. Multiple transformation was achieved by 
mixing relevant cultures prior to infiltration. The plant was then incubated under a 16 hr /8 hr light 
/dark regime at room temperature for 2-6 days before protein extraction. 
 
3.6.2 Vacuum agroinfiltration of Nicotiana benthamiana plants 
 
Large scale transient expression in N. benthamiana was performed by vacuum agroinfiltration. 300 
ml of each A. tumefaciens clone harbouring the specific constructs (p35: HC, p35:LC, p35:p19) 
were grown separately, and bacteria were pelleted by centrifugation at 4000 g, resuspended in 
infiltration buffer (10 mM 2-(N- morpholino) ethanesulphonic acid (MES), 10 mM MgSO4, pH 5.8) 
and mixed together in order to reach a final O.D.600 value of 0.5-0.6 for each construct. Six-week-
old N. benthamiana plants (at the six- to seven-leaf stage) were infiltrated by completely 
submerging each plant in the Agrobacterium-containing solution inside a vacuum chamber. 
Vacuum was then applied, reaching approximately 10 mmHg, and then quickly released. Infiltration 
was confirmed visually, observing infiltrated areas as translucent. The H10XylT/FucT antibody was 
obtained by agroinfiltrating plants of the XylT/FucT Nicotiana benthamiana transgenic line 
(Strasser et al., 2008) with a suspension of A. tumefaciens clones harbouring HC and LC encoding 
sequences exactly as previously described. For antibody purification, batches of 40 g of 
agroinfiltrated leaves were collected and directly processed. 
 
3.6.3 Preparation of protoplasts from N. tabacum SR1 leaves 
 
An enzyme mix (Macerozyme Onozuka R-10, 2 % (w/v); Cellulase Onozuka R-10, 4 % (w/v) in K3 
medium (Gamborg's B5 basal medium with minimal organics, 3.78 g/l; CaCl2.2H2O, 750 mg/l; 
NH4NO3, 250 mg/l; sucrose, 136.2 g/l; xylose, 250 mg/l; 6-BAP, 1 mg/l; a-naphtalenacetic acid 
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(NAA), 1 mg/l) was poured into 10 cm Petri dishes in 7 ml aliquots. 4-6 week old green leaves were 
cut from a sterile plant and carefully scarified on their underside (operating quickly in order to 
avoid excess dehydration of the leaf) and incubated overnight in the dark at 26 °C. The digestion 
mix was carefully removed using a sterile Pasteur pipette and discarded, leaving protoplasts still 
attached to the leaves. 3 ml of K3 was added drop wise over the leaves, and the plates gently 
agitated in order to release the protoplasts. The resulting protoplast solution was removed, using a 
fresh sterile Pasteur, and filtered through a 100 µm brass sieve, flamed and wet with K3 medium 
before use. The harvested, filtered protoplasts were centrifuged at 100 g (600 rpm, Beckman GPR 
bench centrifuge, GM3.7 rotor) for 20 minutes at room temperature. The pellet of broken 
protoplasts and most of the K3 medium in excess were removed, using a Pasteur pipette connected 
to a 25 ml pipette. The remaining 5 ml of medium contained the floating layer of viable protoplasts. 
After mixing gently to redistribute this floating layer, 4 volumes of W5 (NaCl, 9 g/l; KCl, 0.37 g/l; 
CaCl2.2H2O, 18.37 g/l; glucose, 0.9 g/l) was added drop-wise down the wall of the tube. Protoplasts 
were pelleted by centrifugation at 100 g (600 rpm, Beckman GPR bench centrifuge, GM3.7 rotor) 
for 10 minutes at room temperature, and the supernatant aspirated off and discarded. Protoplasts 
were pelleted again and the supernatant discarded. Finally, protoplasts were carefully resuspended 
in 10 ml of W5 and incubated in the dark for 30 minutes at room temperature, and of 50 µl of 
sample was removed for cell count. 
 
3.6.4 Pulse-chase analysis  
 
Forty micrograms of each plasmid (pGemHC, pGemLC, pGemHC-Mut, pGemHC-SEKDEL, 
pGemLC-SEKDEL) were used to transform 106 protoplasts in a volume of 1 ml. Pulse-chase and 
immunoprecipitation were performed essentially as described before (Hadlington et al., 2003). 
Briefly radioactive labeling was performed by incubation 1 h at 26 °C in the dark in K3 medium 
(Gamborg’s B5 basal medium with minimal organics, 3.78 g/L; , supplemented with 750 mg/L 
CaCl2~2H2O, 250 mg/L NH3NO, 136.2 g/L sucrose, 250 mg/L xylose, 1 mg/L 6-
benzylaminopurine, and 1 mg/L a-naphthalenacetic acid, pH 5.5) supplemented with 150 µg/mL of 
BSA and 7 µCi/mL of PRO-MIX (35S-methionine and cysteine; Amersham). Unlabeled methionine 
and cysteine (10 mM and 5 mM, respectively) were used for the chasing. The zero time-point was 
taken by removing protoplasts, immediately after mixing. The protoplasts were pelleted by 
centrifugation at 100 g at 4 °C for 10 minutes. The supernatant was centrifuged as before, in order 
to precipitate any protoplasts carried over from the pellet. The subsequent time-points (2.5 and 5 
hours) were taken in the same manner, and samples were stored at −80 °C until use. Harvesting was 
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performed at 0, 2.5 h, 5 h, after the chasing. Protoplasts and incubation media were frozen and 
homogenized by adding two volumes of ice-cold homogenization buffer (150 mM Tris-HCl, 150 
mM NaCl, 1.5 mM EDTA, and 1.5 % (wt/vol) Triton X-100, pH 7.5). Immunoprecipitation of 
expressed polypeptides was performed using a 1:1 mix of Protein-A-Sepharose® (P3391 Sigma 
Aldrich) and Protein G Sepharose®, (P3296 Sigma Aldrich). Separation was performed by SDS-15 
% (w/v) PAGE. Gels were vacuum dried at 80 °C, using a gel drier (Bio-Rad 583), before being 
exposed to X-ray film (Kodak BioMax MR, UK) in a light-proof cassette stored at −80 °C for an 
appropriate length of time. Films were developed under darkroom conditions using an automatic 
developer (Agfa Curix 60).  
 
3.7 Protein extraction, separation and detection 
 
3.7.1 Protein extraction procedures: Total leaf extract (small scale), Pilot-Scale 
extraction, isolation of leaf Intercellular Fluids 
 
Batches of fresh leaves (40 g) were homogenised in 80 ml of extraction buffer (1 X Phosphate 
Buffered Saline (1 X PBS) containing protease inhibitors (Complete™, Roche, Germany), using an 
Ultra-Turrax homogeniser T25 equipped with a S25N-18G disperser (IKA, Staufen Germany). 
After homogenisation (three pulses of 1 min at 17,500 rpm in ice), the slurry was filtered through 
Miracloth (Sigma-Aldrich, USA) and centrifuged twice at 8,000 g for 20 minutes at 4 °C. For 
purification, after microfiltration through 0.45 µm and 0.20 µm Minisart filters (Sartorius, 
Germany), the extract was directly loaded on a HiTrap™ Protein-A HP column (GE Healthcare, 
Uppsala, Sweden). Total protein and antibody concentration were determined by Bradford and 
ELISA, respectively. 
For pilot-scale purifications, batches of 250 g of leaves (stored at -80 °C) were homogenised using a 
blade blender in extraction buffer (PBS pH 7.4, EDTA 5 mM, and protease inhibitor cocktail 1 % 
(v/v) to a final volume of about 750 ml. The extract was then centrifuged in a Beckmann JA-10 
rotor for 25 min at 8,000 rpm at 4 °C. The pH of the recovered supernatant was adjusted at pH 7.5 
with 5 M NaOH and centrifuged again as described above. The supernatant was pre-filtered through 
a 0.8 µl filter and subsequently through a 0.22 µl Stericup filter (Millipore, MA, USA). Total 
protein and antibody concentration were determined by Bradford and ELISA, respectively. 
Intercellular fluids, from agroinfiltrated N. benthamiana leaves, were collected through an 
infiltration-centrifugation method according to a previous work with minor modifications (Lohaus 
et al., 2001). In order to obtain intercellular fluids for affinity chromatography purification, 80 g of 
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full-size leaves were collected from 15 plants of N. benthamiana at 6 d.p.i. and immediately 
infiltrated in 1 l of room temperature infiltration buffer (PBS, 10 mM phenylmethnesulphonyl 
fluoride PMSF) using a vacuum-infiltration system. After vacuum release, leaves were gently 
paper-dried (15 leaves at a time) and put in 50 ml tubes previously perforated at the bottom to allow 
liquid flow through. Tubes were placed in Beckman 250 ml tubes and centrifuged at 800 g for 10 
minutes in an eppendorf centrifuge 5810 R (A-4-62 rotor). From this step, 80 ml of clear fluid 
(about 1 ml of IFs per g of fresh leaves) were collected. After microfiltration through 0.45 and 0.20 
ml Minisart filters, the fluid was directly loaded on affinity chromatography.  
 
3.7.2 Isolation and purification of protein bands from polyacrylamide gels 
 
Purified antibodies obtained from protein A chromatography were run by SDS-PAGE in non 
reducing conditions in order to obtain the separation of antibody fragment. Fragments were excised 
from the gel, using clean scalpel blades and transferred to eppendorf tubes. Proteins were 
immediately ground with a pestel in presence of 50-70 µl of PBS 1 X and subsequently centrifuged 
at 15000 g at 4 °C for 5 minutes. Supernatants containing the protein fragments were recovered and 
subjected to Western Blot (25 µl of sample per lane), ELISA (70 µl of sample per well).  
 
3.7.3 Western blotting of SDS-polyacrylamide gels 
 
Protein samples obtained by leaf extracts separated by SDS-PAGE were transferred from gels onto 
PVDF membrane (prepared by soaking briefly in MeOH and then for 2 minutes in transfer buffer 
(25 mM Tris; 192 mM glycine; 20 % MeOH) in transfer buffer using Sigma-Aldrich techware 
Semi-dry blot apparatus under a constant current of 40 mA/gel for 1 hour. The membrane was then 
blocked in phosphate-buffered saline (PBS, 137 mM NaCl; 0.27 mM KCl; 10.4 mM disodium 
hydrogen phosphate; 1.8 mM potassium dihydrogen phosphate) containing 5 % (w/v) dried 
skimmed milk powder and 0.2 % Tween-20 with agitation over night. The block was discarded and 
the membrane was washed 3 times, 10 minutes with PBST 1 X (PBS 1 X, 0.05 % Tween 20) and 2 
times 10 minutes with PBS 1 X, than incubated, with continual agitation, in 20 ml PBST 1 X 
containing the primary antibody or the concanavalin A for 2 hour. In the case of non-conjugated 
primary antibodies, the membrane was washed, as described above, and incubated in 20 ml PBST 1 
X containing the horseradish peroxidase-conjugated secondary antibody for 1 hour. The membrane 
was then washed as before, and detection of immunoreactive bands performed using the ECL kit 
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(Enhanced chemiluminescence, Amersham, UK), according to the manufacturer’s instructions, and 
recorded by exposing to X-ray film (Kodak BioMax MR, UK) in a light-proof cassette for an 
appropriate time. The proteins and antibodies used in the Western blot experiments are listed in 
Table M3. 
Purified IgGs from agro-infiltrated plants were analysed by reducing and non-reducing SDS-12 % 
(w/v) PAGE (Tavladoraki et al., 1999) and stained with Coomassie or silver nitrate (Merril et al. 
1981). Plant extracts were also analysed by Western blot as previously described. Glycans were 
analysed using biotin-conjugated Concanavalin A from Canavalia ensiformis (C2272 Sigma) 
diluted 1:10,000 in 1 % BSA, 1 X PBS and peroxidise conjugated streptavidin (S5512, Sigma) 
diluted 1:12,000 in 0.1 % BSA, 1 X PBS. Proteins were detected by enhanced chemioluminescence 
(ECL, Plus, GE Healthcare, UK).  
In the case of band shift analysis of H10-SEKDEL and H10-Mut heavy chain, reducing SDS-9 % 
(w/v) PAGE was performed running gels for a long time period (2.5 h). 
 
Table M3: Reagents used in Western Blot and ELISA experiments. 
 
Antibody/protein Antigen Dilution Used as Obtained in Supplier 
Antibody A8419 Human γ-Chain 1:5000 Primary Ab Goat Sigma-Aldrich 
Antibody A5175 Human λ-Chain 1:5000 Primary Ab Goat Sigma-Aldrich 
Canavalia 
Ensiformis Type 
IV C2272 
Plant Lectins 1:12000 Primary 
ligand 
(Biotinylated) 
Rabbit Sigma-Aldrich 
Streptavidin-PO 
S5512 
Biotin 1:10000 Secondary 
ligand 
 Sigma-Aldrich 
 
3.7.4 ELISA assays 
 
For the quantification of HC and LC expression, agroinfiltrated leaves from N. benthamiana were 
analyzed by double-antibody-sandwich ELISA. Eighty milligrams of leaf tissue were ground in 
liquid nitrogen and homogenized in 500 µl of PBS containing protease inhibitors (Complete™, 
Roche, Mannheim, Germany). After centrifugation at 15000 g for 30 min at 4 °C, the supernatant 
was recovered and quantified for total soluble protein (TSP) using the Bradford colorimetric assay, 
as specified by the manufacturer (Bio-Rad, Hercules, CA, USA). The capture antibody (anti-human 
γ chain (8419, Sigma-Aldrich) or anti-human λ chain (5175, Sigma-Aldrich) at a concentration of 2 
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µg/mL in 1 X PBS) was coated directly on to Nunc-Immuno Maxisorp wells (Nunc-Immuno, 
Roskilde, Denmark) and incubated overnight at 4 °C. The plates were then blocked with 2 % milk 
(w/v) in PBS at 37 °C for 2 h. After washing, different dilutions of leaf extracts, normalized for TSP 
concentration, were added to the wells (100 µl) and incubated at 37 °C for 2 h. After washing, the 
anti-human γ chain horseradish peroxidase (HRP)-conjugated (8419, Sigma-Aldrich) or anti-human 
λ chain HRP-conjugated (5175, Sigma-Aldrich) antibodies were added at a dilution of 1:5000 in 2 
% milk (w/v) in PBS and incubated for 1 h at 37 °C. Enzymatic activity was measured after 30 
minutes at 405 nm on a microtitre plate reader (TECAN-Sunrise, Groedig, Austria) using 2,2-azino-
di-3- ethylbenz-thiazoline sulphonate (ABTS, KPL, Gaithersburg, MD, USA). As a positive 
control, human IgG1-γ (I5029, Sigma-Aldrich) at different dilutions (ranging from 10 to 100 ng) 
was used.  
Quantitative ELISA on agroinfiltrated leaf extracts was performed by coating the recombinant BCD 
domains of mouse TNC (mTN-C BCD) (provided by Philogen S.p.A.) at a concentration of 20 
µg/ml in PBS 1 X onto Nunc-Immuno Maxisorp plates (Nunc-Immuno, Roskilde, Denmark) and 
overnight incubation at 4 °C. Plates were blocked and serial dilutions of leaf extracts (100 µl per 
well), normalised for TSP content using the Bradford colorimetric assay (Bio-Rad, Germany), were 
incubated as described before. After washing, the anti-human λ-chain HRP-conjugated (1: 5,000 in 
PBS 1 X) was added to detect bound mAb H10 and enzymatic activity was measured after 30 
minutes at 405 nm on a microtitre plate reader as previously described. As an internal standard, we 
used mAb H10 previously purified by protein-A and cation-exchange chromatography from 
agroinfiltrated N. benthamiana leaves at known concentrations (ranging from 1 to 100 ng) spiked in 
wild type N. benthamiana extract. Each sample was assayed in triplicate and concentrations were 
interpolated in the linear portion of the standard curve.  
 
3.7.5  2-D Gel elettrophoresis analysis 
 
For 2-DE analysis, solubilized protein samples were supplemented with 350 µL of 
isoelectrofocusing (IEF) rehydration buffer (7 M urea, 2 M thiourea, 13 mM DTT, 2 % w/v ASB-
14, 1 % IPG buffer) and incubated with IPG-strips 3-11NL/18 cm (GE Healthcare, Uppsala, 
Sweden) O/N at room temperature. IEF was performed on an IPGphor unit (GE Healthcare, San. 
Francisco, CA, USA) at 20 °C, using a 50 µA current limit per strip and the following program 
settings: 10 h at 30 V, 1 h at 200 V, 30 min at 3500 V gradient and 3 h at 3500 V step and hold, 2 h 
and 30 min at 8000 V gradient and 8 h at 8000 V step and hold. After focusing, the IPG strips were 
3. MATHERIALS AND METHODS 
 
- 62 - 
incubated in 10 mL of equilibration buffer (6 M urea, 30 % w/v glycerol, 2 % w/v SDS, 0.002 % 
w/v bromophenol blue, 50 mM Tris pH 8.8) containing 1 % w/v DTT for 15 min, and subsequently 
in 10 mL of the same buffer containing 2.5 % w/v iodacetamide for 15 min. The amount of protein 
loaded onto an IPG-strip for analytical and preparative runs was 100 µg and 1 mg, respectively. 
Second dimension was run on 12.5 % (w/v) polyacrylamide gels (18 cm × 20 cm × 1 mm) in 250 
mM Tris-HCl, pH 8.3, 1.92 M glycine, 1 % w/v SDS, at 15 °C, applying 2 W/gel for 30 min and 20 
W/gel for the remaining 4−5 h, using an Ettan DALT twelve unit (GE Healthcare, San Francisco, 
CA, USA). 
3.7.6 N-glycan analysis 
 
N-Glycan analysis was performed as previously reported (Kajiura et al., 2010) with some 
modifications. In brief, N-glycans from purified H10 variants were released by hydrazinolysis at 
100 ºC for 10 h. The hydrazinolysates were lyophilized and N-acetylated with saturated sodium 
bicarbonate and acetic anhydrade, followed by desalting with Dowex 50 x 2 (Muromachi Kagaku 
Kogyo Kaisha, Tokyo, Japan). Pyridylamination of the oligosaccharides obtained was described 
previously (Misaki et al., 2001) and purified by size fractionation-high-performance liquid 
chromatography (HPLC) using Shodex Asahipak NH2P-50 4E (4.6 mmID x 250 mm, SHOWA 
DENKO Co. Ltd., Tokyo, Japan). Pyridylaminated (PA) sugar chains were detected by reverse 
phase (RP)-HPLC. The mobile phase composed of 0.02 % trifluoroacetic acid (solvent A) and 20 % 
acetonitrile/0.02 % trifluoroacetic acid (solvent B). RP-HPLC was performed using a Cosmosil 
5C18-AR-II column (4.6 x 250 mm, Nacalai tesque, Kyoto, Japan) with HITACHI LaChrom by 
linearly increasing solvent B concentration from 0 to 20 % over 35 minutes at a flow rate of 1.2 
mL/min. The eluted fractions were monitored by measuring fluorescence intensity using excitation 
and emission wavelengths of 310 and 380 nm, respectively. 
The molecular masses of the collected PA-sugar chains and the number of their sugar moieties were 
estimated by LC-MS(/MS) using Agilent Technologies 1200 series (Agilent Technologies, Santa 
Clara, CA) equipped with a HCT plus (BRUKER DALTONICS, Bremen, Germany). In LC part, 
the mobile phase was composed of acetonitrile/acetic acid (solvent A: 98/2, v/v) and water/acetic 
acid/triethylamine (solvent B: 92/5/3, v/v/v). The PA-sugar chain was separated using Shodex 
Asahipak NH2P-50 2D (2.0 mmID x 150 mm) by linearly increasing solvent B concentration from 
20 % to 55 % over 35 minutes at a flow rate of 0.2 mL/min. MS/MS parameters were as follows: 
scan range m/z = 350 – 2750, nebulizer flow of 5.0 psi, dry gas flow rate of 3.0 L/min, dry 
temperature of 300 ºC, target count of 200,000, MS/MS Frag. Ampl. of 1.0 V in the positive-ion 
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mode. N-Glycan structures were speculated by their elution positions comparing with glucose-
oligomer units in RP-HPLC (Tomiya et al., 1991) and the intensities of product ions detected in 
LC-MS/MS comparing with in-house PA sugar chain libraries. 
Analysis of glycans was also performed by Western blot using Concanavalin A biotin conjugate 
from Canavalia ensiformis (Jack bean), Type IV (Sigma C 2272). Samples were normalized for 
TSP and separated by SDS 9 % (w/v) PAGE under reducing conditions, and subsequently blotted 
on a PVDF membrane. Blocking was performed in PBS 1 X, 2,5 % BSA over night at 4 °C. The 
immunoblotting was performed with Concanavalin A biotin conjugate at a concentration of 1:12000 
in PBS 1 X, 0,1 % BSA, 1h at room temperature followed by incubation with Streptavidin-PO (S 
5512, Sigma-Aldrich) diluted 1:10000 in PBS 1 X, 0,1 % BSA, for 20 minutes at room temperature. 
Proteins were detected as described before.  
 
3.7.7 IgG purification 
 
For small scale mAb purifications, 40g of agroinfiltrated leaf fresh weight were used for affinity 
chromatography purification. Clarified supernatants from mechanical homogenisation extraction 
procedure and intercellular fluids were purified using separate affinity chromatography columns (1 
ml HiTrap™ Protein-A HP, 1 ml HiTrap™ Protein-G HP and agarose conjugated anti-Fc (109-035-
003, Jackson laboratories) column.  
All columns were previously equilibrated with extraction buffer, at a flow rate of 1 ml/min. The 
column was washed with 10 ml of 1 X PBS (10 column volumes) and the antibody was eluted with 
100 mM citrate, pH 3.0 and buffered with 1:5 (v/v) 1 M Tris-HCl, pH 8.0. Total protein 
concentration was determined by the colorimetric Bradford assay. Antibody yield was evaluated as 
the amount of antibody eluted from the chromatographic column/antibody loaded into the column. 
Antibody containing fractions were pooled, dialyzed against 1 X PBS using a PD10 column (GE 
Healthcare, Germany) following manufacturer instructions and concentrated in Centricon YM30 
(Amicon, Bedford, MA, USA). Antibody concentration was also determined spectrophotometrically 
at 280nm absorbance (Gill and von Hippel, 1989).  
 
3.7.8 Gel filtration Analysis  
 
Purified H10 antibody variants were analysed by size-exclusion chromatography carried out at 20 
°C in 1 X PBS on a calibrated SuperdexTM 200 5/150 GL column (GE Healthcare, Sweden) (at 0.3 
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ml/min flow rate) using an ÄKTA FPLC P920 instrument (GE Healthcare, Sweden). Protein 
absorbance expressed as Absorption Units (mAU) was measured at 280 nm. Column calibration 
was performed using gel filtration calibration kits (Low and High Molecular Weight, GE 
Healthcare) following manufacturer instructions. A purified human IgG1-λ (I5029, Sigma-Aldrich) 
was also used as a positive control. Peaks representing different protein fractions were collected 
using a fraction collector FRAC-920 (GE Healthcare, Sweden). For a better interpretation of results, 
the chromatograms are presented over Kav = (elution volume -void volume)/(column volume - void 
volume) instead of elution volume or retention time. 
 
3.7.9 Surface plasmon resonance analysis 
 
Binding properties of plant purified H10 from pilot scale purifications were evaluated by surface 
Plasmon resonance (SPR) using a BIAcore biosensor system instrument (GE Healthcare) as 
previously described (Villani et al., 2009). Approximately 3400 resonance units (RU) of purified 
H10 (20 ng/ml in 10 mM acetate buffer, pH 5.5) were coupled to the dextran matrix of a CM5 
sensor chip using the Amine coupling kit (GE Healthcare) at 5 ml/min flow rate. 
To estimate the apparent equilibrium constants (KD), concentrations of recombinant BCD domains 
of mouse TNC (mTN-C BCD) ranging from 500 ng to 3 µg in PBS were injected. All binding 
experiments were performed at 25 °C in PBS at 20 ml/min flow rate and pulses of 10 mM NaOH 
were used to regenerate the sensor chip. Rate constants were calculated on the basis of a single site 
model using the BIAevaluation 3.0 software (GE Healthcare). 
 
3.7.10 N-terminal sequencing 
 
The N-terminal sequencing analysis was performed on protein fragments immobilized on a PVDF 
membrane using a filter device (ProSorb from Perkin Elmer) which allows buffers to be washed 
out. Each degradation band was excised from the membrane and analyzed by Edman Degradation 
reaction (Edman, 1950), using an ABI Procise 494HT Protein Sequencer. The analysis was 
restricted to five residues per band. 
The analysis was performed at PNAC Facility (Protein & Nucleic Acid Chemistry Facility) 
Department of Biochemistry, University of Cambridge. 
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3.8 Plant contaminants detection 
 
3.8.1 Analysis of polyphenols and alkaloids 
 
Determination of total phenolics was essentially carried out as described before (Platis et al., 2008). 
To 1 ml of sample 500 µl of Folin–Ciocalteau reagent (Sigma–Aldrich) were added. The samples 
were prepared by diluting 100, 50, 20 and 10 µl of N. benthamiana extracts, intercellular fluids or 
purified fractions eluted from protein A or cation exchange chromatography, in bi-distilled water to 
a final volume of 1 ml. A Na2CO3 solution (20 % w/v, 2 ml) was then added and incubated at room 
temperature before reading the absorbance at 725 nm. As concentration standard serial dilutions of 
gallic acid (Sigma–Aldrich) dissolved in bi-distilled water was used (0–450 µg/ml). Total alkaloids 
were semi-quantitatively determined from the samples described above using Dragendorff’s reagent 
(Sigma-Aldrich) as previously described (Platis et al., 2008). 
 
3.8.2 Endotoxin removal and analysis 
 
Endotoxin removal was performed by affinity chromatography using an Endo Trap Red column 
(Hyglos GmbH, Germany) following manufacturer instructions. Briefly, column was regenerated 
with 3 column volumes of regeneration buffer (provided by manufacturer) and then equilibrated 
with 3 column volumes of equilibration buffer (10 mM Na2HPO4, 80 mM NaCl, pH 7.4). Three 
millilitres of purified mAb H10 (0.5 mg/ml) were added to the column and the flow through was 
collected. Protein concentration was determined spectrophotometrically (280nm absorbance). This 
process was repeated twice. Endotoxin levels in the plant purified antibody samples were 
determined using the Multi Test Lymulus Amebocyte Lysate (LAL; sensitivity limit of 0.25 
endotoxin units (EU)/ml) Pyrogent (CapeCod, MA, USA). Endotoxin-free water, pipette tips and 
test tubes were used (ACILA, Germany). To determine the sensitivity of the LAL reaction and 
obtain a reference standard, 4 dilutions starting from 1 EU/ml up to 0.06 EU/ml of 
lipopolysaccharide (LPS) from E. coli 0113:H10 (CapeCod, MA, USA) were prepared and tested in 
apyrogen certified tubes using manufacturer instructions to determine the lowest concentrations of 
LPS giving a positive LAL reaction. 
The presence of LPS was confirmed by gelification of the sample mixed with the amebocyte lysate 
after 1 h incubation at 37 °C. Tests were performed on plant purified mAb H10 before and after two 
cycles of Endo Trap Red affinity chromatography by mixing with the lyophilised amebocyte lysate 
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100 µl of the undiluted sample as well as 100 µl of eight different dilutions (1:2; 1:4; 1:8; 1:16; 
1:64; 1:128; 1:512; 1:1,024) and incubating 1 h at 37 °C without shaking. 
 
3.9 Bioinformatic analysis  
 
To identify Ab residues potentially responsible for cleavage by N. benthamiana peptidases, we 
searched the MEROPS database (Rawlings et al, 2010; http://merops.sanger.ac.uk/), release 9.5, for 
all the peptidases encoded by the genomes of N. benthamiana or other plants belonging to the 
Nicotiana genus. For each of the peptidases assigned to these organisms we gathered information 
about their substrate specificity.  
Blast (Altschul et al., 1997) has been used to search the NCBI sequence database of proteins whose 
three-dimensional (3D) structures have been experimentally determined for Ab domains with high 
sequence identity with H10. The structures of these Abs have been downloaded with the Protein 
Data Bank (Rose et al., 2011). InsightII (Accelrys Inc.) has been used for structure visualization and 
analyses, DSSP for secondary structure assignment (Hooft et al., 1996) and Naccess (Hubbard and 
Thornton, 1993) for accessible surface area calculations. Ab structural domains have been defined 
as in the Structural Classification Of Proteins database (SCOP) (Andreeva et al., 2008).  
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4.1 OPTIMIZATION OF PLANT EXTRACTION AND PURIFICATION OF 
THE SECRETORY mAb H10 
 
In the first part of the thesis we analyzed different steps of protein extraction from agroinfiltrated N. 
benthamiana leaves in order to optimize the purification process of the secretory mAb H10. The 
aim of the work was to offer additional information about the strategies able to improve antibody 
extraction/purification on large-scale. The extraction procedures analyzed were the mechanical 
homogenization and recovery of intercellular fluids (IFs) in order to compare the purified 
immunoglobulins, in terms of antibody yields, proteolytic degradation and total phenolic 
compounds content. Final data emphasized that the application of different extraction 
methodologies significantly affected the integrity and yield of antibody purified from agroinfiltrated 
N. benthamiana leaves. According to these data, we optimized a pilot-scale purification method, 
using a two-step purification protocol from 250 g of fresh agroinfiltrated leaves leading to the 
purification of milligrams of fully assembled and functional antibody, free of phenolic and alkaloid 
compounds and with low endotoxin levels. 
 
4.1.1 Plant Material 
 
Transient expression of the secretory mAb H10 was performed by co-agroinfiltrating N. 
benthamiana plants with recombinant Agrobacterium strains, containing the plant expression 
vectors harbouring specific 35S T-DNA cassettes.  
 
A
B
 
 
Figure R1: A) Wild type N. benthamiana plants placed in 4-inch pots and organized in vessels to facilitate watering. B) 
6-8 leaves stage plant. 
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In order to prepare the plant material to be used for the agroinfiltration process, wild type N. 
benthamiana plants were typically grown from more than 100 seeds per batch in soiled-filled seed 
trays. Seedlings were transplanted into individual pots with the aim to optimize growth conditions 
(Figure R1, panel A). 
All plants were grown in a containment greenhouse (16 hour light /dark cycle) (Figure R2) at a 
constant temperature of 26 °C. 4–6 weeks old N. benthamiana plants, at a 6-8 leaves stage (Figure 
R1, panel B), were used for agroinfiltration.  
Preparation of Agrobacterium cultures was carried out growing the specific strains in LB medium in 
1L flasks. Bacterial cultures were incubated over night at 28 °C and, after centrifugation, bacterial 
pellet was resuspended in agroinfiltration buffer. 
 
 
 
Figure R2: Containment greenhouse (P2 level) at ENEA Casaccia Research Center, Rome. 
 
4.1.2 H10 transient expression based on vacuum agroinfiltration  
 
As previously described in Materials and Methods section, transient expression system used for the 
production of H10 was performed by vacuum agroinfiltration, a strategy able to ensure infiltration 
of several plants with high efficiency. A. tumefaciens clones containing the H10 Heavy Chain 
(p35:HC), Light Chain (p35:LC) and P19 (p35:p19) expression cassettes were used for the co-
agroinfiltration strategy. The use of the P19 gene silencing suppressor protein from Artichoke 
mottled crinkle virus (AMCV) allowed to enhance the yield of recombinant product. All the vectors 
harbouring these expression cassettes were electroporated into A. tumefaciens strain LBA4404 and 
used in co-agroinfiltration experiments. A schematic representation of the expression cassettes used 
to achieve the expression of the secretory mAb H10 is reported in Figure R3. 
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Figure R3: Schematic representation of the constructs used in the agroinfiltration experiments performed to obtain the 
secretory mAb H10. A detailed description of the construction of every expression cassette is presented in Material and 
Methods section.  
 
All genes were cloned in the pBI-Ω plant expression vector under the control of the CaMV 35S 
promoter, containing the TMV Ω translational enhancer and the NOS terminator sequence (Marusic 
et al., 2007).  
For vacuum infiltration, Agrobacterium suspensions harbouring the different vectors were mixed in 
equal volumes to obtain a final optical density value (O.D.600) of 0.6 for each suspension in the 
infiltration buffer. The agroinfiltration was conducted by completely submerging each plant in the 
Agrobacterium-containing solution inside a vacuum chamber (Figure R4, panel A).   
 
A
B
 
 
Figure R4: A) Vacuum chamber used for the agroinfiltration of N. benthamiana plants. B) Detail of a submerged plant 
leaf subjected to vacuum 
 
Vacuum was then applied and quickly released in order to drive the entrance of the agrobacterium 
solution into the leaves apoplast (Figure R4, panel B). After agroinfiltration (Figure R5, panels A 
to D), plants were grown for six days in the greenhouse before the extraction/purification process. 
The extraction process was typically performed starting from batches of 40 g of fresh agroinfiltrated 
leaves and homogenization in extraction buffer was achieved using an Ultra-Turrax homogenizer. 
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After homogenisation, the slurry was filtered through Miracloth paper and centrifuged. For 
purification, the clarified extract was directly loaded on a HiTrap Protein-A HP column.  
For large scale purifications, extraction was performed starting form batches of 250 g of vacuum 
agroinfiltrated leaf material obtained by vacuum agroinfiltration of high number of plants. This 
system allowed the purification of milligrams of fully assembled, functional and pure antibody free 
of phenolic and alkaloid compounds. A better description of the system is present in Paragraph 
4.1.10. 
 
A B
C D
 
 
Figure R5: Stages of a typical lab-scale extraction and purification process of the mAb H10 from agroinfiltrated N. 
benthamiana plants. A) Leaves disruption was performed with pestle and mortar in presence of liquid nitrogen 
obtaining a fine powder. B) The powder was placed in a beaker with agroinfiltration buffer and homogenized with an 
Ultraturrax homogenizer. C) The slurry was filtered in a double layer of miraclot paper. C) After centrifugation the 
clarified plant extract was processed with HiTrap protein-A column in order to purify the mAb H10.  
 
4.1.3 Antibody expression analysis using the P19 gene silencing suppressor 
protein 
 
In order to evaluate the optimal sampling time point, leaves were collected on days 2, 3, 5 and 6 
post-infiltration (p.i.), and expression was assayed by Western blot analysis on reducing SDS-
PAGE (Figure R6) and by ELISA (Figure R7). In the case of Western Blot, the analysis was 
performed on the leaves sampled on days 2, 3, 5 and 6. Significant differences were observed in the 
expression levels of both HC and LC between plants infiltrated with and without p19 construct 
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(Figure R6). Maximum expression levels were typically observed at 6 days p.i. in the presence of 
p19 gene silencing suppressor.  
 
 
 
Figure R6: Western blot analysis of leaf extracts from N. benthamiana plants co-agroinfiltrated with Agrobacterium 
tumefaciens strains harbouring the heavy chain (HC), light chain (LC) and p19 silencing suppressor from Artichoke 
mottled crinkle virus (AMCV). (a) Both anti-γ and anti-λ chain antibodies were used for detection. Lanes indicated by 
an asterisk were loaded with extracts obtained from plants co-agroinfiltrated with HC, LC and p19; the other lanes refer 
to plants co-agroinfiltrated with HC and LC only. Numbers indicate days post-infiltration. Plant extracts were 
normalized for total soluble protein (TSP) content (20 µg of TSP were loaded on to each well). 
 
This result was confirmed also by a sandwich ELISA assay performed using an anti-γ antibody for 
the coating and anti-λ antibody for detection (Figure R7). In this case, the analysis was performed 
directly on crude extracts from plants agroinfiltrated with HC and LC in presence of the p19 gene 
silencing suppressor. Sampling was performed at 2, 4 and 6 days p.i. ELISA results showed a 
gradual increase of the expression levels of the protein that reached the highest concentration at the 
6th day p.i.. Further time points were not assayed since an occurrence of leaf necrosis from the 7th 
day p.i. was observed.  
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Figure R7: Sandwich ELISA (anti-γ/anti-λ-HRP) assay performed on crude extracts of N. benthamiana plants 
agroinfiltrated with HC, LC and p19 expression cassettes. Every value is presented in mg/Kg FW and represents the 
mean ± standard error of the mean of triplicate samples. Dilutions are reported on a side from 1 to 1:64. 
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4.1.4 Extraction of H10 from fresh agroinfiltrated leaves, lyophilized leaves and 
intercellular fluids 
 
The strategies used to obtain plant extracts from agroinfiltrated leaves have been based on several 
extraction techniques such as, total extract from fresh or lyophilized leaves (stored at room 
temperature), intercellular fluid recovery (IFs), total extract form leaves depleted of intercellular 
fluids (total extract – IFs) (Figure R8).  
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Figure R8: Schematic representation of the extraction strategies used for mAb H10 purification.  
 
In the first strategy, agroinfiltrated leaves were directly processed by mechanical homogenization 
(total extract), or lyophilized and then treated with the same extraction methodology used for fresh 
leaves. The recovery of Intercellular Fluids from fresh agroinfiltrated N. benthamiana leaves was 
achieved using an infiltration-centrifugation method (as described in Materials and Methods 
section). The technique was performed applying a mild and immediate centrifugation of the leaves 
after vacuum infiltration with the extraction buffer, allowing the recovery of the intercellular fluids 
from the apoplast. Leaves after IFs extraction were also homogenized in order to obtain a total 
extract from leaves depleted of IFs. For every extraction procedure, agroinfiltrated leaves were 
collected six days post infiltration (d.p.i.), since maximum expression levels of mAb H10 were 
typically observed at this time point (Figure R6 and R7). In the case of the analysis of lyophilized 
material, lyophilization was performed on batches of 40 g of fresh agroinfiltrated leaves 
immediately after plant sampling. This process led to the complete dehydration of the plant leaves 
that, were kept 8 months at room temperature and therefore analyzed (Figure R9). Also for this leaf 
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material, the extraction process was performed using the standard mechanical homogenization 
methodology.  
 
 
Figure R9: Falcon tube containing plant leaf material subjected to lyophilization. 
 
4.1.5 ELISA assay of different plant extracts  
 
To compare mAb H10 expression levels, a quantitative ELISA was performed on the extracts 
obtained with different strategies. Before the analysis, all extracts were normalized for TSP content 
using the Bradford colorimetric assay. In the case of IFs, a TSP value of 0.6 mg/ml was obtained, 
resulting significantly lower if compared to total extracts (1.5 - 2 mg/ml).  
 
 
Figure R10: Quantitative ELISA assay performed on the crude extracts obtained with different extraction strategies. 
Every value is presented in mg/Kg FW and represents the mean ± standard error of the mean of triplicate samples. The 
experiment has been performed by coating the plate with an anti γ chain antibody and detecting with an anti λ chain 
HRP antibody. 
 
The results showed an average IgG expression level of 160 mg/Kg FW for IFs, 300 mg/Kg for 
lyophilized leaves and 640 mg/Kg in the case of total leaf extract (Figure R10 and Table R1). 
Antibody expression levels, reported as percentage of Total Soluble Proteins ( % TSP), revealed 
values of 16 % in the case of total extract and 4 and 10 % for lyophilized leaves and total extract-
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IFs, respectively. Furthermore, the IFs analysis revealed a surprisingly high value of about 27 % 
TSP (Table R1).  
 
Table R1: Comparison of different extraction procedures in terms of antibody yield, antibody degradation and plant 
contaminants in the final purified product. 
 
 a
 Total soluble protein (TSP) content in the extract was determined by Bradford colorimetric assay. Values 
are the mean ± standard error of the mean (SEM) of triplicate samples. 
b
 IgG concentration in the extracts was calculated by quantitative ELISA as described in Materials and 
Methods and values are the mean ± standard error of the mean (SEM) of triplicate samples. 
c
 The purification yield is the mean value obtained from three purifications of different batches (40 g) of 
agroinfiltrated leaves using protein A affinity chromatography.  
d
 Percentage of intact mAb H10 was calculated from the size-exclusion chromatography analysis.  
e
 Total phenol concentration was determined using Folin-Ciocolteau reagent. Values are the mean ± standard 
error of the mean (SEM) of triplicate samples. 
n.d.: not detected.  
4.1.6 Western blot analysis of different plant extracts 
 
The evaluation of the expression and degradation pattern of the H10 in all extracts, was performed 
by Western blot analysis. The samples analyzed were normalized for TSP content. The Western blot 
analysis performed with an anti-γ antibody revealed the presence of a major band around 50 kDa 
corresponding to the heavy chain (HC) in all extracts (Figure R11 panel a) and by a specific 
degradation band at 20 kDa. Furthermore, in the case of IFs, two additional degradation band 
around 35 kDa and 12 kDa, barely visible in the other extracts, were observed. Western blot 
analysis, performed using an anti-λ antibody, showed in all extracts only the expected band at 25 
kDa corresponding to the intact light chain (LC); in this case, degradation bands at lower molecular 
weight were not detected (Figure R11 panel b). 
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Figure R11: Western blot analysis of the different plant extracts on reducing SDS-12 % (w/v) PAGE. Immunoblotting 
with a peroxidase-conjugated anti-human γ chain (a) or anti-human λ chain (b). Plant extracts were normalized for TSP 
content and a total of 500 ng TSP were loaded on each well in both gels. Lanes 1 and 10: extracts from plants 
agroinfiltrated only with the p19 silencing suppressor used as a negative control; 2 and 7: total extracts from fresh 
agroinfiltrated leaves; 3: 10 ng of commercially purified human IgG used as a reference; 5 and 11: 20 ng of 
commercially purified human IgG used as a reference; 4 and 8: Intercellular Fluids (IFs) recovered from agroinfiltrated 
plants; 6 and 9: extracts obtained from homogenization of lyophilized agroinfiltrated leaves. 
4.1.7 Purification of H10 from total leaf extracts or intercellular fluids of 
agroinfiltrated plants 
 
The purification procedure used for mAb H10 was carried out starting from batches of 40 g (total 
leaf extracts) or 80 g (IFs) of agroinfiltrated N. benthamiana leaves. Protein-A affinity 
chromatography was used for all extracts using 80 ml of plant extract in 1 X phosphate saline buffer 
pH 7.0 (1 X PBS), and the average purification yields obtained from three independent experiments 
are reported in Table R1. The values obtained showed that the mechanical homogenization from 
total leaf extracts presented the highest yield of 75 mg/Kg FW, whereas purification from IFs 
yielded an average value of 17 mg/Kg FW. The functionality of the purified H10 obtained from 
different extracts was confirmed by antigen-binding ELISA on mouse TNC-BCD (Figure R12).  
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Figure R12: ELISA assay against the antigen (TNC) performed on the purified H10 obtained with different extraction 
strategies. Every value is presented in Optical Density absorbance at 405 nm. Dilutions are reported on a side from 1 to 
1:64. 
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Protein-A purified antibodies obtained from all extraction strategies were further analyzed by non-
reducing SDS-PAGE. A band at about 150 kDa, corresponding to the intact antibody, and a major 
degradation band at about 45-50 kDa (indicated by an arrow) was observed for all antibodies 
(Figure R13). Moreover, two additional degradation bands at 75 and 100 kDa (indicated by 
asterisks) were also present, most abundantly in the H10 purified from lyophilized leaves and from 
total extracts - IFs.  
 
 
Figure R13: Analysis of mAb H10 purified from different extracts of vacuum-agroinfiltrated plants. Analysis was 
performed loading 1 µg of antibody purified by protein A affinity chromatography from batches of 40 g of vacuum-
agroinfiltrated leaves onto non reducing SDS-10 % (w/v) PAGE stained with Coomassie blue (a). Lane 1: antibody 
purified from extracts of lyophilized leaves; 2: Molecular weight marker; 3: H10 purified from total extracts of fresh 
agroinfiltrated leaves; 4: antibody purified from intercellular fluids (IFs); 5: Antibody purified from leaves from which 
IFs were previously extracted (Total extract-IFs); 6: commercially purified human IgG1 used as a control. The arrow 
indicates a major band observed at *45 kDa while asterisks indicate additional bands observed at about 75 and 100 kDa. 
 
4.1.8 Analysis of the phenol contaminants in plant extracts and purified antibody 
preparations  
 
The next analysis was focused on the evaluation of phenolic contaminants in the extracts. In the 
case of fresh or lyophilized leaf extracts, a similar value of 420 and 370 µg/g FW respectively was 
observed, whereas the analysis of IFs exhibited a strong reduction (10-fold lower) in phenolic 
compounds (21 µg/g FW) (Table R1). Also pigments in IFs were greatly reduced compared to total 
extracts as illustrated in Figure R14. After purification, also protein-A eluted fractions were 
subjected to the analysis of phenolic compounds. This assay revealed a level of about 1 % of total 
loaded phenolics both in the eluted fractions obtained from total and lyophilized extracts, while in 
the case of the purified fractions from IFs no plant phenols were detected (Table R1). As expected, 
such a low level of phenolics and pigments observed in the IFs extract revealed to have a positive 
impact on the maintenance of protein A column performances. In fact, due to the reduced 
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contamination of the resin, the same column could be reused up to 5 times without showing 
significant activity loss. Protein A columns after 3 cycles of purification either from total extracts or 
from IFs are shown in Figure R14 indicating a visible difference in resin pigmentation.  
 
 
 
Figure R14: Visual comparison between intercellular fluids (IFs) (1) or clarified total extract from fresh agroinfiltrated 
leaves obtained by mechanical homogenization (2). In the bottom part, protein A chromatography columns after three 
purification cycles from the corresponding extracts are shown. 
 
4.1.9 Gel-filtration analysis of purified mAb H10 
 
The assembly and the molecular weight of the purified mAb H10 from total or lyophilized leaves 
extracts and from IFs, after the preliminary analysis performed by Western blot, was further 
characterized by size-exclusion chromatography with a Superdex 200 5/150 GL Column (GE 
Healthcare) (Figure R15). Results of the gel filtration analysis obtained in the case of the antibody 
purified from the total extract showed the presence of a major peak at a value of 0.34 Kav, perfectly 
matching with that obtained for a full-size human purified IgG1
 
used as a control (Figure R15 panel 
a, broken line). After the evaluation of the peak area, it was demonstrated that 75 % was 
represented by intact IgG (Figure R15 panel a and Table R1). On the other hand, in the case of 
mAb H10 purified from IFs, only 40 % of the antibody consisted of full size IgG (elution peak at 
0.35 Kav) (Figure R15 panel b and Table R1). In this case, a major degradation product (elution 
peak at about 0.5 Kav) with a calculated molecular weight of ∼50 kDa was observed. This result 
was also confirmed by the non-reducing SDS-PAGE, in which a band of the same molecular weight 
was observed (Figure R13). 
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Figure R15: Characterization of H10 purified from different agroinfiltrated N. benthamiana leaf extracts by size-
exclusion chromatography. H10 antibody was purified by protein A chromatography from batches of 40 g of 
agroinfiltrated leaves and was analyzed on a SuperdexTM 200 5/150GL column as described in the ‘‘Materials and 
Methods’’. For a better interpretation of results, the chromatograms are presented over Kav = (elution volume - void 
volume)/(column volume - void volume) instead of elution volume or retention time. Kav values of the major peaks are 
reported. A typical chromatogram obtained for mAb H10 purified from total extracts of fresh agroinfiltrated leaves. The 
broken line in this panel represents the chromatogram resulting from a commercially available purified human IgG1 
used as reference (Kav value of about 0.3). Typical chromatograms of mAb H10 purified from intercellular fluids (IFs) 
(b) and from lyophilized leaf extracts (c). 
 
 
The degradation reported for the H10 purified from IFs was even more evident in the lyophilized 
leaf extract, in which only 10 % of the purified antibody resulted fully assembled (Figure R15 
panel c), confirming what previously observed in the non-reducing SDS-PAGE (Figure R13). 
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4.1.10 Pilot-scale purification and characterization of H10 from fresh 
agroinfiltrated leaves 
 
Pilot-scale purifications were carried out starting from batches of 250 g of agroinfiltrated N. 
benthamiana leaves. Extraction was achieved by mechanical homogenization to a final volume of 
750 ml. The solution was clarified by centrifugation and the pH was adjusted to a value of 7.5. A 
second centrifugation and a filtration through 0.22 µm filters was performed in order to further 
clarify the extracts. The solution obtained was stable up to 24 hours at 4 °C without the appearence 
of any precipitate. In order to increase the recovery of clear eluted fractions and reduce the antibody 
loss, the column was further washed with 1 X PBS 5 % isopropyl alcohol, 1 M NaCl and Glycine 
pH 4.0 and then antibody elution with Glycine pH 3.0 was performed. From this first 
chromatographic step, we obtained an average yield of 80-100 mg/Kg FW of purified H10. The 
efficiency of every purification step was monitored by functional ELISA on mouse tenascin-C, with 
the aim to verify purification efficiency at every step (Figure R16).  
 
 
 
Figure R16: ELISA assay performed on each step of the mAb H10 pilot-scale purification. Batches (250 g) of fresh 
vacuum-agroinfiltrated N. benthamiana leaf extracted by mechanical homogenization were used. 
 
The analysis of the quality of the H10 fractions eluted from protein-A affinity chromatography was 
achieved both by gel filtration using a Superdex 200 10/300 GL column and reducing SDS-PAGE 
analysis. Gel filtration assay showed the presence of a major elution peak at a Kav value of 0.33, 
corresponding to the intact immunoglobulin, flanked by a small fraction at about 0.51 Kav 
(degradation product) corresponding to a molecular weight of about 50 kDa (Figure R17 panel a). 
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Reducing SDS-PAGE analysis revealed the presence of some barely visible degradation bands 
corresponding to minor degradation products (Figure R17 panel d, lane 1).  
Elution fractions obtained from protein-A affinity chromatography were further purified by cation-
exchange chromatography (CEX). This analysis was performed using a Source 30S resin and 
elution was performed with a 0-50 % linear gradient. The typical chromatogram obtained from this 
analysis showed the presence of two partially overlapping peaks (A and B) (Figure R17 panel b). 
 
 
 
Figura R17: H10 pilot-scale purifications from batches (250 g) of fresh vacuum-agroinfiltrated N. benthamiana leaves 
extracted by mechanical homogenization. a) Typical size exclusion chromatogram obtained from the pooled fractions 
eluted from preparative protein A affinity chromatography. Analysis was performed using a calibrated SuperdexTM 
200 10/ 300 GL. Kav values of the major peaks are indicated. b) Fractions eluted from the preparative protein A affinity 
column were subjected to cation-exchange chromatography (CEX) using Source 30S resin. Elution was performed with 
a 0–50 % linear gradient using a high ionic strength buffer (50 mM acetic acid, 1 M NaCl, 5.0 mM EDTA, pH 6.0). 
Two protein peaks are distinguishable and are indicated as A and B; eluted fractions collected from the column are 
indicated as F2, F3, F4 and F5. c) Typical size-exclusion chromatogram obtained from the F3 and F4 fractions eluted 
from preparative CEX. Analysis was performed using a calibrated SuperdexTM 200 10/300 GL column. Kav values of 
the major peaks are indicated, with the 0.3 Kav peak corresponding to full-size IgG. d) Analysis of eluted fractions 
from pilot-scale H10 purification by reducing SDS-10 % (w/v) PAGE stained with silver nitrate. Lane 1: fraction eluted 
from preparative protein A (1 µg); 2 and 3: purified human IgG1 used as a control (500 and 200 ng respectively); 4 and 
7: protein molecular weight marker; 5 and 6: pooled F3 and F4 CEX elution fractions (1 µg and 500 ng respectively) 
 
Peak B, corresponding to fraction 3 and 4 was additionally analyzed by gel filtration, functional 
ELISA and reducing SDS-PAGE. Gel filtration analysis using a Superdex 200 10/300 GL column 
showed that both fractions had a unique elution peak at about 0.3 Kav, corresponding to the fully 
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assembled antibody with a high purity grade of 99.4 % (Figure R17 panel c). The quality of the 
CEX purified antibody was verified by reducing SDS-PAGE confirming a very high level of 
integrity of the IgG (Figure R17 panel d, lanes 5 and 6). Furthermore, the analysis of phenolic and 
alkaloid compounds demonstrated that H10 was highly pure and free from plant contaminants. 
Antibody purification yields after this second chromatographic step were in the range of 40 mg/Kg 
FW, corresponding to a 45 % recovery of total antibody loaded on the CEX column. 
4.1.11 Endotoxin Removal 
 
The final eluted product was further analyzed with the Lymulus Amebocyte Lysate Test (LAL) to 
verify the presence of endotoxins. The plant purified antibody after CEX (mAb H10 concentration 
of 0.5 mg/ml) showed an endotoxin level between 125 and 250 EU/ml, and in order to decrease this 
value, an endotoxin removal was performed using an Endo Trap Red affinity chromatography 
column as described in ‘‘Material and Methods’’. After two cycles of affinity chromatography, the 
remaining endotoxin levels in the sample were 1 EU/ml and a 20 % loss of antibody was observed 
with a final mAb H10 concentration of 0.4 mg/ml. Moreover, the specificity of plant purified H10 
to tenascin-C was assayed by Surface Plasmon Resonance analysis, revealing a KD value of 10 nM, 
perfectly matching the previously reported mAb H10 antigen-binding kinetics data (Villani et al., 
2009) 
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4.2 DISCUSSION  
 
In the last years significant progresses have been made in the development of novel transient 
expression platforms to increase the levels of recombinant immunoglobulin production. These 
systems initially used for rapid validation of expression constructs, are now being employed for the 
production of high amounts of recombinant proteins within a few weeks (Vézina et al., 2009). In 
particular, in the case of the H10 antibody, the use of a transient expression system based on 
vacuum-agroinfiltration boosted by the use of the Artichoke mottled crinckle virus (AMCV) p19 
gene silencing suppressor protein, it was possible to obtain high levels of antibody in N. 
benthamiana plants in a reduced period of time. Furthermore, using a protein-A affinity 
chromatography, it was possible to purify up to 100 mg of antibody per Kg FW (Villani et al., 
2009).  
However, upstream technological achievements observed in the last years have not been matched 
by downstream processing advancements since information on the main factors influencing this step 
are still limited. In fact, even if some progresses have been achieved in terms of 
extraction/purification strategies, the methodologies used have been optimized for several proteins 
just on a case-by-case basis, leading to the development of platform-dependent approaches.  
Based on this concern, the first part of the thesis has been focused on different aspects of protein 
extraction from agroinfiltrated N. benthamiana leaves with the aim to optimize the purification 
process of the H10 antibody and to investigate alternative purification strategies able to provide 
additional information for the large-scale production.  
Extraction is an essential step to be addressed during the purification of plant derived proteins 
because it could affect the quality, the purity and the final yield of the protein product (De Muynck 
et al., 2010). In particular, in the case of purification of plant-derived antibodies, the choice of the 
optimal extraction methodology could dramatically influence the yield of the purified IgG 
modulating also the amount of plant contaminants in the purified protein. In fact, as shown by 
Hassan et al., (2008), the efficiency of the extraction technique could be influenced by the target 
location of IgG in the plant cell, and by the physical extraction methodology used. Moreover, it was 
shown that the less vigorous extraction methodologies such as freeze thaw, led to the accumulation 
of antibody levels perfectly comparable to the more severe mechanical extraction procedures. 
Furthermore, the use of mild extraction techniques provided a reduction in the level of unwanted 
plant contaminants in the extract increasing the purity of the final product (Hassan et al., 2008).  
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In this study, the evaluation of different extraction strategies from agroinfiltrated N. benthamiana 
leaves emphasized that mechanical homogenization from fresh leaves provided the highest antibody 
yields (640 mg/Kg FW), with an accumulation level reaching 16 % TSP. However, this extract 
showed also high levels of total polyphenol contaminants (420 µg/g FW). This data, in accordance 
with the results obtained in a previous work reported in Nicotiana tabacum (Platis and Labrou, 
2006), confirmed that extraction obtained with mechanical homogenization of plant leaves 
increased the level of plant contaminants reducing the purity of the final product.  
The same extraction procedure was applied also to lyophilized agroinfiltrated leaves stored at room 
temperature. This strategy was assayed since lyophilization could represent a significant 
methodology for long-term storage of agroinfiltrated material for the possibility to reduce the cold-
chain costs needed for the preservation of recombinant proteins. The reported antibody yield was 
sensibly lower (160 mg/Kg FW), with a high grade of antibody degradation observed both in size 
exclusion chromatography and in SDS-PAGE analysis. This observation represents a limitation for 
this strategy leading to a dramatic reduction of intact IgG. A second extraction procedure based on 
the recovery of intercellular fluids (IFs) from agroinfiltrated leaves was assayed. In this case, the 
levels of purified antibody were comparable with those obtained using mechanical homogenization 
of lyophilized leaves (160 mg/Kg), but considerably lower in comparison to the previously reported 
yield obtained from the mechanical homogenization of fresh agroinfiltrated leaves (25 % 
reduction). However, it must be noted that antibody concentration in the IFs was considerably 
higher, reaching 26.6 % TSP, which corresponded to about a two fold increase compared to the 
concentration in the total extract (16 % TSP). The most interesting data obtained from this 
extraction methodology was represented by the analysis of polyphenol contaminants contained in 
the plant IFs before antibody purification with protein-A. In fact, a 10 fold decrease compared to the 
total leaf extract obtained by mechanical homogenization was observed, with levels (21 µg/g FW) 
comparable to the results obtained using an aqueous two-phase partitioning system (ATPS) 
previously reported by Platis et al., (2008). This reduction in contaminants (phenolics, alkaloids and 
pigments) represented a crucial point in the protein-A purification steps. In fact, a chromatography 
step performed using a clarified extract could favor the preservation of Protein-A affinity column 
performances even after repeated use, having an impact on downstream processing costs reduction. 
Another important consideration is related to the quality of the plant derived antibodies obtained 
from different extraction procedures based on the observed degradation profiles in both gel 
filtration analysis and non-reducing SDS-PAGE. In the case of the extraction of H10 from total 
fresh leaves, almost 75 % of the purified antibody was in its intact tetrameric form. In particular, 
two degradation bands at about 35 and 20 kDa were observed in the Western blot analysis of the 
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HC indicating specific antibody degradation. No detectable degradation was observed in the case of 
the light chain analysis. A fine analysis of H10 degradation in plant will be treated in Paragraph 
4.3. Size exclusion analysis performed on H10 purified from IFs showed that only about 40 % of 
H10 was recovered as full-size mAb while major degradation fragments with a molecular weight 
lower than 50 kDa were observed. In particular, SDS-PAGE analysis, showed three major HC 
degradation fragments at 35 and 20 kDa as well as an abundant lower molecular weight band at 
about 12 kDa. The 35 and 20 kDa bands confirmed the results obtained in the previously described 
Western blot analysis of total fresh leaves crude extract, indicating that these fragments have been 
specifically bound by protein-A purification chromatography and represent degradation products 
derived from the plant cell processing. It must be noted that both the 35 and 12 kDa bands were 
already evidenced in the IFs of tobacco leaves expressing the chimeric rat/human LO-BM2 mAb 
(De Muynck et al., 2009). The presence of a more severe antibody degradation observed in the IFs 
could be ascribed to the significantly higher level of plant peptidases in the apoplast, as previously 
demonstrated both in N. benthamiana and N. tabacum (Delannoy et al., 2008; De Muynck et al., 
2009; Drake et al., 2009). Surprisingly, also in the case of IFs, no degradation of the light chain was 
observed, in contrast with what already documented in Intercellular Fluids of transgenic tobacco, 
where a strong degradation of the light chain of the Lo-BM2 antibody was observed (De Muynck et 
al., 2009).  
Antibody degradation was even more evident in the lyophilized leaves where the size exclusion 
analysis revealed a 10 % of full size IgG. SDS-PAGE analysis highlighted the presence of 
additional degradation bands at around 100 and 75 kDa. Based on these results, it is possible to 
suppose that the lyophilization process and the long-term storage could further affect the integrity of 
the whole IgG. Nevertheless, in spite of the antibody degradation, the H10-derived fragments 
resulted functional in ELISA.  
In general, it must be noted that all purification processes yielded a low antibody recovery. This 
result could be explained hypothesizing that an unwanted overestimation of antibody expression 
yields had occurred in the quantitative ELISA, due to the specific degradation of the plant expressed 
antibody, leading to the formation of functional Fab fragments. The extraction/purification results 
obtained indicated that the optimal strategy to ensure the highest amount of IgG recovery was 
represented by mechanical homogenization. For this reason, using this strategy, a pilot-scale 
purification from 250 g of fresh agroinfiltrated leaves was performed, in order to obtain a robust and 
reproducible purification protocol on a larger scale. After clarification of the extract, obtained by 
pH adjustment and two sequential centrifugations, it was verified that no precipitate formation 
occurred within 24 hours. Due to the high extract volume to be passed through the affinity column, 
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the purification step was necessarily conducted over-night, therefore, to ensure the best performance 
of this process, an high grade of stability of the extract was required. Additionally, it was shown 
that to increase final product purity and column binding an additional washing step with Glycine pH 
4.0 was required before antibody elution. This procedure allowed the recovery of a clear eluate 
exhibiting low levels of polyphenols, without any substantial antibody loss in the flow through. 
According to this optimized extraction/purification protocol, after protein A affinity 
chromatography, it was possible to obtain an antibody yield in the range of 20-25 mg starting from 
an amount of 250 g of fresh leaves. These values, corresponding to an amount of 80-100 mg/Kg 
FW, were in the range of those obtained from small-scale purifications achieved starting from 40 g 
FW. The second purification step was conducted in order to increase the antibody purity and further 
clarify the eluate from plant typical contaminants. In fact, purity of the final product is essential for 
antibodies to be used in biopharmaceutical applications. Based on this concern, we decided to use a 
purification procedure normally applied to animal-cell culture supernatants, based on protein A 
affinity chromatography followed by a cation-exchange chromatography step aiming to further 
purify the antibody eluate from contaminants (Birch and Racher, 2006; Shukla et al., 2007). This 
cation-exchange chromatography column (CEX) allowed to separate the protein fraction 
corresponding to the intact fully-assembled human IgG from the antibody degradation products, 
obtaining a 99.4 % pure mAb H10 free of phenolics and alkaloids. Other examples in literature 
reported the use of cation-exchange chromatography as a first column step for the removal of 
unwanted compounds from the extract, giving substantial advantages in the next purification steps 
(Platis et al., 2008). In this work authors used a first CEX step followed by immobilized metal ion 
affinity chromatography (IMAC). Although, the use of protein A column was shown to be still 
required to obtain a highly purified final product free from other protein contaminants.  
In conclusion, this work shows the possibility to use the vacuum-agroinfiltration system, boosted by 
a plant virus gene silencing suppressor protein, as a successful strategy for antibody production. 
This new methodology has been recently validated also by other research groups that demonstrated 
the possibility of producing antibodies endowed with a humanized glycosylation profile with a 
similar approach (Vézina et al., 2009; Strasser et al., 2009). Furthermore, it was demonstrated that 
this platform could ensure antibody levels perfectly comparable to those obtained using viral 
vectors. Moreover, we described the use of different extraction processes from agroinfiltrated leaves 
and showed that each extraction methodology differentially affected the integrity and yield of a 
purified tumour-targeting antibody, offering additional information about the purification/extraction 
processes. Best results, in terms of antibody recovery, were typically obtained using mechanical 
homogenization of fresh leaves, but the strategy of purification from IFs appeared to be a very 
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promising methodology in terms of ease of extraction, low contaminants content and maintenance 
of protein A column performances. Finally, we also described a reproducible pilot-scale purification 
protocol from fresh vacuum-agroinfiltrated N. benthamiana leaves extracted by mechanical 
homogenization, that allowed the purification of mg quantities of highly pure mAb H10, providing 
useful indications for large-scale antibody production. 
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4.3 MODULATION OF THE GLYCOSYLATION PROFILE OF mAb H10: 
INFLUENCE ON EXPRESSION YIELD AND ANTIBODY 
DEGRADATION.  
 
The aim of this part of the thesis was to investigate different strategies for the production of H10 
optimized glycoforms in order to study the effect of the different glycosylation profiles on antibody 
quality and plant expression yield. The glycosylation pattern of plant produced H10 antibody was 
modulated using three different strategies: a) mutation of the glycosylation site of H10 heavy chain 
in order to obtain an aglycosylated antibody (H10 Mut); b) retention of H10 in the Endoplasmic 
Reticulum (ER) of plant cells by fusing the SEKDEL retention sequence to the C-terminal of both 
HC and LC (H10 SEKDEL); c) expression of the H10 in N. benthamiana plants in which fucosil 
transferase and xylosil transferase gene expression is downregulated by RNAi (∆xyl, ∆fuc plants). 
 
4.3.1 Gene constructs 
 
In addition to the previously described H10 heavy chain (p35:HC) and light chain (p35:LC) and P19 
(p35:p19) plant expression constructs that allowed the expression of the secretory mAb H10, we 
engineered additional expression cassettes to produce H10 variants. In particular, for the ER 
retained H10 SEKDEL, we obtained the p35:HC-SEKDEL and p35:LC-SEKDEL constructs by 
fusing the DNA sequence coding for the SEKDEL ER retention signal, to the 3’ of both HC and LC 
coding genes. Moreover, in order to produce an aglycosylated H10-Mut variant we generated a 
mutated H10 HC construct (p35:HC-Mut) in which the glycosylation site (Asn297) was mutated to 
Ala by site-directed mutagenesis. All genes were cloned into the pBI-Ω plant expression vector 
under the control of the CaMV 35S promoter, the TMV Ω translational enhancer and the NOS 
terminator sequences (Marusic et al., 2007). All plasmids were electroporated into A. tumefaciens 
strain LBA4404 and used in co-agroinfiltration experiments. A schematic representation of the 
constructs is reported in Figure R18. 
In parallel, we performed vacuum co-agroinfiltration of XylT/FucT RNAi-silenced N. benthamiana 
plants, in which endogenous β 1, 2-xylosyltransferase and α 1, 3-fucosyltransferase gene expression 
was down-regulated (Strasser et al., 2008), with a mixture of two A. tumefaciens clones harbouring 
p35:HC and p35:LC obtaining the H10XylT/FucT variant. In this case, the p19 silencing suppressor 
was not used to avoid any interference with down regulation of the glycosylation enzymes. Leaves 
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were collected 3 d.p.i. since maximum expression levels in the absence of p19 was typically 
observed at this time point.  
 
 
Figure R18: Schematic representation of the constructs used in the agroinfiltration experiments. A description of the 
constructs is presented in the Material and methods section. All genes were cloned in the pBI-Ω plant expression vector 
under the control of the CaMV 35S promoter and containing the TMV Ω translational enhancer and the NOS terminator 
sequence. 
 
4.3.2 Transient expression of H10 variants in tobacco protoplasts  
 
The different H10 formats (H10, H10-Mut and H10-SEKDEL), were transiently expressed in 
mesophyll protoplasts of N. tabacum SR1 in order to assess their accumulation and localization in 
plant cells. This evaluation was achieved co-transforming separately tobacco protoplasts with 
pGEM plasmids harbouring HC and LC (H10); HC-Mut, and LC (H10-Mut); HC-SEKDEL and 
LC-SEKDEL (H10-SEKDEL) plant expression constructs (Table M2). 
Pulse labeling of the protoplasts was carried out with 35S-methionine and 35S-cysteine for 1 hour 
and chasing was performed at 2.5 and 5 hours. Cellular (C) and secreted (S, culture media) protein 
fractions were mixed with a protein-A/protein-G Sepharose resin mix and then subjected to 
immunoprecipitation and autoradiography (Figure R19 panel a). Analysis of the expression 
performed by Western blot revealed that in C protein fractions H10 level was uniform for all the 
time points demonstrating a comparable expression profile for all variants. In the case of the S 
fractions, an high secretion of the full size H10 in the media was observed, for H10 and H10-Mut, 5 
hours after pulse. In fact, at this time point, a very strong band at 150 kDa, corresponding to the 
complete immunoglobulin, was detected. On the contrary, in the case of H10-SEKDEL, the same 
band at 150 kDa was barely visible, demonstrating low secretion of the antibody in the culture 
media. In addition, H10-Mut profile showed several weak bands at lower molecular weight, 
indicating possible degradation products. Negative control panel obtained from the analysis of 
untransformed protoplasts (Figure 19 panel a, right picture) did not show cross-reaction of protein-
A and protein-G with endogenous plant proteins.  
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Figure R19: a) Pulse chase analysis performed in SR1 N. tabacum mesophyll protoplasts transfected with plasmids, 
separately encoding the heavy and light chain of each antibody glycoform (H10, H10 SEKDEL, H10-Mut), or with 
empty vector (negative control, C-).  Transfected cells were labelled for 1h and chased at three time points: 0 (pulse), 
2,5 hours, 5 hours; the analysis involved cellular (C) and secreted (S) fractions. A non-reducing sodium 
dodecylsulphate-polyacrylamide 15 % gel electrophoresis SDS-15 % (w/v) PAGE and fluorography was performed. 
Numbers at right indicate molecular weight markers in kDa.  
b) Analysis by sodium dodecylsulphate-polyacrylamide 9 % gel electrophoresis (SDS-9 % (w/v) PAGE, 25 mA for 1 h 
40 minutes) and Western blot of the plant extract obtained from vacuum agroinfiltrated N. benthamiana plants with H10 
and H10 SEKDEL constructs. Immunoblotting was performed with a peroxidase-conjugated anti-human γ-chain (left) 
or anti-human λ chain (right). Plant extracts were normalized for TSP content and a total of 1 µg TSP were loaded on 
each well in both gels. Arrows indicate the band shift produced by presence/absence of SEKEL peptide. 
 
4.3.3 Transient expression of H10 antibody variants in N. benthamiana plants  
 
The expression of H10 antibody was obtained by vacuum-agroinfiltration of N. benthamiana plants 
as previously described. In order to evaluate the expression levels and the degradation profile of 
antibody glyco-variants Western blot analysis, using an anti-γ antibody, was performed on fresh 
plant extracts. The analysis emphasized that all antibody variants showed a similar degradation 
pattern. In fact, a band at 50 kDa, corresponding to the HC, and a major degradation band around 20 
kDa were clearly visible. In the case of the secretory H10, the degradation bands were essentially 
less intense compared to other variants, while H10-Mut showed a more severe degradation pattern 
with a very strong band at 20 kDa and an additional fragment around 12 kDa (Figure R20 panel a). 
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On the contrary, the analysis of plant extracts using an anti-λ antibody showed only the expected 
band at 25 kDa indicating that no degradation bands were detectable (Figure R20 panel b). 
 
 
 
Figure R20: a) Western Blot analysis of H10 glycosylation variants performed on crude extracts using peroxidase-
conjugated anti-human γ-chain (reducing SDS-12.5 % (w/v) PAGE analysis). b) Western Blot analysis of H10 
glycosylation variants performed on crude extracts using peroxidase-conjugated anti-human γ-chain (reducing SDS-10 
% (w/v) PAGE analysis). H10, H10-Mut: 1 µg TSP; H10XylT/FucT: 10 µg TSP; H10-SEKDEL: 2 µg TSP. 
 
A comparison of H10 variants expression levels in plant extracts was obtained by quantitative 
antigen-binding ELISA. This assay revealed an average expression level ranging from 46 mg/Kg 
FW for H10XylT/FucT produced in XylT/FucT N. bentamiana plants to 620 mg/Kg in the case of H10-
Mut (Table R2). Surprisingly, expression levels of the ER retained antibody H10-SEKDEL were 
lower (480 mg/Kg FW) if compared to its secretory counterpart H10, used as a reference (640 
mg/Kg FW). Antibody levels reported as TSP percentage, showed values of 15.5 and 12 % TSP for 
H10-Mut and H10 SEKDEL, respectively, while H10 values (16 %) matched closely those 
previously reported (Lombardi et al., 2010). The lower values observed for the H10XylT/FucT (1.15 % 
TSP) were caused by the different agro-infiltration protocol used in this case, since the transient 
expression was performed in the absence of the AMCV P19 gene silencing suppressor protein. It is 
important to point out that the expression levels obtained in ELISA, estimated all functional 
antibody products in the extracts and not necessarily intact fully assembled H2L2 immunoglobulins.  
A detailed analysis of the H10-SEKDEL expression in agro-infiltrated N. benthamiana plant 
extracts was obtained by Western blot using both anti-γ and anti-λ detection antibodies (Figure 
R19 panel b). Western blot analysis performed with the anti-γ antibody (Figure R19 b, left panel) 
revealed the presence of two close bands around 50 kDa, with the lower band corresponding to the 
molecular weight of the H10 HC used as a reference. The second band exhibited a higher molecular 
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weight than 50 kDa, probably indicating a gel shift due to the presence of an HC population still 
harbouring SEKDEL C-terminal sequence. Western blot analysis performed with an anti λ antibody 
(Figure R19 b, right panel), differently to what observed for the HC, showed a unique higher band 
at about 25 kDa compared to the H10 LC used as reference. This shift is probably due to the 
presence of a unique population of LC maintaining the SEKDEL peptide. 
 
Table R2: Results of plant production of H10-Mut, H10-SEKDEL and H10XylT/FucT in terms of antibody expression 
yield, purification yield and percentage of intact IgG. 
 
IgG Form a Yield 
(mg/Kg) 
a
 IgG levels ( % TSP) b IgG purification 
yield (mg/Kg FW) 
c
 Percentage 
of intact IgG 
H10 640± 20 16 75 75 
H10-Mut 620± 18 15.5 73 3 
H10-SEKDEL 480± 20 12 60 24 
H10XylT/FucT  46± 12∗ 1.15∗ 10∗ 32∗ 
 
 a
 IgG concentration in the extracts was calculated by quantitative ELISA as described in Materials and Methods and 
values are the mean ± standard error of the mean (SEM) of triplicate samples. 
b
 The purification yield is the mean value obtained from three purifications of different batches (40 g) of agroinfiltrated 
leaves using protein A affinity chromatography.  
c Percentage of intact H10 was calculated from size-exclusion chromatography analysis.  
∗
 Expression yields of H10XylT/FucT are lower because agroinfiltration of N. benthamiana plants was performed without 
the AMCV P19 gene silencing suppressor protein.  
 
4.3.4 Purification and characterization of H10 antibody variants from 
agroinfiltrated leaves 
 
Purification of H10 variants was carried out, as previously described, starting from batches of 40 g 
of agroinfiltrated N. benthamiana leaves by protein-A affinity chromatography. Based on the 
previous results, protein extraction was carried out from fresh vacuum-agroinfiltrated leaves using 
mechanical homogenization. For the secretory H10 and H10-Mut similar purification yields were 
achieved (75 and 73 mg/Kg FW, respectively). In the case of the ER retained H10-SEKDEL, lower 
but comparable values were obtained (60 mg/Kg FW). As expected, in the case of H10XylT/FucT, as 
agro-infiltration experiments were performed in the absence of the P19 silencing suppressor, a 
significantly lower purification yield of 10 mg/Kg FW was obtained (Table R2). The binding 
activity of all purified antibody formats was confirmed through an ELISA assay against the 
recombinant C domain of human TNC-C (Figure R21). Results revealed a similar binding activity 
for H10, H10-SEKDEL and H10XylT/FucT, while a lower binding activity was observeed for H10-
Mut probably due to the high degradation of the plant purified product.  
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Figure R21: Functional ELISA assay of all H10 glycosylation variants. The antigen binding activity of plant produced 
purified H10 variants was assayed by ELISA. Plates were coated with recombinant human tenascin-C (C-domain) and 
detection was achieved using a peroxidase conjugated anti-human λ chain antibody. 
 
Analysis of the quality of the purified immunoglobulins was performed through SDS-PAGE, in 
order to compare the degradation profile of each H10 variant. The reducing gel analysis revealed 
the presence of two expected bands at about 50 kDa and 25 kDa, corresponding to the intact IgG, 
even if an additional strong degradation product was visible around 23 kDa (Figure R22 panel a). 
In the case of H10-Mut, a very faint band at 50 kDa (corresponding to the whole HC) was visible, 
while a strong band at 25 kDa as well as at about 23 kDa were present. Most notably, the H10-
SEKDEL variant showed an additional degradation product at about 28 kDa (as indicated by the 
arrow). As expected, HC-SEKDEL band showed a slightly higher molecular weight if compared to 
H10, due to the presence of the SEKDEL peptide. This result was also confirmed by reducing anti-γ 
chain Western blot analysis on purified H10-SEKDEL, in which HC showed a band shift compared 
to H10 (Figure R22 panel b).  
In parallel, non-reducing SDS-PAGE analysis performed on H10, H10-SEKDEL and H10XylT/FucT 
(Figure R22 panel c) showed, for all antibody formats, an expected band of about 150 kDa 
corresponding to the full size immunoglobulin. On the contrary, in the case of H10-Mut, a barely 
visible band at 150 kDa was detectable. Furthermore, in all antibody glyco-variants, additional 
degradation fragments with different intensities were visible at about 100, 70, 50 and 40 kDa 
(indicated by arrows). In contrast to what observed in the reducing SDS-PAGE analysis, in which 
only strong bands at about 25 kDa were present in H10-Mut (Figure R 22 panel a), under non-
reducing conditions, bands at 50 and 40 kDa were evident indicating the presence of assembled 
degradation fragments (Figure R22 panel c). 
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Figure R22: Characterization of purified H10 variants. (a) Reducing SDS-12.5 % (w/v) PAGE analysis of purified 
H10, H10-Mut, H10-SEKDEL and H10XylT/FucT stained with Coomassie blue. Two micrograms of H10 and 1 µg of H10-
Mut, H10-SEKDEL, H10XylT/FucT were loaded on gel. The arrow indicates the additional degradation band at about 28 
kDa observed in H10-SEKDEL. (b) Western blot analysis of purified H10 and H10-SEKDEL on reducing SDS-12.5 % 
(w/v) PAGE. Immunoblotting was developed with an anti-human γ-chain. Lanes 1 and 2: 50 and 25 ng of purified H10 
respectively; lane 3: purified H10-SEKDEL (25 ng). (c) Non-reducing SDS-9 % (w/v) PAGE analysis of purified H10 
(2 µg), H10-Mut (2 µg), H10-SEKDEL (2 µg) and H10XylT/FucT (1 µg). Arrows indicate degradation bands at about 100, 
70, 50 and 40 kDa present with different intensities in all samples. (d) Western blot analysis of purified H10 variants on 
non-reducing SDS-9 % (w/v) PAGE. Immunoblotting was developed with an anti-human λ-chain. Fifty ng of each 
antibody were loaded. Arrows indicate degradation bands at about 100, 70, 50 and 40 kDa present in all samples. 
 
Moreover, protein profile of all antibody variants was also assayed by a reducing anti-λ Western 
blot assay. This analysis showed the presence of the full-size antibody in all samples as a band at 
150 kDa, even if at a significantly lower intensity, in the case of H10-Mut (Figure R 22 panel d). 
Two major bands at about 40 and 50 kDa (indicated by arrows) and two minor bands at about 70 
and 100 kDa at different intensities between the samples were also clearly visible, perfectly 
matching those observed on non reducing SDS-PAGE (Figure R22 panel c), indicating the 
presence of LC in all these antibody degradation products.  
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4.3.5 Gel-filtration analysis of purified IgGs 
 
To assess the assembly and integrity of all IgGs purified from N. benthamiana agro-infiltrated 
leaves, size exclusion chromatography was performed using a Superdex S-200 column (GE 
Healthcare) (Figure R23). Analysis of H10-SEKDEL showed that only 24 % of the purified IgG 
was a full-size antibody (peak at a Kav value of about 0.3) with a major degradation product (elution 
peak at about 0.5 Kav) corresponding to a calculated molecular weight of about 45-50 kDa (Figure 
R23 panel a, Table R2). This degradation product was also clearly visible in the non-reducing 
SDS-PAGE analysis, lane of the H10 SEKDEL (Figure R22 panel c). The same degradation profile 
was observed for the purified H10XylT/FucT with only 32 % of intact antibody (peak at a Kav value of 
about 0.3) (Figure R23 panel c).  
 
 
Figure R23: Characterization of purified H10 variants by size-exclusion chromatography. Protein A purified H10 
variants were analyzed on a SuperdexTM200 5/150 GL column as described in Material and Methods. For a better 
interpretation of results, the chromatograms are presented over Kav= (elution volume- void volume)/ (column volume-
void volume) instead of elution volume or retention time. Kav values of major peaks are reported. (a) Chromatogram 
obtained for H10-SEKDEL. The broken line represents the chromatogram obtained from a commercially available 
purified human IgG used as a reference (Kav value of about 0.3). Typical chromatograms obtained from purified H10-
Mut (b), H10XylT/FucT (c) and H10 (d). 
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Even stronger degradation was observed in the gel filtration analysis of the purified H10-Mut. In 
this case, only 3 % of the purified IgG appeared as full-size antibody (the peak at about 0.3 Kav) 
with two major specific degradation products, at about 0.5 and 0.7 Kav (Figure R23 panel b). 
This result confirmed the data observed in the non-reducing SDS-PAGE in which the fully 
assembled H10-Mut was barely detectable and a strong band at about 50 kDa was present (Figure 
R22 panel c). As a reference, we report the chromatogram obtained for the purified H10 in which a 
major peak at about 0.3 Kav (75 % of intact antibody) and a minor degradation peak at about 0.5 Kav 
were observed confirming the results previously reported. 
  
4.3.6 N-glycan analysis 
 
The absence of HC N-glycosylation in the H10-Mut variant was first confirmed by gel-shift 
analysis in a reducing SDS-7.5 % (w/v) PAGE analysis (Figure R24 panel a). A clear lower 
molecular weight of the purified H10-Mut HC compared to H10 HC was visible. Glycan analysis of 
H10, H10-Mut and H10-SEKDEL variants was also performed by concanavalin A (Con A) Western 
blot. Normalized amounts of the intact HC of each purified antibody (since H10-Mut HC was 
heavily degraded, a five times higher amount of total purified antibody was loaded on gel with 
respect to H10 and H10 SEKDEL) were subjected to Western blot analysis using Con A, a lectin 
able to preferentially bind high mannose sugars of glycoproteins (Figure R24 panel b). As 
expected, in the case of H10 and H10-SEKDEL a clear band at 50 kDa, corresponding to the HC 
was visible while no bands were detected in H10-Mut, confirming the lack of sugar chains.  
 
 
Figure R 24: Analysis of H10-Mut variant. (a) Silver Stained reducing SDS-7.5 % (w/v) PAGE of purified H10 and 
H10-Mut. One µg of total protein for each sample was loaded on gel. Arrows indicate band shift between H10 and H10-
Mut. (b) Glycosylation analysis by Western blot on non-reducing SDS-10 % (w/v) PAGE of purified H10, H10-Mut 
and H10-SEKDEL. In order to normalize the amount of intact HC (since H10-Mut HC was heavily degraded) a five 
times higher amount of total purified H10-Mut (1 µg) was loaded on gel compared to H10 and H10 SEKDEL (200 ng). 
Proteins were blotted on a nitrocellulose membrane and detection was performed probing with biotinylated 
Concanavalin-A. 
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The N-glycan structures of H10, H10-SEKDEL, and H10XylT/FucT were determined and compared. 
N-glycans were released by hydrazynolysis and the resultant free glycans were 2-aminopyridine 
(PA)-labeled, analyzed by RP-HPLC (Figure R25 and R26), followed by LC-MS/MS (Figure 
R27).  
 
 
 
Figure R25: N-glycan structures analysis of H10, H10-SEKDEL, and H10XylT/FucT. All peaks (indicated by a number) 
were subjected to LC-MS/MS. Furthermore, N-glycan composition was determined by ESI-MS/(MS) analysis by 
comparing spectra with in-house PA (2-aminopyridine) -sugar chain libraries (Kaulfürst-Soboll, 2011). For simplicity, 
only predominant structures are indicated in chromatograms. All structures associated to each peak are shown in detail 
in Table R3. Analyzed peaks belonging to non PA-N-glycan derivatives or contaminants are indicated by an asterisk. 
Glucose Oligomer Unit (3-15mer) (GU) is indicated on the upper part of chromatograms to better compare results 
between chromatograms. 
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Figure R26: Peaks eluted from the RP-HPLC analysis of H10 (A), H10-SEKDEL (B) and H10XylT/FucT (C) (Figure 
R25) were subjected to LC-MS/MS. The LC part was performed by size-fractionation HPLC analysis using Shodex 
Asahipak NH2P-50 4E column allowing to separate similar N-glycan structures and their ratio was calculated from the 
peak area of resulting chromatograms. N-glycan structures (corresponding to the peaks indicated by letters in the 
chromatograms) are shown in Table R4. Peaks that are not identified by letters belong to non PA-N-glycan derivatives 
or contaminants. To better compare results between chromatograms Glucose Oligomer Unit (3-15mer) (GU) is 
indicated.  
 
The relative amounts of N-glycans detected in H10 variants were calculated on the basis of their 
HPLC peak areas detected in LC-MS (Figure R27). RP-HPLC demonstrated that H10, H10-
SEKDEL, and H10XylT/FucT contained predominant peaks composed of PA-labeled glycans. The 
relative amounts of N-glycans detected in H10, H10-SEKDEL, and H10XylT/FucT are summarized in 
Table R3.  
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Figure R27: Typical MS spectra for predominant structures are shown. N-glycan structures were determined by 
comparing with Glucose oligomer unit and spectra with in-house PA-sugar chain libraries (Kaulfürst-Soboll, 2011). 
Results for H10, H10 SEKDEL and H10-Mut are reported in panels A, B, C respectively. 
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Table R3 Relative amounts of N-glycan structures detected in H10, H10-SEKDEL, and H10XylT/FucT. The relative 
ratio ( % ) of structures was calculated on the basis of peak area of SF-HPLC analysis performed in LC-MS/MS. 
 
 
 
H10 antibody variants contained high-mannose type N-glycans, such as M3, M4, M5, M6, M7A, 
M7B, M8A, and M9 (abbreviations of sugar structures are summarized in Table R5), however, the 
ratios were substantially different. Particularly, in H10-SEKDEL and H10XylT/FucT, the ratios 
accounted for approximately 64 % of total N-glycan, while the ratio of H10 was ~15 %. On the 
other hand, H10 contained GN2M3, which is a common precursor of mammalian-type N-glycan, as 
the most abundant N-glycan, which accounts for 46.5 %. These results suggest that ER retention 
signal in H10-SEKDEL successfully worked to retrieve glycoproteins from Golgi to the ER, 
resulting in accumulation of M8A. 
However, results also showed that about 33 % of H10-SEKDEL was transported to medial and late 
Golgi and modified with Golgi-N-glycosylation machineries, which resulted in residues carrying β 
1,2-xylose and α 1,3-fucose, indicating a sort of escape from ER retrieval system. Moreover, while 
H10XylT/FucT did not contain potentially immunogenic complex plant sugars, 33 % of H10 N-glycans 
harboured β 1,2-xylose and α 1,3-fucose residues. As for H10XylT/FucT N-glycans, high-mannose 
type N-glycans, especially M8A and M5, were added.  
 
 
 
H10 H10-SEKDEL H10 XylT/FucT
M3 2.4 - 4.8
M4 2.4 1.3 7.0
M5 6.9 12.6 20.7 
M6 2.8 6.7 3.4
M7A - 3.4 2.9
M7B 0.7 12.9 -
M8A - 26.3 22.0 
M9 - - 3.4
GNM3 5.6 1.2 0.5
GN2M3
- - 6.4
M3X 2.3 - -
GN2M3X 10.2 6.8 -
M3FX 2.7 3.7 -
GNM3FX 2.3 - -
GN2M3FX 15.2 10.5 -
15.2 63.2 64.2 
79.8 33.1 35.8 
32.7 21.0 0
Ratio ( % )N -Glycan structure
Total mannose type
Total complex type
Total GlcNAc-linked
Mannose type 
GlcNAc linked 
Complex type
46.5 14.6 28.9 
GNM3 
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Table R4: N-glycan structures determined by LC-MS/MS analysis. 
H10
Peak n.    Sugar type
H10-SEKDEL
Peak n.    Sugar type
H10XylT/FucT
Peak n.    Sugar type
1-a M3FX 1-a M3FX 3-a M8A
4-a GN2M3FX 1-b M8A 4-a M7A
5-a M7B 2-a M7A 5-a M9
6-a GNM3FX 4-a GN2M3FX 6-a M6
6-b
9-a
M6
M3
5-a
6-a
M7B
M6
8-a
8-b
M4
GNM3
9-b M3X 8-a M4 9-a M3
9-c M4 8-b M5 9-b M4
9-d M5 9-a GN2M3X 9-c M5
10-a GN2M3X 10-a GN2M3 10-a GN2M3
11-a GN2M3 11-a GNM3 11-a GNM3
12-a GNM3
 
 
Table R5: Table indicating abbreviations of glycan structures. In parenthesis are shown numbers of the corresponding 
SF-HPLC peaks. 
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4.4 DISCUSSION  
 
In the previous section we showed the possibility to express high levels of mAb H10 in N. 
benthamiana leaves using a vacuum agro-infiltration system based on the use of the P19 gene 
silencing suppressor protein. Moreover we demonstrated that H10 could be efficiently purified 
obtaining an extremely pure product (99.4 %), free from plant contaminants and endotoxins. 
However, analysis of the final product showed that the antibody exhibited a typical plant 
glycosylation profile with the presence of complex-type oligosaccharides exposing β 1,2-xylose and 
α 1,3-fucose moieties. The presence of these sugars represents a limitation to its use in 
immunotherapy, as it has been suggested that xylose and fucose moieties may cause immunogenic 
reactions in mammals (Gomord et al., 2010). Moreover, it has been demonstrated that plant 
complex glycan structures may also interfere with the binding to Fcγ receptors (Forthal et al., 2010). 
In this section, we present data on three different H10 antibody glyco-variants in which the 
glycosylation profile was modulated through three different procedures: site-directed mutagenesis 
to abolish the glycosylation site, Endoplasmic Reticulum retention (C-terminal SEKDEL fusion) to 
ensure predominantly high-mannose type glycans, and expression in a N. benthamiana RNAi 
down-regulated line in which β 1,2- xylosyltransferase and α 1,3- fucosyltransferase gene 
expression was silenced. 
Prior to transient over-expression in leaves, we preliminarily characterized H10, H10-Mut and H10-
SEKDEL formats by transient expression in tobacco protoplasts, in order to identify the sub-cellular 
localization of each variant. This study, carried out through a pulse-chase experiment, showed that 
H10 and H10-Mut were efficiently secreted by tobacco cells while H10-SEKDEL was barely 
detectable in the culture medium, indicating the substantial retention of this antibody in the ER. 
However, a partial escape of the antibody from the Endoplasmic Reticulum could not be excluded. 
In fact, in a previous study presented by Fujiyama and colleagues (2009), the ER retained form of a 
mouse antibody expressed in suspension-cultured tobacco BY2 cells, bearing the SEKDEL signal 
on both heavy and light chain, exhibited a partial escape of the immunoglobulin from the ER, in 
spite of the retention signal. As evidence, this IgG showed the presence of complex-type 
oligosaccharides with β 1,2-xylose and α 1,3-fucose moieties typical of the Golgi compartment, 
indicating a partial escape from ER retention/cis-Golgi retrieval. To further investigate the H10-
SEKDEL behavior during the expression process in agro-infiltrated N. benthamiana leaves we 
verified the preservation of the SEKDEL peptide fused to both H and L chains. Surprisingly, 
Western blot analysis of crude extracts of the agro-infiltrated H10-SEKDEL carried out using an 
heavy chain detection antibody, revealed the presence of two consecutive bands, one matching with 
4. RESULTS AND DISCUSSION 
 
 
106 
the HC of the secretory H10 used as control, the second, with higher molecular weight. This result 
indicated the coexistence of two populations of heavy chains deriving either from a partial cleavage 
of the SEKDEL or to a different glycosylation pattern. On the contrary, Western blot analysis of the 
H10-SEKDEL light chain from the crude extract, revealed the presence of a unique band with an 
higher molecular weight compared to secretory H10 LC used as control. This reduced 
electrophoretic mobility, indicated the presencence of the SEKDEL peptide fusion at the C-
terminus. However, analysis of the purified H10-SEKDEL carried out both by Coomassie stained 
SDS-PAGE and Western blot detected with an anti-γ antibody, did not confirm the presence of a 
double band in the case of the HC analysis. In fact, in this case a unique heavy chain (~50 kDa) and 
a unique light chain band (~25 kDa) both showing a lower electrophoretic mobility, compared to 
H10 were detected, indicating that the purified antibody maintained the SEKDEL retention peptide. 
This result was confirmed by the LC–MS glycosylation analysis performed on the purified H10-
SEKDEL due to the high percentage of typical high-mannose ER sugar moieties compared to the 
secretory H10. In fact, in this case, in comparison to the secretory H10, an high percentage (63 % 
compared to 15 % of H10) of the sugar residues, were typical high-mannose ER glycans (M5 - M6 - 
M7 - M8 forms), indicating the retention of the H10 SEKDEL in the Endoplasmic Reticulum. In 
fact, as reported in literature, Man7 (Tekoah et al., 2004; Triguero et al., 2005) or Man7/8 (Sriraman 
et al., 2004) were the most abundant N-glycans in mAbs expressed in plants with KDEL ER-
retention signal. So, the finding of M8 as the major N-glycan in H10-SEKDEL, strongly supports 
the full functionality of the ER-retention signal. Nevertheless, glycan analysis showed also the 
presence of a fraction (21 %) of complex sugars (β 1,2-xylose and α 1,3-fucose residues) as result of 
a specific modification of H10-SEKDEL by the Golgi-N-glycosylation machineries. This effect 
revealed an escape of the antibody from the ER retrieval system in spite of the presence of the 
SEKDEL retention peptide. However, a similar evidence was previously described by other groups 
that reported the same result for antibodies harbouring the KDEL fusion peptide (Tekoah et al., 
2004; Triguero et al., 2005; Rademacher et al., 2008; Floss et al., 2008). In these studies, it was 
shown that antibody forms bearing an ER retention signal did not always guarantee a complete 
retention of the immunoglobulin in the cells since in all these cases a low percentage of β 1,2-
xylose and α 1,3-fucose residues was reported. On the contrary, other studies on the expression of 
immunoglobulins harbouring the KDEL tag fusion, described the complete retention of the antibody 
in the ER of both transgenic tobacco plants and agro-infiltrated N. benthamiana (Sriraman et al., 
2004; Petruccelli et al., 2006; Floss et al., 2009; Sainsbury et al., 2010; Loos et al., 2011). Many 
factors can explain the variability of the glycosylation pattern such as the sensitivity of the 
methodology used for N-glycans identification or, most likely, the plant expression system used or 
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the antibody sequence itself which may influence accessibility to the KDEL sequence. In the case of 
the H10 produced in a XylT/FucT N. benthamiana mutant, analysis of the glycosylation profile 
showed a high percentage of high-mannose type N-glycans as well as a high amount of GN2M3, a 
common precursor of mammalian-type N-glycans. Most interestingly, as expected, the glycan 
profile showed the absence of the typical plant complex residues β 1,2-xylose and α 1,3-fucose 
confirming the efficiency of these plants to block the activity of the fucosiltransferase and 
xilosiltransferase glyco-enzymes. These findings substantially matched those obtained in the 
transient expression of the 2G12 antibody in N. benthamiana XylT/FucT mutants by agro-
infiltration (Forthal et al., 2010; Strasser et al., 2008). On the contrary, in the case of the analysis 
performed on the secretory H10 expressed in wild type N. benthamiana plants, the presence of 
higher percentages of complex N-glycans (32 %) represented by M3X, GN2M3X, M3FX, 
GN2M3FX, GNM3X was observed. Surprisingly, the most represented sugar structure identified 
for H10 was the GN2M3, with a percentage of 46.5 %. Several studies presented in literature 
emphasized that this sugar was normally present at low percentages in antibodies targeted to the 
secretory pathway. Nevertheless, it must be noted that in a recent work reported by Vezina et al., 
(2009), high percentages of GN2M3 were described for the secretory murine mAb C5-1 produced 
in N. benthamiana plants using a vacuum agroinfiltration system (Vezina et al., 2009). 
The analysis of expression levels of the H10-SEKDEL glyco-variant, surprisingly emphasized that 
this value was lower compared to the secretory H10 counterpart (480 mg/kg FW instead of 640 
mg/kg FW). This result is somehow unexpected as the ER retention strategy is normally used to 
increase antibody accumulation in plant cells (Schillberg et al., 2003; Petruccelli et al., 2006). 
Nevertheless, as reported by a recent work, ER targeting of a mouse IgG produced in agro-
infiltrated N. benthamiana plants, using a viral suppressor of gene silencing (HCPro), did not show 
any significant higher accumulation of the antibody in leaves if compared to its secretory 
counterpart (Vezina et al., 2009), confirming that in some expression systems, the ER retention 
could even result detrimental for antibody accumulation.  
Characterization of the integrity of the purified antibodies was conducted by SDS-PAGE analysis 
and gel filtration chromatography. Electrophoresis performed on the purified antibodies revealed 
that all H10 variants had very similar specific degradation profiles with a major band at 50 kDa in 
the non reducing analysis, likely corresponding to Fab fragments, and minor products at about 100, 
70 and 40 kDa. We previously demonstrated that protein-A affinity chromatography specifically 
captured not only the Fc portion of H10 but also the Fab fragment due to the presence of an HC 
VH3 variable domain able to bind D domain of protein A. This double binding valency explained 
the specific enrichment for H10 Fab fragments in the purified product, rendering this molecule an 
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interesting model system to study antibody degradation in plant (Villani et al., 2009). Major striking 
differences were found for the aglycosylated H10-Mut. In fact, the reducing gel evidenced a very 
faint band corresponding to the intact heavy chain (~50 kDa) and a strong band at ~25 kDa that 
indicated a specific degradation of the heavy chain around the hinge region. This hypothesis was 
confirmed by the non-reducing analysis, in which an almost unique band at ~50 kDa was present. 
These data were supported also by the Western blot analysis performed on the crude extracts.  
This analysis highlighted that H10 SEKDEL and H10 produced in the XylT/FucT N. benthamiana 
mutant did not show significantly different profiles in comparison to the H10 secretory form, 
making difficult to find a direct correlation between glycosylation pattern and antibody stability. In 
contrast, a direct correlation between stability and glycosylation status was evidenced by the 
comparison between H10 and H10-Mut. In this case, the Western blot analysis revealed a more 
severe degradation profile, in which, compared to the secretory H10, the band corresponding to the 
intact HC was significantly reduced and the presence of additional degradation bands was observed. 
These antibodies differ only by a point mutation in the Asn 297 glycosylation site and were 
expressed in plants using exactly the same conditions. Besides, pulse-chase analysis revealed a 
similar secretory performance in plant cells indicating that glycosylation has no influence in 
antibody localization within the cell. 
Moreover, gel filtration analysis revealed that almost 97 % of the antibody was degraded with a 
major elution peak at a Kav value of 0.51, corresponding to a molecular weight of 50 kDa. This 
evidence, together with the antigen binding activity of H10-Mut suggests that this antibody variant 
is specifically degraded in plants, leading to the formation of functional Fab fragments. A possible 
explanation of this tendency is the susceptibility to a specific proteolytic cleavage of the H10 heavy 
chain hinge region. Furthermore, we give evidence that the aglycosylated H10-Mut produced in 
agro-infiltrated N. benthamiana is significantly more prone to proteolytic degradation if compared 
to its glycosylated counterpart (H10). There is a large body of work demonstrating that N-
glycosylation of the heavy chain is fundamental not only for Ab effector function but also for 
protein stability and prevention of aggregation phenomena (Kayser et al., 2011). It should also be 
pointed out that H10-SEKDEL showed higher degradation if compared to its secretory counterpart 
(24 and 75 % of the antibody being an intact H2L2 molecule, respectively). In this case, reducing 
analysis revealed the presence of a band with a molecular weight of about 28 kDa, which was not 
present in all other samples, indicating a peculiar degradation product of HC-SEKDEL. Apparently, 
this result is in contrast with the general assumption that ER retention protects antibodies from 
degradation.  
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Recent results reported no significant differences in the degradation profile between secretory and 
ER retained form of the transiently expressed 2G12 in N. benthamiana plants (Sainsbury et al., 
2010). On the contrary, the expression of 2G12 in Arabidopsis thaliana seeds, showed that retention 
in the ER was detrimental for both expression yields and antibody integrity, although, in this case, 
antibody accumulation was specifically directed to the protein storage vacuoles (Loos et al., 2011). 
Most surprisingly, also the secretory H10 produced in the XylT/FucT N. benthamiana mutant 
showed higher degradation (32 % of intact antibody) if compared to H10. In this case, it is 
important to point out that transient expression was performed without the use of the p19 silencing 
suppressor protein, resulting in lower accumulation levels in leaves.  
Data herein provided a thorough characterisation of different variants of the tumour targeting H10 
antibody produced at high yields in agro-infiltrated N. benthamiana plants. Protein stability and 
degradation is known to be influenced by different factors (peptide sequence, protein targeting 
compartment, genetic constructions and purification procedures), overall data obtained for H10 
variants suggest that also glycosylation might play an important role. It is evident that both ER 
retention and secretory expression of H10 in the XylT/FucT N. benthamiana double mutant are 
promising strategies for the modulation of antibody glycosylation. Future work will be directed 
towards the identification of possible ‘fragile’ sites in the H10 antibody hinge region particularly 
prone to be cleaved by the plant protease machinery in order to explore new strategies to reduce 
antibody degradation and increase the yield of intact IgG.  
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4.5 CHARACTERIZATION OF THE DEGRADATION PROFILE OF mAb 
H10 PRODUCED IN PLANT  
 
Proteolytic processes occurring in the plant cell, are essential to ensure metabolic functions but 
could represent, in some cases, a drawback for the production of biologically active heterologous 
proteins in plants. In particular, in the case of plant-derived antibodies unintended proteolysis 
driven by this complex proteolytic machinery can dramatically affect the final yield of intact IgG 
causing the degradation of more than 90 % of the final purified immunoglobulin (Villani et al., 
2009). Many studies reported a strong degradation for a number of plant-derived antibodies 
detectable in SDS-PAGE analysis as additional smaller fragments between 20 and 150 kDa under 
non-reducing conditions (De Muynck et al., 2010). In this part of the work, I characterized the 
proteolysis of the plant-derived mAb H10 in order to study in planta antibody degradation profile 
and to identify specific cleavage sites of the immunoglobulin. Furthermore, an in silico analysis 
permitted the identification of proteases responsible of the cleavage. In order to protect the antibody 
from cleavage, a site directed mutagenesis of specific aminoacid sequences recognized by these 
proteolytic enzymes was performed. 
4.5.1 Purification of H10 from plant extracts 
 
Purification of mAb H10 was performed using three different affinity chromatography columns: 
anti γFc, protein A and protein G column. The use of different affinity columns enabled the 
comparison of the purification efficiency of each methodology, in terms of final recovery yield and 
quality of the purified immunoglobulin. Plant extracts were prepared from 40 g of vacuum-
agroinfiltrated N. benthamiana leaves without the addition of any protease inhibitor and, after 
clarification, were loaded on the affinity column. The non reducing SDS-PAGE analysis of H10 
purified using three different strategies, is shown in Figure R28. In all cases, the protein profile 
presented a major band at 150 kDa, corresponding to the intact form of the mAb H10. Nevertheless, 
several bands at lower molecular weight, corresponding to partially assembled or degradation 
products of the antibody, were visible.  
In the case of H10 purified with the Anti γFc-affinity column, nine bands were detected between 
140 and 10 kDa. This profile was comparable to that obtained after purification with protein G 
column. In fact, except for the fragment around 10 kDa, absent in the protein G purifications, all 
bands seem to match with Western blot, ELISA and N-terminal sequencing.  
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Figure R28: Analysis of H10 purified from extracts of vacuum-agroinfiltrated N. benthamiana leaves using different 
affinity chromatography strategies (Anti γFc, protein A and protein G affinity chromatography column). Analysis was 
performed loading 20 µl of antibody purified from batches of 40 g of vacuum-agroinfiltrated leaves onto non-reducing 
SDS 4-20 % (w/v) PAGE stained with Coomassie blue. Each purified sample was concentrated 10 times by 
lyophilization before gel loading. Asterisks indicate the two additional major bands present in the purification of mAb 
H10 performed with protein A column. 
 
Even if the protein profile obtained with the three techniques is generally comparable, two major 
differences are clearly evident in the case of protein A column in which the presence of two 
additional bands between 50 and 25 kDa is clearly observable (indicated by an asterisk). The higher 
band (around 45 kDa) is present at barely detectable levels also in the purification profile obtained 
with the γFc column while the lower band (around 30 kDa) is not present in any protein profile 
analyzed. The band at 45 kDa shows a strong intensity compared to the one at 30 kDa, confirming 
the high affinity of protein A for this specific fragment. It must be noted that all purifications were 
conducted using the same batch of agroinfiltrated material starting from 40 g of leaf material and in 
the case of protein A, a higher purification efficiency (75 mg of total purified proteins from Kg FW 
compared to 15 mg/Kg FW in the case of Anti γFc, and protein G columns) is clearly evident as 
well as the difference in the relative abundance of some protein products compared to the Anti γFc, 
and protein G columns. All degradation bands (nine in total, Figure R30) were excised from the gel 
and analyzed using different techniques (Figure R29). 
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Figure R29: Example of cut band from SDS-PAGE Coomassie blue. Each excised band containing a single degradation 
fragment was analysed with different techniques (Western Blot, ELISA, N-terminal sequence). 
 
 
 
Figure R30: Coomassie staining of the SDS-PAGE analysis of the purified mAb H10. To each band was assigned an 
identification number.  
 
4.5.2 Western blot analysis of purified H10 bands excised from SDS-PAGE gel 
 
Affinity purified mAb H10 from vacuum-agroinfiltrated N. benthamiana plants was analyzed in 
order to characterize the observed protein degradation products. Protein A affinity-chromatography 
revealed to be the best technique to isolate the most abundant H10 degradation fragments. 
Therefore, the 9 most abundant Coomassie stained SDS-PAGE protein bands were excised from the 
gel (Figure R29), proteins were eluted and again individually analyzed by SDS-PAGE followed by 
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Western blot analysis using an anti-human γ IgG1 (Figure R31 panel A) or anti human-λ antiserum 
(Figure R31 panel B). This method allowed to reveal the presence of HC and/or LC derived 
fragments in each excised protein band.  
Western blot analysis performed using the anti-human γ antibody showed the presence of HC in all 
degradation bands, except for band 8 (15 kDa) and 9 (13 kDa). On the other hand, the anti-λ 
Western blot analysis of excised bands proved the presence of the LC in all bands except for band 5 
(50 kDa), 8, and 9 (15 and 13 kDa, respectively) indicating an absence of LC.  
 
 
Figure R31: Western blot analysis performed on proteins eluted from the bands excised from the SDS-PAGE analysis 
(analyzed bands are shown in Figure R30 and identified by a number). Bands were excised from gel, homogenized in 
PBS 1 X and separated again by 4-20 % SDS-PAGE under non-reducing conditions. Proteins were blotted to a PVDF 
membrane and probed with either anti-human γ IgG1 antiserum (A) or anti human-λ antiserum (B).  
 
Degradation bands where further studied by Western blot analysis using Concanavalin A, a lectin 
with an high saccharide binding specificity. As previously described, mAb H10 contains N-glycans 
attached to the asparagine-297 (Asn297) residue of the CH2 domain of the immunoglobulin HC. 
Western blot analysis in reducing conditions of the single protein fragments with Concanavalin A, 
allowed the identification of bands harbouring the glycan chain on the CH2 domain (Figure R32).  
The presence of the glycan chain was detected in all protein fragments, except for band 3 and 6, 
indicating that these bands do not contain the CH2 domain of the antibody. Moreover, band 1, 2 and 
4 showed a molecular weight of 50 kDa corresponding to the size of the intact HC. Interestingly, 
band 5 in this reducing Western blot analysis showed a molecular weight reduced by half (25 kDa), 
indicating the presence of a truncated HC fragment.  
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Figure R32: Western blot analysis of mAb H10 degradation bands excised from the SDS-PAGE Coomassie blue 
(Figure R30) of the mAb H10 purified from N. benthamiana leaves by protein A. Bands were excised from gel, 
homogenised in PBS 1X and separated again by 4-20 % SDS-PAGE under reducing conditions. Proteins were blotted to 
a nitrocellulose membrane and probed with biotinylated Concanavalin A, a lectin with an high saccharide binding 
specificity, and detected with peroxidase conjugated Streptavidin. Numbers indicates the analysed bands as reported in 
the Coomassie blu gel. 
 
4.5.3 ELISA of purified H10 bands excised from SDS-PAGE 
 
The study of the degradation fragments of the mAb H10 was improved by ELISA, in order to verify 
which of the H10 fragments maintained the capability to bind to the antigen. To this aim, each band 
of interest was ground in presence of PBS 1 X and centrifuged. The recovered supernatant, 
containing the eluted fragment, was loaded on an ELISA plate coated with Human Lung Cancer 
cells (A 549). These cells expose on their surface the large isoform of tenascin including the C 
domain specifically recognized by the mAb H10 (Fitch et al., 2011). Bands 1, 3, 4, 5 and 6, that 
showed a molecular weight above 40 kDa, were selected for the analysis. As positive control 150 ng 
of a plant purified mAb H10 were used. As the intensity between the bands in SDS-PAGE was 
markedly different and some bands were very faint (bands 4 and 5 in particular), it was not possible 
to normalize for the TSP content loaded on each well. Results obtained in the ELISA experiment 
(Figure R33) revealed that band 1, representing the intact IgG as expected is able to bind the 
antigen. Moreover we show that also band 3 and 6 have antigen binding specificity. In the case of 
the weaker bands 4 and 5, only band 4 showed a significant binding activity to tenascin-C. It must 
be noted that Western blot analysis performed on bands 3, 4 , and 6 evidenced the presence of both 
HC and LC while in the case of band 5 only HC was detected (Figure 31 panel A, B). This data 
support the hypothesis of the presence of the binding site in bands 3, 4 and 6. 
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Figure R33: Whole cell ELISA performed using Human Lung Cancer cells (A 549) performed loading on the wells the 
band coming from the SDS-PAGE analysis of the H10 (Figure R30). The experiment was carried out loading on the 
wells the supernatant coming from each ground band in 50 µl of 1 X PBS. The detection was performed with a 
peroxidase anti human-λ chain antibody. C+ H10 (positive control): 150 ng of plant purified mAb H10. The absorbance 
is detected at a wave length of 450 nm. 
 
4.5.4 Two-dimensional gel electrophoresis of protein A purified mAb H10 
 
The study of the protein profile of mAb H10 purified with protein A was also conducted using a 
reducing two-dimensional gel electrophoresis (2-DE) analysis. As shown in Figure R34 all 
degradation spots were localized around 15-25 kDa with an experimental isoelectric point (pI) 
range of 3-7. Furthermore, spots 1-6 are all restricted around a molecular weight of 25 kDa and 
distributed in a pI range of 4-7. In the pI range of 3-4, four major spots are identified: spot 7 at a 
molecular weight of ~23 kDa; spots 9 and 10 at a molecular weight of ~20 kDa and spot 8 at 
about~18 kDa. In order to identify each degradation spot, a MALDI-TOF analysis was performed. 
Spots 1- 6 were identified as LC, while spots 7-9 as HC derived fragments; surprisingly spot 10 
showed to contain both HC and LC peptides. Molecular weight of spots 1- 6 (25 kDa) confirmed 
the presence of the intact form of the LC, while the different pI values observed are probably related 
to different post-translational modifications. Based on these results, spots 7 and 10 were selected for 
the N-terminal sequencing analysis. 
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Figure R34: Coomassie stained two-dimensional gel electrophoresis of the the mAb H10 purified with protein A from 
vacuum-agroinfiltrated N. benthamiana plants. 800 µl of purified mAb H10 were separated by isoelectrofocusing (IEF) 
at pH 3-11 Non Linear (NL) strips, followed by SDS-12.5 % (w/v) PAGE. The major visible spots are indicated by 
numbers. 
 
4.5.5 N-terminal sequencing analysis 
 
N-terminal sequencing was performed with the aim to identify mAb H10 amminoacid sequences 
prone to proteolytic cleavage in plants. This analysis involves a series of chemical reactions that 
derivatize and remove one amino acid at a time from the N-terminus of purified peptides or protein, 
enabling the identification of the residues belonging to the N-terminus. Analysis was performed on 
all 9 protein bands obtained in the mono-dimensional gel electrophoresis (1-DE) of the protein A 
purified mAb H10 (Figure R30) as well as on spots 7 and 10 obtained after 2-DE gel 
electrophoresis. In both cases proteins were blotted on a PVDF membrane and subsequently 
processed. N-terminal analysis of proteins was limited to five residues, representing the minimum 
amount of aminoacids required to univocally identify a proteolytic cleavage site. The N-terminal 
analysis of the bands/spots obtained with 1-DE or 2-DE separation are summarized in Table R8 
panel A and Table R8 panel B, respectively. 
N-terminal sequencing performed on band 1 (1-DE analysis) showed, as expected, the presence of 
amminoacid sequences corresponding to the most N-terminus sequence of the intact LC (positions 
1-5) and HC. In the case of band 3 and 4, N-terminal analysis produced a similar result identifying 
sequences corresponding to HC and LC (positions 1-5). In particular, the amminoacid sequences 
found for band 3 exhibited a strong detection signal (> 2 pmol) for all the amminoacids identified, 
indicating the reliability of the result. On the other hand, in the case of the analysis of band 4, the 
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first two amminoacids (t and s in lower case letters), both in heavy and light chain, showed a 
weaker detection (< 2 pmol), but the strong signal for the next amminoacids in position 3-5 
validated the identification of the sequence. No other sequence belonging to HC or LC was 
identified. Band 5 N-terminal analysis did not reveal any sequence corresponding to the LC 
matching perfectly with the results obtained by Western blot analysis (Figure 31, panel A, B). 
However, the presence of an internal sequence of the HC was identified at the position 232-236 
(KKVEP), corresponding to the end of the CH1 (KKV) and the starting point of the hinge region 
(EP) of mAb H10. This position, contained in the hinge region, produced a protein fragment 
corresponding to the Fc part of the mAb H10. This hypothesis was confirmed by the size of the 
analyzed band (55 kDa) corresponding to the theoretical mass of two assembled Fc fragment of the 
mAb H10. Furthermore, we also showed that Concanavalin A Western blot analysis under reducing 
conditions of band 5 highlighted the presence of a single band with a molecular weight of about 25 
kDa. 
Band 6 and 7 showed a similar result for band 3 and 4, obtaining sequences corresponding to the N-
terminus of intact HC and LC. In the case of band 6, the positions 1-2 of the light chain presented a 
missing amminoacid in position 1 and a weak signal for the amminoacid in position 2. In spite of 
the first two positions, all the other amminoacids in positions 3-5 clearly matched (signal > 2 pmol) 
the N-terminal part of the of LC. In the case of HC, the signal was weak for positions 1-2, but clear 
for the positions 3-5 confirming the presence of an intact HC N-terminus. Band 6 most likely 
corresponded to a Fab fragment (molecular weight of 45 kDa), with the proteolytic cleavage 
occurring in position 232-236, as observed in band 5. This conclusion is strengthened by the results 
previously shown in Western blot analysis (Figure R31 panel A, B) and ELISA (Figure R33). The 
analysis of protein fragments contained in band 7 indicated the presence of two sequences 
corresponding to the position 1-5 of both heavy and light chain. In the case of LC the signal was 
weak for amminoacids in position 1-4 (< 2 pmol), but stronger for the amminoacid in position 5. 
For the HC, analysis identified the N-terminus of the intact chain (position 1-5) with a strong signal 
(>2 pmol for all the amminoacids). From these results and from the size of the band in SDS-PAGE 
(25 kDa) it can be hypothesized that it corresponds to different protein species co-banding at the 
same molecular weight (unassembled intact LC and degradation fragment of HC). This result is 
confirmed by the western blot analysis in which a band at 25 kDa is recognized by both anti-γ and 
anti-λ antibodies. Furthermore, we also showed that Concanavalin A Western blot analysis under 
reducing conditions highlighted the presence of a single band with a molecular weight of about 25 
kDa (Figure R32). 
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A single N-terminal analysis was performed for both bands 8 and 9 because of the difficulty to 
isolate the single bands on the PVDF membrane. This analysis enabled the identification of three 
amminoacid sequences corresponding to positions 353-357 (KTISK), 355-359 (ISKAK) and 357-
361 (KAKGQ) of the HC.  
The first two sequences (KTISK and ISKAK) corresponded to the final part of CH2, while the third 
sequence (KAKGQ) was localized between the end of CH2 (KAK) and the early CH3 (GQ). The 
sequences overlapped in three positions possibly identifying three possible overlapping cleavage 
sites on the CH3 interdomain region. A strong signal for all the amminoacids was obtained (> 2 
pmol), enabling the unambiguous recognition of the HC sites. No detection for LC sequences was 
observed. These bands both corresponded to a short fragment of HC (15-13 kDa) which was not 
recognized on Western blot analysis by anti-γ antibody. 
N-terminal sequence of spot 7 (pI 4, 23 kDa) and spot 10 ( pI 3, 20 kDa) from the 2-DE gel was 
also performed (Table R8, panel B). Analysis of spot 7 indicated the presence of the sequence 
STKGP (> 2 pmol) corresponding to position 138-142 of the HC. The sequence was localized at the 
level of the interdomain region, at the beginning of the CH1 domain. The molecular weight of 
23kDa, most likely, indicated that the most C-terminal sequence of this protein fragment was 
localized in the interdomain region CH2-CH3 in which a cleavage sequence was identified in the 1-
DE bands 8 and 9. The analysis of spot 10 (20 kDa) revealed the unexpected presence of an 
amminoacid sequence corresponding to the N-terminus of the intact LC. 
4.5.6 Structural assignment of 1DE bands and 2DE spots.  
 
From all experimental results obtained from Western blot analysis (Figure R31), antigen binding 
by ELISA (Figure R33), Fc sugar-chain analysis (using Concanavalin-A on Western blot, Figure 
R32), which are summarized in Table R7, and from N-terminal sequencing results, we were able to 
assign a structural footprint to each 1-DE band or 2-DE spot (Table R8, panel A and Table R8, 
panel B).  
In the case of band 1, as summarized in Table R7, both HC and LC were present, and both binding 
site and sugar chain were detected (Figures R31, R33 and R32 respectively). In addition, N-
terminal analysis showed the presence of the intact LC (Table R8 panel A) while an experimental 
molecular weight of 150 kDa was observed. These data indicated that this band corresponded to the 
full size H2L2 H10 form. Band 3 showed all the features of the band 1 except for the absence of the 
sugar chain (Figure R32). This evidence indicated that this antibody fragment lacked of the Fc 
region (40-50 kDa), as confirmed also by the molecular weight of about 110 kDa. Based on these 
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results, the fragment can be described as a Fab2 like fragment (Table R8 panel A). In the case of 
band 4, the presence of both HC and LC (Figure R31), binding site (Figure R33) and sugar chain 
(Figure R32) was confirmed. Furthermore, the N-terminal sequencing revealed the presence of the 
intact starting point of both HC and LC (Table R8 panel A). However, a molecular weight 
corresponding to about half of the whole immunoglobulin size was found (about 80 kDa) indicating 
that this antibody fragment represents a partially assembled IgG represented by an H1L1 molecule. 
An interesting result was obtained with the analysis of band 5 that allowed the identification of the 
first internal cleavage site of the immunoglobulin. This fragment, as confirmed by Western blot 
analysis (Figure R31), contained only the HC and the sugar chain (Figure R32) and the signal of 
the antigen binding site (Figure R33) was absent, while LC was not detected. The most N-terminal 
sequence of this of this fragment corresponded to the end of CH1 domain close to the hinge region 
(Table R8 panel A). This was confirmed by the size of the analyzed band (55 kDa) matching the 
theoretical molecular weight of the Fc fragment. Furthermore, the Concanavalin A Western blot 
analysis of band 5 under reducing conditions highlighted the presence of a single band with a 
molecular weight of about 25 kDa indicating half of an intact Fc (Figure R32). Band 6 (about 50 
kDa) showed different features, the antigen binding site was present (Figure R33), the HC and LC 
were both recognised in Western blot analysis (Figure R31) while the sugar chain was not (Figure 
R32). In addition, N-terminal sequencing confirmed the presence of the first aminoacid residue of 
both HC and LC indicating that this fragment matched the Fab portion of the immunoglobulin 
(Table R8 panel A). In the case of band 7, HC and LC were identified, but also the sugar chain was 
observed. From these results and from the size of the band verified on SDS-PAGE (25 kDa) it can 
be hypothesized that it corresponded to different protein species co-banding at the same molecular 
weight (unassembled intact LC and degradation fragments of HC). Moreover, N-terminal 
sequencing of bands 8 and 9 indicated that these two fragments were the result of a cleavage 
occurring in the CH2-CH3 region (Table R8 panel A). 
In conclusion, the most informative results were obtained from the analysis of bands 5, 8 and 9 in 1-
DE and from spot 7 in 2-DE (Table R8 panel A, B red square). The N-terminal sequencing analysis 
of these peptides allowed the identification of the internal cleavage site KKVEP (CH1-CH2 region) 
in the case of band 5, of the cleavage sites KTISK, ISKAK and KAKGQ (CH2-CH3 region) for 
bands 8 and 9, and the cleavage site STKGP (VH-CH1 region) in the case of spot 7 (Table R8 panel 
A, B). 
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Table R7: Summary of the experimental results obtained from the mAb H10 degradation bands analyzed with the 
different strategies. (+)present; (-)absent. 
 
Band WB Hc fragment 
recognition 
WB Lc fragment 
recognition 
Sugar 
chain 
Binding 
site 
MW (kDa) 
1 + + + + 150-145 
2 + + + na 140 
3 + + - + 110 
4 + + + + 80 
5 + - + - 55 
6 + + - + 40 
7 - - + na 28 
8 - - - na 15 
9 - - - na 13 
n.a.: not analyzed. 
 
Table R8 A/B: Summary of the N-terminal sequencing analysis. For every band is reported the position of the N-
terminal sequence detected on HC and LC and the deducted molecular species corresponding to each band. na: bands 
not analyzed.  
 
A) 
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B) 
 
Red square: fragments containing internal cleavage sites. 
 
4.5.7 Analysis of potential cleavage sites on H10 susceptible to plant proteases 
 
A list of proteolytic enzymes encoded by the genomes of plants belonging to the Nicotiana genus 
has been obtained from the MEROPS database (Rawlings et al., 2010). The five potential cleavage 
sites identified in the HC of the H10 Ab purified from N. benthamiana  are shown in Table R9.  
 
Table R9: Potential cleavage sites identified in the H10 aminoacid sequence. ( | ) cleavage position (P) aminoacid 
position before the cleavage site; (P’) aminoacid position after the cleavage. In red are indicated the sequences 
recognized by N-terminal sequencing. In green are highlighted the residues specifically recognized by plant proteases. 
 
 
Analysis of these cleavage sites allowed the identification of several residues potentially responsible 
for the recognition and cleavage by Nicotiana peptidase. In particular, from MERPOS database 
analysis it was found that in the 1st cleavage site (region VH-CH1), Arginine in P2 was recognized 
with high specificity by cathepsin B (Peptidase family C1, Cystein protease) and frequently also by 
Phytocalpain (Peptidase family C2, Cystein protease), both of which are encoded by the N. 
Cleavage site 
 Positions of the cleavage 
P5  P4  P3 P2 P1|P1’P2’P3’P4’P5’ 
Position in the 
aminoacid sequence 
1st T    V    S   R  A | S   T   K   G   P 138-142 
2nd N    T    K   V  D| K   K  V   E   P 232-236 
3rd P     A    P   I   E | K   T   I    S   K 253-257 
4th P     I     E   K  T |  I   S   K  A   K 255-259 
5th E     K    T   I  S  |  K  A  K  G   Q 257-261 
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benthamiana genome, as well as other Nicotiana species. In the 2nd cleavage site, close to the hinge 
region, two residues are specifically recognized by plant proteases. In particular Valine in position 
P2, recognized by phytocalpain, and the Aspartic acid in position P1 recognized by a Legumain 
(Peptidase family C13, Cystein proteases). In the case of the 3rd and 5th cleavage sites (region CH2-
CH3) Phytocalpain with a specificity for bulky hydrophobic residues, might recognize Isoleucine in 
position P2.  
Interestingly, it was observed that identified cleavage sites occurred both within antibody non 
structured loop regions (VH-CH1), or within secondary structural elements such as beta-strands 
(CH1-CH2 and CH2-CH3). Cleavage sites are all located in antibody regions accessible to the solvent 
(Figure R35). 
 
 
 
 
 
Figure R35: H10 Heavy Chain aminoacid sequence. The cleavage sites identified are reported in red and the cleavage 
positions are indicated by black vertical bars. H10 Antibody structural domains (i.e. VH, CH1, CH2 and CH3 of the HC) 
and signal sequences are labelled and separated by black vertical bars. Details about secondary structure and solvent 
accessible surface area were obtained with antibodies of known 3D structure found in literature. Secondary structure 
elements (SSE) are indicated by 'E' (extended, i.e., beta-strand), 'H' (alpha-helix). Residues whose solvent accessible 
surface area (SASA) is ≤ 20 Å2 are indicated by 'B' (buried). 
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4.5.8 Site directed mutagenesis of identified H10 internal cleavage sites  
 
We engineered three H10 HC mutants (-H10VH-CH1, H10CH1-CH2, H10VH-CH1-CH2-) in which key 
aminoacid residues in the identified consensus sequences recognized by specific plant proteases 
were mutated. All genes were cloned into the pBI-Ω plant expression vector under the control of the 
CaMV 35S promoter, the TMV Ω translational enhancer and the NOS terminator sequences 
(Marusic et al., 2007). All plasmids were electroporated into A. tumefaciens strain LBA4404 and 
used in co-agroinfiltration experiments. A schematic representation of the constructs is reported in 
Figure R36. 
 
 
Figure R36: Schematic representation of constructs used for the expression of H10 mutants. Specific aminoacid 
mutations are indicated on every construct. A description of the constructs is presented in Material and methods section. 
All genes were cloned in the pBI-Ω plant expression vector under the control of the CaMV 35S promoter and 
containing the TMV Ω translational enhancer and the NOS terminator sequence. 
 
4.5.9 Analysis of mAb H10 mutants 
 
In order to protect H10 from plant proteolysis, three mutant mAb H10 constructs were generated: 
HCVH-CH1, HCCH1-CH2, HCVH-CH1-CH2. Key residues were mutated in two of the identified cleavage 
sites in order to avoid specific recognition by Cathepsin B, Phytocalpain and Legumain. All 
mutations were performed based on the homology with other IgG1 aminoacid sequences found in 
literature in order to preserve the same physic-chemical characteristics (i.e. pI, pH, hydrophobicity) 
of replaced residues without altering antibody structure and assembly. We decided to mutate only 
aminoacids of the cleavage sites of VH-CH1 and CH1-CH2 since these cleavages generated the most 
visible degradation bands in the 1-DE of purified H10. The HCVH-CH1 construct was obtained 
replacing the Arginine in position P2 with a Serine, since  this residue is usually found in most IgG1 
sequences and likely not recognized by Cathepsin B. In the case of HCCH1-CH2 both Valine in P2 and 
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Aspartic acid in P1 were modified. In particular, Valine was replaced by a Threonine since it 
maintained the same Valine’s hydrophobic interaction, while in the case of Aspartic acid it was 
replaced by a Serine since it preserved the orientation towards the solvent and did not seem to make 
specific interactions with other plant proteases. The H10VH1-CH1-CH2, instead, was obtained inserting 
both HCVH-CH1 and HCCH1-CH2 together on the same construct. 
The three constructs (HCVH-CH1, HCCH1-CH2, HCVH-CH1-CH2) were separately expressed in N. 
benthamiana plants by co-agroinfiltration with the LC. The crude extracts obtained from 
agroinfiltrated plants, were subsequently analyzed by reducing and non reducing SDS-PAGE 
Western blot assay with an anti-human-γ antiserum (Figure R37). The mutated constructs were 
compared to the mAb H10 in order to verify if the mutation could have produced any difference in 
the degradation profile. A preliminary Western Blot analysis showed that all H10 mutants were 
expressed at high levels and showed a degradation profile comparable to the original H10 molecule. 
This preliminary result represents only an early indication of the behaviour of the mutated 
antibodies in the plant cell. Further analysis to evaluate the effectiveness of these mutations needs to 
be performed in order to evaluate their potential to confer protection to the plant-derived 
immunoglobulin. 
 
 
Figure R37: Western blot analysis of the different plant extracts on reducing SDS 4-20 % (w/v) PAGE. The 
immunoblotting was performed with a peroxidase-conjugated anti-human γ chain in non reducing (right side) and 
reducing (left side) conditions. Plant extracts were normalised for TSP content and a total of 500 ng TSP were loaded 
on each well in the gel. 1: H10, 2: H10VH-CH1, 3: H10CH1-CH2, 4: H10VH-CH1-CH2. M: molecular marker (kDa). 
4. RESULTS AND DISCUSSION 
 
 
125 
4.6 DISCUSSION  
 
Many studies showed that degradation phenomena in a range of antibodies expressed in plants, 
represented a major issue to be addressed for the optimization of plant production (Table 11, 
Introduction) (Villani et al., 2009; de Neve et al., 1993; Ma et al., 1994; Stevens et al., 2000; Sharp 
and Doran 2001). Several strategies have been used in the past few years to overcome protein 
degradation by plant proteases, either by stabilizing the extraction medium with protease inhibitors 
or by targeting the antibody to sub-cellular compartments considered to have a lower proteolyitc 
activity (Nuttall et al., 2002; Faye et al., 2005). However, only few of the above mentioned 
approaches demonstrated to be efficient in preventing antibody proteolysis.  
In this study, we characterized the degradation profile of the tumour targeting H10 antibody 
purified from agroinfiltrated N. benthaminana plants, in the attempt to identify specific internal 
cleavage sites of the plant derived immunoglobulin. To this aim, we performed a detailed analysis 
of all degradation fragments and spots obtained from 1-DE and 2-DE separation of the protein A 
purified mAb H10. In the case of 1-DE analysis, we used three different affinity columns (Protein 
A, Protein G and anti-γFc column) in order to compare the purification efficiency of each 
methodology in terms of recovery of antibody fragments and quality of the purified 
immunoglobulin. Even if the protein profiles obtained with the three techniques were generally 
comparable, two major differences were evident in the case of protein A column in which the 
presence of two stronger protein bands at 50 and 25 kDa was clearly observable. This different 
pattern was related to the fact that H10 HC variable domain belongs to the subgroup III (VH3) of 
human IgGs which binds to the D domain of Protein A (Bouvet, 1994). Thus, protein A affinity 
chromatography specifically captured not only the Fc but also the Fab portion of H10. This double 
binding valency explained the specific enrichment of H10 Fab fragments in the protein A purified 
product. This evidence renders H10 an interesting model to study antibody proteolysis in plant. H10 
degradation profile was also reported in a previous work (Villani et al., 2009) in which the antibody 
purified from transgenic N. tabacum leaves revealed a high degradation (more than 90 % of the 
final product), leading to the accumulation of antigen-binding fragments (Fab) observable in the gel 
as a main degradation band around 50 kDa.  
In the second part of the work all H10 protein bands/spots obtained from both 1-DE and 2-DE 
analysis were isolated and studied in detail using different techniques (Western Blot, ELISA) and 
finally characterised by N-terminal sequencing. The main strategy used to assess degradation of 
antibodies has usually been Western Blot analysis, but this strategy presents some limitations. In 
fact, the detection could be affected by the affinity of the secondary antibody used for the analysis, 
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or by the fact that smaller fragments may not be recognized at all, leading to an underestimation of 
degradation phenomena. In other studies, degradation bands of plant purified immunoglobulins 
separated by SDS-PAGE were also analyzed using mass spectrometry (MS) (Ramessar et al., 2008; 
Villani et al., 2009) although, an accurate determination of internal cleavage sites could not be 
made. The only example of the specific identification of an antibody plant protease cleavage site 
was reported by De Muynck and colleagues (2009) that determined, by Edman degradation, the 
sequence of the N-terminal part of a heavy chain degradation product of a human/mouse chimeric 
antibody expressed in tobacco. In our methodology we used a combination of different detection 
strategies allowing to specifically identify the N-terminal part of antibody degradation fragments. 
Using this approach, we were able to identify  five specific internal cleavage sites, one in the 
interdomain region between VH and CH1, another in the CH1 close to the hinge region and three 
very close sites that were in the interdomain CH2-CH3 region. It must be noted that all cleavage sites 
occurred in inter-domain regions, within a solvent surface accessible area, indicating that these 
exposed antibody regions are more accessible by plant peptidases. Most interestingly, we identified 
three very close sites in the CH2-CH3 region, one is KTISK while the other two sites are generated 
by the sequential removal of two residues from the N-terminus. This could be interpreted as the 
result of the sequential trimming of the exposed N-terminus by specific plant peptidases. These 
identified aminoacid sequences were analyzed using the MEROPS database in order to identify 
possible specific plant proteolytic enzymes responsible of the recognition. This analysis allowed the 
identification of three Cystein proteases (Cathepsin B, Legumain and Phytocalpain) able to 
recognize specific residues in position P2 and/or P1 of the five identified aminoacid sequences. 
Interestingly, a recent work presented by Goulet and colleagues, identified intracellular Cysteine 
proteases and some Sereine proteases of N. benthamiana as responsible for the cleavage of a human 
IgG1, confirming the susceptibility of antibodies to Cystein protease family (Goulet et al., 2011). In 
our case, this indicates that proteolysis of the secretory H10 could take place in the cell along the 
cell secretory pathway. This could be confirmed by the observation that the H10-SEKDEL variant 
retained in the Endoplasmic Reticulum has a higher degradation compared to the secretory 
antibody. We also demonstrated that this variant is not fully retained in the ER but shows Golgi 
typical glycosylation patterns. This data was supported by many other research groups that 
extensively studied the degradation patterns of several antibodies in different plant expression 
systems. In these works, it was suggested that antibody degradation in plants could probably occur 
in the apoplast as well as during secretion, (Sharp and Doran 2001, De Muynck et al., 2010). In fact, 
it has been shown that ER retained antibodies harbouring a SEKDEL retention signal were 
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subjected to degradation as the native counterpart and, in some cases, degradation profile was more 
severe than the native IgG (Loos et al., 2011, Vezina et al., 2009).  
Accordingly, in order to protect the antibody from proteolysis, we mutated the aminoacids of the 
cleavage sites specifically recognized by these cysteine proteolytic enzymes. The effects of 
mutations on H10 stability were verified by Western Blot on crude extract. This preliminary 
analysis showed that the antibody, in spite of the mutations, exhibited a proteolytic pattern almost 
comparable to the one observed for the cognate antibody indicating that, possibly, the mutations 
inserted seemed to not influence the specific protease recognition. However, further investigation 
are needed to collect additional data, since proteolysis is a mechanism likely occurring on different 
close sites equally accessible to the solvent and operated by different proteases. Besides, it is 
important to point out that the information about proteases collected so far in the MEROPS 
database are still limited and could lead to ignore additional data about proteolysis.  
In conclusion, it is possible to assert that this work represents the first example of the specific 
characterisation of the degradation of a human IgG1 antibody in plants and provides new important 
data for the development of a successful strategy for the study of the proteolysis of plant-derived 
immunoglobulins. Additionally, in our study we found that the three proteases responsible of the 
cleavage of the mAb H10 were all belonging to the Cystein proteases family. Based on these 
results, and supported also by the findings  obtained by Goulet et al., (2011), next step will be to 
perform new experiments in which specific inhibitors of the Cystein proteases family of N. 
benthamiana will be co-expressed with H10, in order to induce a specific protection from the plant 
proteolytic attack and increase the final yield of intact antibody.  
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5. THESIS CONCLUSIONS 
 
Plant-based expression systems have emerged as a competitive platform for the production of 
recombinant biopharmaceuticals and, among the molecules effectively produced in plants, antibodies 
are undoubtedly those most successful and near to marketableness as herbal recombinant molecule. 
Compared to other expression platforms, plants present several advantages for the expression of 
recombinant molecules such as the ability to assemble complex multimeric proteins, the possibility 
to achieve post-translational modifications similar to those found in mammalian cells, low 
management costs and ease of scalability. Despite these advantages, some drawbacks need to be 
addressed. An important limit, in the plant system, is represented by downstream purification steps, 
in which many factors, such as low antibody concentration, extraction methodologies and 
purification strategy, could influence the effectiveness of the purification. In addition, the presence of 
several unwanted plant compounds, such as alkaloids, phenolics, polysaccharides, and proteases able 
to interact with the recombinant IgGs, could affect their final quality and yield, reducing in some 
way the efficacy of protein A chromatography step.  
Another important issue to be addressed in the use of plants for antibody expression, is represented 
by plant glycosylation. Differences between sugar moieties harbored by proteins expressed in plants 
and mammals, represents a major drawback in the application of plant-derived immunoglobulins in 
human therapy. In fact, the presence of typical plant sugars has been demonstrated capable of 
inducing immunogenic responses in humans, leading also to a remarkable reduction of 
pharmacokinetic properties and biological activity of plant derived proteins (Sethuraman & 
Stadheim, 2006).  
Besides, an additional drawback of recombinant antibodies obtained from plants is represented by 
the final recovery yield, that can be, in some cases, unsatisfactory. One of the factors playing a 
significant role in the reduction of the final yield and quality of heterologous immunoglobulins, is 
represented by the unintended proteolytic processes taking place in the plant cell. Particularly, in the 
case of antibody expression, degradation could produce a protein reduction of about 90 % of the final 
purified product as reported in many studies. 
In this work, we described the expression of the human recombinant tumour targeting mAb H10 in 
Nicotiana benthamiana using a transient expression system based on vacuum agroinfiltration, 
focusing our research efforts on expression and purification strategies, glycosylation profile and 
proteolysis.  
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As a first approach, we optimized the antibody plant production system by analyzing different 
extraction procedures (mechanical homogenization of fresh agroinfiltrated leaves and recovery of 
intercellular fluids -IFs-) in terms antibody expression levels, percentage of intact IgG, purification 
yields and presence of alkaloids and polyphenols in the final product. The results showed that 
mechanical grinding from fresh leaves allowed to achieve the highest purification yield (75 mg/Kg 
Fresh Weight -75 % intact tetrameric IgG-) while extraction from IFs guaranteed the lowest presence 
of polyphenols (21 µg/g FW) in the extract. Based on these results, we optimized a pilot-scale 
purification protocol for the extraction of mAb H10, obtaining an average yield of 40 mg per Kg 
fresh weight of intact IgG with 99.4% purity, with endotoxin levels <1 EU/ml, free of phenolic, 
alkaloid compounds.  
The second part of the work was focused on the analysis and modulation of the glycosylation pattern 
of plant produced H10 using different strategies: a) mutation of the H10 antibody glycosylation site 
of H10 heavy chain in order to obtain an aglycosylated antibody (H10 Mut); b) retention of H10 in 
the Endoplasmic Reticulum (ER) of plant cells by fusing the SEKDEL retention sequence to the C-
terminal of both HC and LC (H10 SEKDEL); c) expression of the H10 in Nicotiana benthamiana 
plants in which fucosyl transferase and xylosil transferase genes were downregulated (∆xyl, ∆fuc 
plants) preventing the addition of complex plant sugars to the glycan chain of the antibody 
(H10XylT/FucT). As a result, all antibody formats showed similar expression levels compared to H10, 
except for H10XylT/FucT that exhibited a lower expression yield because the over-expression was 
carried on without the boost of the P19 gene silencing suppressor protein in these downregulated 
mutants. Analysis of the plant-purified aglycosylated H10 Mut confirmed the lack of the sugar chain 
showing its higher susceptibility to the unintended proteolysis. In addition, retention of the H10 
SEKDEL in endoplasmic reticulum was proved, and also the lack of complex plant sugars in the case 
of the H10XylT/FucT glycoform was observed.  
In the last part of the work, the study was based on the analysis of proteolysis of the plant-derived 
mAb H10, in order to evaluate the degradation profile and to identify the cleavage sites of the 
immunoglobulin. We found three specific cleavage sites localized in the three inter-domain regions 
of the H10 heavy chain. Moreover, based on bioinformatics analysis performed using the MEROPS 
proteases database, three proteolytic enzymes were individuated, belonging to the cystein proteases 
family. In spite of that, no clear evidences of antibody protection were observed from a preliminary 
experiment, in which the aminoacids within the cleavage sites responsible of the proteases 
recognition were modified. Based on these preliminary results, a future perspective to avoid the 
cleavage of the H10 in plants could reside in the use of specific cysteine protease inhibitors to be co-
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expressed in plants together with the antibody,in order to induce a specific protection from plant 
resident proteases thus increasing the final yield of intact product.  
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